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Abstract  
This project investigated the cytotoxicity profiles and toxicological properties of 
inhalable iron-rich particles generated by mining activity. National Environment 
Protection Measure (NEPM) ambient air quality regulations specifically regulate sub-
10 µm (PM10) and sub-2.5 µm (PM2.5) diameter particle fractions corresponding to 
thoracic and respirable lung penetration, respectively. However, atmospheric 
concentrations of fugitive iron-rich particulates in iron ore mining and processing 
associated settlements raised concerns that NEPM limits may inadequately address 
the specific toxicological profile of iron-rich PM10 and potentially adsorbed organics in 
these regions. To address this, comparative cytotoxicity experiments were carried 
out in-vitro using a variety of particulate standards, featuring other frequently studied 
metal-oxides, to help bridge in-vivo and epidemiological knowledge in the literature 
with in-vitro toxicological results. This also required the development of a novel 
framework to interpret physical and physiological characteristics of coarse, poorly 
soluble metal-oxide particles by conducting a critical systematic literature review. 
Analysis by the ChemCentre, WA was taken into account with relation to potentially 
absorbed organics and the influence of Polycyclic Aromatic Hydrocarbons (PAHs) 
investigated.  
 
The protocols developed by this project are applicable to high-throughput 
assessment of particulate matter generated by mining activity, having defined 
methodology to rapidly acquire sufficient quantities of PM10 for assays which can be 
multiplexed and the effects of particulate interference on assays minimised. This 
includes the integration of non-destructive sterilisation techniques, physical 
characterising by particle-sizing, particle solubility analysis and observation of 
particle morphology by electron microscopy and elemental analysis. Epithelial 
(A549), fibroblast (LL24) and monocyte differentiated macrophage (U937) cell lines 
were tested to build a picture of particulate effects on the major lung cell types in the 
lung parenchyma; the alveolar epithelium, connective tissue and immune system. 
The effect of lung fluid surfactants on cytotoxicity was determined, and advanced 
tissue culture methods were trialled to improve the differentiation between particles 
provided by the endpoints. 
 
ii 
 
The ore samples from the Mining Area C (MAC), Yandi and Newman Hub mines in 
the Pilbara region were found to have an effect comparable to the cytotoxicity of 
micron-size iron oxide standards and selected standards of titanium dioxide, silicon 
dioxide and carbon black, whereas copper oxide was found to have some ten-fold 
greater cytotoxicity across the cell lines. However cytotoxicity as a principle 
differentiator of toxicity was found to be insufficient in differentiating the physiological 
response to iron-rich PM10 and insoluble metal-oxide standards. At high 
concentrations the dose-response relationship plateaued at a maximum value for 
iron-oxide standards and iron ore samples in the A549 and LL24 cell lines, while at 
low doses the U937 cell line showed increased proliferation as a result of increased 
differentiation. Under coculture conditions, U937 was found to increase the 
proliferation of A549 cells in response to the Yandi, Newman and silicon PM10 
particles, suggesting a key role for the inflammatory response in driving cellular 
hyperplasia. The cytotoxic effect of Benzo-a-Pyrene (B[a]P) was assessed to 
represent toxic components of Polycyclic Aromatic Hydrocarbon (PAH) compounds 
potentially adsorbed onto iron-ore dust particles as it is of known carcinogenicity, and 
was found to have additive toxicity. The order of toxicity by oxidative stress is 
determined to be: CuO 5 µm > SiO2 10 µm > TiO2 0.1 µm > Yandi 10 µm > Newman 
10 µm > MAC 10 µm > Fe3O4 5 µm, with the iron-rich PM10 samples producing some 
60% the response of silicon dioxide PM, an important occupational air quality 
pollutant with internationally recognised inhalation limits established by the World 
Health Organisation (WHO). It was found that iron in the iron-ore samples remained 
constrained to the solid phase by Inductively Coupled Plasma Mass Spectrometry 
(ICPMS), while silicon dioxide and copper oxide were partially soluble, potentially 
explaining their increased cytotoxic potential.  
 
Lung cell lines tested were found to have differential inflammatory cytokine 
responses to particulates, suggesting a complex immunological involvement 
between particles and the lung parenchyma drives health outcomes. This endpoint 
showed a range of differential effects between the samples and standards 
dependent on sample composition and cell type. Cocultures were used to determine 
interactions between fibroblast cells and immune cells upon exposure to particles, 
and were found to alter cytotoxicity and interleukin expression profiles. In all 
experiments, strong cytokine responses highlighted the inflammatory potential of the 
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copper oxide, carbon black, silicon dioxide, titanium dioxide, Yandi, and MAC 
samples, although the nature of which cytokines were acutely or chronically induced 
and inhibited likely has a complex duration-dependent signature. 
 
A 28-day single dose animal experiment was conducted on 8-week old C57BL/6J 
mice, via intratracheal dry powder insufflation. Increases in collagen deposition in the 
lungs were found, with the order of toxicity found to be Carbon Black 150 nm > SiO2 
10 µm > CuO 5 µm > Newman 10 µm > MAC 10 µm > Yandi 10 µm > Fe3O4 5 µm. 
Due to the short duration of the experiment, the observed differences were less than 
10% the control. The strongest two fibrosing particulates, carbon black and silicon 
dioxide, were also observed to have strong proliferative effects on monocyte 
differentiated macrophage and cocultures thereof combined with epithelial cells in-
vitro, as well as strong cytokine induction. 
 
In conclusion, comparative determinations of poorly-soluble particulate toxicity in-
vitro can inform the risk of fibrotic potential in-vivo. However, interpreting these risks 
requires careful consideration of both the physical characteristics as well as 
immunological function, including the cytotoxic, proliferative, inflammatory and redox 
potential of the particles. This implies inhalation of PM10 incurs a baseline toxicity 
related to inflammation and immune clearance, upon which shape, solubility and 
chemistry determine secondary toxic effects. Results from in-vitro studies can flag 
those particles which pose increased or differential risk at NEPM values. The iron-
rich PM10 samples tested are suspected pose systemic health risk at concentrations 
significantly exceeding NEPM values, albeit a general risk due to its insolubility 
which this study and the literature suggest is shared by other insoluble metal-oxide 
particulates of limited reactivity. The experiments in this study do not show 
consistently greater toxicological activity of the iron-ore PM10 above silicon dioxide 
PM10 of similar shape amongst the endpoints tested, however more broadly, some 
three-quarters of the toxicological activity was observed. 
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1. Introduction 
1.1 Fugitive Iron-Rich Dust in Western Australia 
Iron ore production and trade in Australia has more than doubled over the past 
decade making it the world’s largest iron ore exporter, fuelled by strong growth in 
Asian markets. China is the world’s largest iron ore consumer and Australia’s key 
import partner, with demand being driven by China’s accelerating urbanisation and 
the development of heavy industries. Australia produced 488 million tonnes (Mt) of 
iron ore in 2011, a quarter of world production, and this was largely mined and 
exported from Western Australia. The high grade haematite and haematite goethite 
ore in WA is sought after amongst steelmakers, and is exported with minimal 
processing as fines consisting of about 60% iron, netting the state over $60 billion 
annually. The WA treasury estimates that by 2015 the state will produce 659 Mt per 
annum, and forecasts sustained growth for decades to come 1,2.  
 
Approximately 48 billion tonnes of iron ore resources lie in the Hamersley Basin, in 
the Pilbara Region of north-western WA. The Pilbara is an arid interior expanse of 
over 500,000 square kilometres, known for its red earth and rich mineral reserves. 
Hamersley accounts for an impressive 74% of Australian iron resources, and is a site 
of many existing high capacity mines as well as projected expansions. The largest of 
these take the shape of surface or open-pit mines. The overburden (unwanted top 
layer crustal material) is removed and the ore extracted in a heavily mechanised and 
large scale process. After crushing, the ore is transported via rail to port cities some 
350 km to the west and loaded onto bulk carriers mainly destined for China, but also 
Japan, Korea and Taiwan 3. 
 
The intense growth and high volume mining of iron ore has created burgeoning 
townships associated with mining, shipping and support operations. The town of Port 
Hedland is one such town and one of the largest settlements in the Pilbara, home to 
more than 15,000 residents and competing with Port Dampier (over 1,300 residents) 
as the region’s largest port by tonnage. BHP Billiton currently has 199 Mt per annum 
of iron ore shipping capacity, and has approval to build an outer harbour raising 
capacity to 240 Mt per annum by 2017. The relatively large population of Port 
Hedland and high iron ore throughput has brought public and stakeholder attention 
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towards potential short term and long term health risks associated with the inhalation 
of elevated levels of fugitive iron-rich particulate matter (PM), which are highest in 
concentration near port facilities in West End.  Here, iron-oxides account for up to 
93% of total suspend particulates (TSP) by volume 4–6. 
 
Arid low rainfall conditions and high tropical winds exacerbate the dust problem, 
increasing the cost and reducing the effectiveness of dust control methods such as 
wetting. Port Hedland receives only about 12.3 inches of rainfall per year, with 
virtually none in the December-June period. Seaspray, inland soil erosion resulting 
from mine operations and natural crustal dust combine with industrial activity at Port 
Hedland to create some of the highest ambient particulate levels in Australia 7. 
Naturally high levels of PM and problems controlling particulate emissions near 
loading operations at the port facilities have put pressure on the Department of 
Environment and Conservation, WA to allow greater leeway for exceeding national 
guideline values for ambient PM 6. 
 
The current Australian National Environmental Protection Measures (NEPM) ambient 
air quality standard was put into effect in 1998 and specifically prescribes limits for < 
10 µm (PM10) and < 2.5 µm (PM2.5) diameter particle fractions (added in 2003). The 
PM10 fraction corresponds to particles small enough to invade thoracic small airways 
of the lung, and the PM2.5 fraction corresponds to particles small enough to be 
respirable, contacting the alveoli 8,9. Setting limits for ambient PM by size is common 
practice and supported by the World Health Organization (WHO), the US EPA and 
European regulators, as well as others around the world.   
 
Based on a consensus of epidemiological data, the WHO has determined 
progressively improving targets for limiting airborne PM mass for both PM10 and 
PM2.5 should be implemented globally. The staggered timeline for reducing ambient 
levels of these particulates reflects the difficulties developed and developing 
countries face implementing PM reduction measures. The EU, Australian and US 
Ambient Air Quality Guidelines (AAQG) are listed in Table 1, some of which are still 
under development. 
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Table 1: EU, US and Australian AAQG for PM10 and PM2.5 10,11 
International Limits on Thoracic and Respirable PM 
 PM10 PM2.5 
Government Daily Mean 
Target 
(µg/m3) 
Allowable 
Excesses 
(Days/Year) 
Yearly Mean 
Target 
(µg/m3) 
Daily Mean 
Target 
(µg/m3) 
Allowable 
Excesses 
(Days/Year) 
Yearly Mean 
Target 
(µg/m3) 
European 
Union 
50 35 40 - - 25 
United States 
of America 
150 1 - 35 1 15 
Australia 50 5 - 25 5 8 
 
Problems controlling PM10 emissions near loading operations at the port facilities 
have put pressure on the Department of Environment and Conservation, WA to raise 
daily mean exposure limits by up to 40% to 70 µg/m3 with greater leeway for 
exceeding that value 4. However, this has raised concerns that NEPM limits may 
inadequately address the specific toxicological profile of iron-rich PM10 specific to the 
geology of WA and other industrial pollutants possibly adsorbed by them, such as 
Volatile Organic Compounds (VOCs), Polycyclic Aromatic Hydrocarbons (PAHs) and 
combustion products like Benzene, Toluene, Ethylbenzene – collectively known as 
BTEX. 
 
 
1.2 Informing Air Quality Regulations through In Vitro Toxicology 
Several multi-city epidemiological studies, some including Australian cities 12, have 
established clear causal links between respirable particulate matter concentration 
and subsequent acute and long-term morbidity and mortality. These serve as the 
basis for the WHO ambient Air Quality Guideline (AQG) which underpins the current 
framework developed by leading regulatory bodies. The AQG is targeted at the 
minimum concentration at which health effects are observable to a 95% confidence 
interval, and is to be reached through a series of phased transitions known as 
Interim Targets 1-3 followed by the AQG itself. 
 
The guidelines primarily stratify particulate matter by size fractions. Although 
particles up to 100 µm in diameter are inhalable, most of this fraction is filtered or 
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cleared rapidly into the gut. TSP limits have not featured in the AQG since 1987, and 
PM10 and PM2.5 penetrating the deeper lung have been more clearly associated with 
morbidity and mortality than larger fractions. These particles are also more likely to 
be carried by winds over large distances. 
  
The ambient air quality NEPM makes few distinctions in addition to PM10 and PM2.5, 
be they aerosols or liquids, nor the respective composition of particulates bar a 
select few pollutants specified; ozone, sulphur dioxide, nitrogen dioxide, carbon 
monoxide and lead. The focus has instead been acceptable mean daily and annual 
concentrations, with chronic exposure recognized as more hazardous than acute 
exposure. This format works well for urban air pollution from which the 
epidemiological supporting data is based, although extending the NEPM to 
environments where the ambient PM profile is very different in composition is not a 
scientifically validated process. 
 
Given there may be no threshold of effect for PM10 and PM2.5 pollutants, specific 
investigation of particulate matter dominating the airspace of rural and outback 
communities with ambient PM profiles vastly different to ambient urban PM is logical. 
In the case of Port Hedland, understanding the risks posed by iron-rich PM10 clearly 
carries some urgency as the health effects of ambient iron rich PM10 under these 
conditions is not well understood in a chronic exposure civilian setting. Yet 
stakeholder interests are also mindful of unnecessarily strict regulation and 
unacceptable economic impacts, therefore limits must be as rational as possible. 
While the question remains as to the level of absolute protection the public can 
expect from regulatory measures, without firm data commercial interests and civilian 
interests may end up at odds with one another. 
 
1.3 Aims 
The premise of this project is that there is a lack of specific information on the toxicity 
of iron-rich PM10 from Port Hedland for accurate Australian air quality policy making, 
as iron-rich PM10 is a major component of all PM10 found in the Port Hedland area, 
and current regulations are based on meta-studies of urban PM10 toxicity where the 
iron-rich component may be insignificant. This is important as substantial 
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discrepancies in toxicity can arise from the unique chemical compositions and 
adsorbed species specific to Port Hedland iron-ore. The information gathered from 
in-vitro experiments may therefore warrant the consideration and development of air 
quality regulations for atmospheric iron-rich PM10 separate from existing regulations 
in settlements at risk of high iron-rich PM10 exposure. 
 
The project aim is therefore: 
 To develop the means to comparatively assess the toxicology of iron ore 
dusts affecting Port Hedland in-vitro more effectively than previously possible, 
so that the risks inhalation of iron ore PM10 may hold to human health are 
understood in respect to the effectiveness of current NEPM exposure 
guidelines.  
 
Because the work involves environmental samples, it is important to not only 
characterise toxicity but characterise physical properties to know what is being 
examined. To this end, the project operates in partnership with the Chemistry Centre 
of Western Australia to physically characterise the particulate matter. Furthermore, 
the University of Sydney has been involved to conduct a desktop literature review to 
properly define what is known, unknown and what is relevant in terms of Australian 
policy making on particulate matter and iron-rich dusts in general. 
 
1.2 Objectives 
The project objectives are designed to provide a series of deliverables building an 
understanding of iron-rich PM10 toxicity under in-vitro models of increasing 
complexity. The comparative component of testing against other metal oxides and 
materials creates many combinations of results that aid in understanding both the 
toxicological profiles of the materials and how methodological developments affect 
these outcomes. 
  
 To determine a sample test set including iron ore samples from mines 
delivering to Port Hedland and particle standards comparable to the literature 
and occupational exposure regulations 
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 To establish an effective high-throughput means of extracting and sterilising 
the PM10 component from crushed iron ore fines while minimising changes in 
aerodynamic-size representation and surface chemistry 
 To characterise extracted samples by size, morphology and elemental 
analysis 
 To determine a set of relevant human cell lines to use for use in-vitro 
representing target tissues in lung disease 
 To establish appropriate exposure intervals and dosing metrics to build 
comparative cytotoxic dose-response relationships between samples and 
standards in-vitro 
 To establish an oxidative stress profile for samples and standards 
 To establish the effect of additional adsorbed organic combustion products 
 To assess improvements to in-vitro testing by using lung fluid components 
 To assess improvements to in-vitro testing by using 3D culture techniques 
 To assess improvements to in-vitro testing by using cocultures 
 To assess inflammatory cytokine profiles expressed by monolayer and 
coculture techniques for samples and standards 
 To examine the cellular uptake of particles by lung cells and immune cells 
 To conduct and in-vivo study on fibrotic changes associated with samples and 
standards to assess the relationship between biochemical endpoints in-vitro 
and histological changes in-vivo  
 
This project entails several iterative stages of method development, and testing, as 
well as a variety of samples cell lines to be tested as appropriate, outlined in Figure 
1. Samples are chosen for their prevalence and importance in lung toxicology 
literature, while the cell lines are chosen to represent aspects of lung physiology or 
provide valuable information. A549 cells represent aspects of both Type I and Type II 
lung epithelial cells, while LL24 fibroblasts are active in the lung basement 
membrane. Together, they are used to model parts of the gas exchange 
parenchyma of the lungs. U937 monocytes can be differentiated to macrophages 
and are useful in modelling immune interactions which are important to the 
development of respirable particle mediated disease. AREc32 cells are not directly 
related to lung physiology but are used to model oxidative stress which is an 
7 
 
important aspect of how insoluble transition metals mediate their toxicity in-vivo. All 
cell lines are of human origin. Combinations of extraction methods, characterisation 
methods, cell culture methods, and samples and cell types will be explored to find 
the most meaningful data. Polycyclic Aromatic Hydrocarbons (PAH) will be 
investigated for their effect on toxicity if adsorbed onto iron-rich particles from 
combustion sources. Animal studies will be conducted to help determine the 
relationship between in-vivo and in-vitro data. 
 
 
Figure 1:  Infographic outlining the major method development steps planned, culture methods to investigate, and 
inventories of samples. Preliminary samples are deidentified iron ore samples supplied by BHP Billiton prior to 
characterised samples Mining Area C (MAC), Yandi mine (Yandi) and Newman Hub Mine (Newman) being supplied 
through ChemCentre (WA) in 2012. 
 
1.4 Thesis format 
This thesis is comprised of both thesis chapters and manuscripts to be submitted for 
review. Chapter 1 introduces the reader to the state of the iron-ore mining industry in 
Australia, and the iron-ore dust problems that have befallen the industry-associated 
town of Port Hedland in the shadow of its economic success. Chapter 2 is written as 
a systematic literature review manuscript discussing the current state of knowledge 
in the relevant literature and inherent strengths and weaknesses in in-vitro inhalable 
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particulate research. This chapter is purposefully extensive, to bring together aspects 
of human physiology, the methods available for in-vitro respirable particulate 
toxicology, as well as regulatory aspects of dealing with particulate pollution, in order 
to build solid foundations for interpreting project’s necessity and direction. Chapters 
3 through to 6 are composed of results manuscripts which describe significant 
methodology developments and the toxicology of the iron-ore samples 
representative of those affecting Port Hedland, including an in-vivo experiment. 
Chapters 7 and 8 bookend the thesis, discussing the meaning and the importance of 
the results circumspect of the thesis aims and objectives, as well providing directions 
for progress given the accomplishments within the framework of the project’s original 
conception. The complex underpinnings of this project benefit from this format, with a 
mix of technical stages and key iron-ore results having a tightly focused and clear 
perspective, though some repetition consequently occurs. 
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2. Review: Pathways for Comparative In-Vitro Inhalation 
Toxicology of Poorly Soluble Mineral Ore Particulate 
Emissions from Mining Industry 
 
2.1 Abstract 
The translation of in-vitro toxicological data to ambient air quality standards has met 
little success despite decades of research. In its place, epidemiological data has 
shaped such standards. However, the need for high-throughput toxicological 
monitoring of mine-site dusts has not abated, rather increased, due to increasing 
economies of scale applied to open-pit mines, generating enormous quantities of 
poorly-soluble inorganic particulate matter, rich in metal-oxides, with relatively 
unknown toxicological effects from a population health perspective. Successful 
integration of toxicological data engenders the search for the key drivers of 
particulate matter toxicity; a task fit for Bellerophon, the hero of Greek mythology 
whom defeated the Chimera. Particulate matter toxicity is found to depend on size, 
shape, composition, crystallinity and solubility. The cellular targets of such particles 
include cytotoxic, metabolic, inflammatory, oxidative, genotoxic and coagulative 
endpoints. We explore relevant information for each of these factors, and propose 
that a hierarchical comparative toxicity model may help to determine the differential 
effects of particulate matter under standardised experimental and dosage conditions. 
 
2.2 Introduction 
By the early 20th century, the toxicology of airborne particulate matter (PM) inhalation 
had branched into two broad categories; PM associated with pulmonary fibrosis 
induced morbidity and mortality, and nuisance PM with little evidence for health 
effects 13. Varieties of miner’s pneumoconiosis, including silicosis, coal worker’s 
pneumoconiosis (CWP) and asbestosis, were recognised as most hazardous and 
fibrosing for their distinguishable pathologies commonly affecting miners 13–16. The 
view that nuisance PM could be ignored as a cause of morbidity and mortality began 
to change with highly increased occupational exposures to mining dusts such as iron 
ore, associated with the introduction of the pneumatic drill when used in inadequately 
ventilated environments, allowing fibrosis to develop 17,18. More recently, chronic 
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exposure to low concentrations of ambient PM has been found to affect health 
outcomes without apparent threshold, suggesting multiple properties independent of 
composition determine toxicity, requiring the health impact of all significant emission 
sources to be evaluated 16,19. Open-pit mining operations are some of the largest 
industrial contributors to ambient PM concentrations, necessitating closer scrutiny 
from a toxicological standpoint 20. 
 
Mechanistic in-vivo and in-vitro studies of the late 1980s and early 1990s 
investigating pulmonary pathology resulting from PM inhalation focused on 
biopersistence as a fundamental aspect of particulate toxicology, finding enhanced 
inflammation and fibrosis 13,21. In the resulting models, the clearance rate of PM from 
the lung parenchyma by pulmonary alveolar macrophages (PAMs) was a central 
feature in the development of fibrotic pathology 22. Both PM toxicity and 
concentration were independently found to exacerbate PAM death, reducing 
clearance rate and therefore increasing PM retention in the interstitial spaces of the 
lung. Persistent pro-inflammatory and pro-fibrotic immunological signalling was 
theorised to then initiate the fibrosing aspects of lung tissue damage and remodelling 
13,23–32. Under this paradigm, experiments were designed to show how otherwise 
inert PM could exhaust the PAM pool increasing insoluble alveolar PM load and half-
life in acute exposures 30,33,34,  demonstrating the importance of volumetric load, in 
addition particle number alone. Toxicity mediated by particle shape was also 
investigated. High aspect ratio particles including asbestos and glass fibres were 
found to cause chronic inflammation and reactive oxygen species (ROS) production, 
resulting from lysosome dysfunction triggered failure of the phagocytic process, 
termed frustrated phagocytosis 30,35–39.  
 
From the 1990s to the present, dose-response relationships derived from 
epidemiological meta-studies have helped define environmental air quality standards 
around the world 40. Findings in major multi-city prospective cohort studies such as 
the Harvard Six Cities Study 41, American Cancer Society (ACS) Study 42 and many 
more recent studies 12,43–54 associate relatively small fluctuations in annual and daily 
mean PM concentrations to excess morbidity and mortality in the general population. 
These associations can often be attributed to fluctuations in PM fractions less than ≤ 
10 µm (PM10) in nominal diameter, which are able to enter the thoracic portion of the 
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respiratory tract without being completely filtered, and more strongly with fractions ≤ 
2.5 µm (PM2.5) in nominal diameter which can reach the respiratory parenchyma 55. 
There can be some variation in the impaction and diffusion of these size fractions 
throughout the lungs, arising from irregular particle shape, chemical composition, 
state and environmental characteristics 9,23,26,56, although the dominance of these 
factors is toxicologically relevant is unclear 57. These factors also influence debate 
over the relative importance of the PM10-PM2.5 fraction, with some studies showing 
negligible PM10 contribution 49,50 and others similar or greater PM10 contribution than 
PM2.5 51,53,58,59 to respiratory and cardiovascular morbidity and mortality. Studies from 
arid climates suggest that coarse dusts can cause acute respiratory distress and 
long term fibrotic outcomes 60,61, while urban studies tend to suggest chronic lung 
diseases are more strongly associated with PM2.5 62. Common classifications and 
depositions of PM are detailed in Table 2.  
 
Table 2: Common size classifications describing inhalable PM 
PM Fraction PM size range (μm) Fraction Equivalent 
TSP N/A Total Suspended Particulate 
PM100 ≤ 100 Inhalable 
PM10-2.5 2.5 – 10 Coarse 
PM10 ≤ 10 Thoracic 
PM2.5 ≤ 2.5 Respirable 
PM1.8 ≤ 1.8 Fine 
UFP ≤ 0.1 Ultrafine 
 
The World Health Organization (WHO) has determined Air Quality Guideline (AQG) 
and interim targets listed in Table 3 55, and with US Environmental Protection Agency 
(EPA) National Ambient Air Quality Standards (NAAQS) provide common 
benchmarks underlying many national Ambient Air Quality Standards (AAQS) 63. The 
2005 WHO AQG update reflects recent analyses predicting annual concentrations of 
PM2.5 above 11-15 µg/m3 lead to significant increases in all-cause public morbidity 
and mortality 11,55,64,65. Increased respiratory and cardiovascular hospitalization 
events can be expected, most strongly associated with heart disease in adults, 
asthma in children, and exacerbation of any pre-existing cardiovascular or 
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respiratory problems 15,58,62,66–76. Daily increases of PM10 over 150 µg/m3 can lead to 
declines in lung function of up to 7% 67. Newborn birth weight and mortality may also 
be affected 59,77–79.  Despite the described risks, global national AAQS average 95 
µg/m3 per 24 h and many do not feature PM2.5 63. This may be a result of practical 
difficulties in compliance with low values, and occasionally failure to update AAQS or 
accept cost-effectiveness as a public health measure 15,80–82. While compliance can 
be costly, in some implementations potential savings in healthcare costs may 
dramatically outweigh these costs 65. 
 
Table 3: WHO AQG 2005 and US EPA 2013 air quality for particulate matter: annual and 24 h mean concentrations. 
Adapted from WHO Air Quality Guidelines - Global Update 2005 (2006) 55,65:  
Standard PM10 
(µg/m3) 
PM2.5 
(µg/m3) 
Basis for selected annual PM2.5 
concentration limit 
WHO Interim 
target-1 
(IT-1) 
24 h 150 75 These levels are associated with about a 
15% higher long-term mortality risk 
relative to the AQG level. 
annual 70 35 
WHO Interim 
target-2 
(IT-1) 
24 h 100 50 In addition to other health benefits, these 
levels lower the risk of premature 
mortality by approximately 6% [2-11%] 
relative to the IT-1 level. 
annual 50 25 
WHO Interim 
target-3 
(IT-1) 
24 h 75 37.5 In addition to other health benefits, these 
levels reduce the mortality risk by 
approximately 6% [2-11%] relative to the 
IT-2 level. 
annual 30 15 
WHO Air quality 
guideline (AQG) 
24 h 50 25 These are the lowest levels at which 
total, cardiopulmonary and lung cancer 
mortality have been shown to increase 
with more than 95% confidence in 
response to long term exposure to PM2.5 
annual 20 10 
US EPA National 
Ambient Air 
Quality Standard 
(US) 
24 h 150 35 Provides protection against excess 
aggravated asthma, chronic bronchitis, 
non-fatal heart attacks, and premature 
death in children, elderly, and 
cardiopulmonary disease suffers, and 
those of lower socioeconomic status 
most at risk. 
Annual None 12 
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Efforts to construct source-apportionment models attributing risk to particulates by 
chemical components have met considerable challenges in the differentiation of co-
pollutant effects, especially in the PM2.5 size fraction dominated by combustion 
products in multiple co-existing phases 83–87. Toxicological input is widely seen as 
necessary to isolate the driving factors behind PM10 and PM2.5 toxicity and biological 
activity, underscored by lack of an apparent no-effect threshold epidemiologically, to 
provide convincing AAQS for public health risk management at reasonable cost 
15,19,63,88–90. Major institutions have made concerted effort in answering these 
questions by various in-vitro biochemical and in-vivo physiological endpoints 88,91. 
Still, the translation of causal mechanisms to clinical outcomes is often considered 
weak 57,92. Modern AAQS remain largely independent of in-vitro or in-vivo literature 
on PM component toxicology and as such, AAQS dependent on the predominating 
pollutant source at given geographic locations are unlikely to be defined 92,93, despite 
defined occupational exposure limits for mining dust pollutants such as coal and 
quartz 14,94–96.  
 
Given the wealth of existing publications on a wide range of PM, it is surprising an 
increasingly detailed mechanistic understanding has failed to interface with 
epidemiological data. Aspects of this problem arise from limitations inherent in data 
provided by each approach. The largest epidemiological studies are unable to 
disentangle pollutant toxicity drivers 19, and many criticisms are levelled at the 
associative conclusions drawn from them 97. Studies of low population regional 
centres greatest affected by primary industry emissions may fail to reach significance 
and suffer greater confounding 70. From the experimental perspective, the toxicity of 
PM10 and PM2.5 may lie in the effects on vulnerable subpopulations with as yet to be 
identified genetic factors 75, and the correlation between acute laboratory models and 
long-term chronic exposure outcomes is questionable 34,97. The complexity of 
unidentified mixtures present in the environment requires PM standards to be 
validated against captured PM, which can be time-consuming to collect with high-
volume air samplers and are nonetheless subject to aerodynamic sizing and spatial 
resolution limitations 57,90. As a result, the translation of ambient PM concentrations 
affecting toxicity endpoints to proportional morbidity and mortality in humans is 
challenging using both in-vivo studies and in-vitro studies, with modelling caveats 
attenuating the scope of even the most complex experimental methods. 
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Future investigations into the pulmonary toxicology of PM10 and PM2.5 generated by 
mining must follow lines of enquiry carefully drawn to produce ample and robust 
data, with a view towards compatibility with current AAQS. Comparative in-vitro 
toxicology offers a pathway to draw upon existing occupational exposure limits for 
PM against crystalline silica, asbestos, coal and materials with similarly quantified 
exposure risks if acceptable methodology and endpoints can be standardised. An 
advantage such investigations have over tracing toxicity drivers in urban centres is 
the relative homogeneity of physical characteristics in PM generated by open-pit 
mining operations, generally composed of poorly-soluble coarse and fine metal-oxide 
PM 98. This reduces the number of possible mixtures interactions with noxious 
gases, though the potential remains for surface adsorption of active organic and 
Volatile Organic Compounds (VOC) onto PM 99. Finding comparative endpoints 
which functionally describe common and fundamental pathophysiological 
interactions between PM and the lung parenchyma in-vitro that lead to fibrosis would 
enable development of biosensors to monitor PM for toxicity risks that warrant in-vivo 
studies. A mix of toxicological characterisation in parallel with current PM 
concentration monitoring hardware would benefit communities subject to high levels 
of mining dust pollution, forewarning of health risks chronic exposure may cause. 
The principle challenge is to reach a consensus on the importance of various 
molecular endpoints to disease outcomes, using a biologically relevant exposure 
system. This review details toxicity drivers most likely relevant to comparative in-vitro 
toxicology investigations of poorly-soluble PM generated by mining activity, and the 
methods and endpoints which best capture these drivers. 
 
2.3 Generation of Mining Dusts 
Impacts of dust generation from surface mining operations are felt at national and 
international scales, contributing a large proportion of PM to national airborne 
pollutant inventories and often overwhelming settlements associated with mining 
activity 20. The economic success of large-scale open-pit mining processes is 
tempered by the environmental costs, in terms of displaced crustal material, release 
of fugitive PM and production of tailings and other waste products 100. Blasting, 
crushing and processing of mineral ores produces particulate emissions at different 
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stages over the mining process, creating variances in PM composition and size 
distributions. The nature of the mined ore itself may also change over geographic 
variations by composition, texture and foliation, influencing particle shape and 
friability 98. Particles < 75 µm in diameter are considered to be ‘dusts’ and can 
remain suspended in the atmosphere long enough to spread over large distances 
depending on weather conditions, and large open-pit mines can generate dozens of 
Mt/year 101. Transportation of mined material to handling and shipping sites can also 
spread high concentration emissions to areas distal to the mine-site 82. Typically 
crustal dust comprises 10-25% of urban PM2.5 102, however in arid environments in 
close proximity to ore processing and shipping operations, ore dust contributions can 
rise to 80% or more in addition to increased overall concentrations of poorly soluble 
PM 103,104. This can create conditions where distal populations in addition to those 
adjacent to mining sites are chronically exposed to PM10 and PM2.5 concentrations 
higher than WHO AQG IT-1 values 82.  
 
Increasingly stringent measures are being introduced to control PM emissions in the 
USA, EU, Australia and other nations with high mining output 100. Compliance is 
often not straightforward and can itself have negative environmental impacts, being 
costly and often putting pressure on water resources for wetting or introducing toxic 
materials 94,101. For these reasons, PM limit values must be designed bearing in mind 
the ability to determine apportionment of PM to mines accurately and whether steps 
to control emissions will bear measureable improvements in public health. 
Toxicological arguments against enforcing limits similar to the WHO AQG centre on 
the differences between mining particulate emissions and combustion products 
typical of urban PM pollution that informs much of the AQG. Unlike urban PM the 
bulk composition of airborne mining dusts is largely poorly-soluble minerals such as 
metal oxides and silica 101, having a size-distribution shifted away from the ultrafine 
fraction, centred on the fine fraction 20,105 or coarse fraction depending on proximity 
to crushing activity 98. The morphological distribution of particles can also vary by 
ore, for example high aspect ratio fibres originating from friable ores in asbestos 
production 98,105. These fractions are generally most significant in terms of both 
particle number and mass, comprising approximately 1/3 of the TSP entrained in the 
atmosphere dispersed by mining sites 105. 
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2.4 Inhalation of Particulate Matter 
For individuals exposed to mining dusts, the quantity of dust entering the lungs 
depends on respiration rate, tidal volume and particle size. At resting respiration 
rates, 10,000-15,000 L of air is exchanged in the lungs every 24 h 106. Air entering 
the nasopharyngeal region is humidified and filtered, and particles larger than 4.6 µm 
are efficiently impacted and prevented from reaching the tracheobronchial region 107. 
The airway structure of the trachea then bifurcates, symmetrically branching 16 
times creating the bronchial tree of the lungs. The acinar airways branch from 
generation 17 to 24 terminating in the alveoli at generation 25 108, where gas 
exchange takes place over a surface area of approximately 150 m2  109,110. 
Sedimentation of particles between 4.6-2.2 µm occurs in the bronchi and first three 
generations of bronchioles, while diffusion dominates thereafter 107. Particles 
reaching the alveoli are generally smaller than 1.1 µm (see Figure 2) 107, although 
deposition may vary based on respiration characteristics which can be 
computationally modelled 108. Therefore PM10 generally corresponds to particle 
deposition in the upper respiratory tract, and PM2.5 the lower respiratory tract, with 
both fractions being subject to immune-mediated clearance to the mucociliary 
escalator and exiting to the gastrointestinal tract 106. However soluble or degradable 
PM may be absorbed, and insoluble PM can also be retained in the parenchyma 
taking from weeks to years to clear, depending on particle size, morphology, 
concentration and exposure duration 8,34,111. It is worth noting that clearance to the 
gastrointestinal tract does not guarantee complete systemic clearance of inhaled 
PM, and may increase leaching of metals from mining dusts 112,113. 
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Figure 2: Human respiratory tract and nominal particle deposition in an adult male at rest as a function of particle size, 
based on International Commission on Radiological Protection (ICRP) models 56. 
 
2.5 Pulmonary Pathologies of Mining Dust Inhalation 
A variety of respiratory tract problems arise from acute and chronic exposures to 
toxins. Severe acute lung injury is likely to manifest as pulmonary oedema, while 
milder insults can cause bronchitis or asthma. Chronic injuries manifest in a variety 
of ways, including chronic bronchitis, emphysema, granulotomas lung disease, 
pulmonary fibrosis, pulmonary oedema and cancers of the lung or mesothelium 114. 
Inhalation of excessive mineral and coal dusts often occurs through occupational 
exposure due to mining, drilling, construction and manufacturing activity 115,116. 
Mineral dusts generated by mining can also cause systemic toxicity through 
chemical speciation and free radical generation 117, provoke hyperplasia and cancer 
28,100,118 and elevate cardiovascular risks, likely through inducing systemic 
inflammation 73, as well as cause pneumoconiosis with potentially distinctive 
characteristics on X-ray 100. Clinical pathologies of excess mineral dust inhalation 
often take years to manifest, but usually present as a fibrotic pneumoconiosis of 
18 
 
variable granulation, nodulation and opacity with possible complications depending 
on exposure, as distinguishable on x-ray radiographs (see Table 4)  95,100,119. 
 
Table 4: Natural minerals associated with human disease 100 
Rock type/ore Human health implications 
Chrysotile, crocidolite, 
anthophyllite etc. 
Used as asbestos. Asbestosis, lung cancer; cancer of the 
gastrointestinal tract; pleural, mesothelioma 
Mica group minerals Pulmonary fibrosis; silicosis; strong association with free 
silica, likely a major factor in producing fibrosis 
Feldspar Silicosis; often attributed to the included crystalline silica 
Fullers earth—Bentonites Pneumoconiosis without massive fibrosis and nodules; 
mottled X-ray appearance; some related silicosis 
Granite, quartzite, 
sandstone, slate 
Silicosis; silico-tuberculosis; nodular silicosis; fibrosis; 
enlarged and hardened lymph glands 
Limestone, marble, 
dolomite 
Bronchitis, emphysema, some scarring reported; 
calcinations increases toxicity; caustic burns; dermatitis 
Silica, quartz, flint, 
crystobalite, tridymite 
Silicosis; silicotic nodules in spleen; silico-tuberculosis; 
progressive pulmonary fibrosis; cristobalite-tridymite are 
more fibrogenic 
Talc Talcosis; talc pneumoconiosis 
Bauxite ore; corundum Aluminosis; lung scarring; pneumoconiosis; emphysema 
Chromite Lung cancer; ore may be associated with crhysotile 
asbestos 
Iron ore (hematite, 
magnetite, taconite) 
Siderosis; reports of increased lung cancer among 
taconite ore 
Lead ore (galena, 
cerussite, anglesite) 
Pneumoconiosis; diseases of the central nervous system; 
nephritis; anaemia 
Uranium, thorium and 
vanadium ores 
Excess lung cancer 
Tin, titanium Severe X-ray changes in miners; tin pneumoconiosis; 
severe lung scarring; titaniosis 
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A range of occupational pneumoconiosis conditions are differentiated in name by the 
causative PM source (see Table 5). 
 
Table 5: Nomenclature of common pneumoconiosis by PM source 
Nomencalture of Pneumoconiosis 
Dust Species Pneumoconiosis 
 Carbon Anthracosis  
 Coal Coalworker's pneumoconiosis (black 
lung) 
 Asbestos Asbestosis  
 Silica Silicosis (grinder's disease)  
 Bauxite Bauxite fibrosis  
 Beryllium Berylliosis  
 Iron Siderosis  
 Cotton Byssinosis  
 
Airborne silica, asbestos and coal have been subject to extensive study given the  
ubiquity of these dusts and early recognition of their health impacts 95,120,121. Silicon 
constitutes 26% of the earth’s crust, making it the second most abundant element to 
oxygen. It is found in combination with or as a component of many mineral ores and 
may be partially responsible for shared outcomes resulting from inorganic mineral 
pneumoconiosis, confusing apportionment of toxicity 95,122. Acute silicosis can occur 
from inhalation of high concentration crystalline silica encountered in occupations 
such as surface drilling and tunnelling. It is characterised by pulmonary oedema, 
interstitial inflammation, accumulation of proteinaceous fluid and eosinophils in the 
alveoli, lung lesions and X-ray opacities 95,123. These effects result in dyspnoea and 
reduced lung function. Accelerated silicosis and chronic silicosis may include 
symptoms of acute silicosis combined with pulmonary remodelling including 
development of fibrotic granulomas. The alveolar sacs become hypertrophic, and 
hyperplasia of type II epithelial cells occurs causing emphysema. Histopathology of 
granulomas show nodules with concentric collagen ring development and central 
hyalinised zones. Calcification and necrosis may occur, with macrophage and 
lymphocyte build-up on the nodule periphery  95,121. For a working life of 45 years, 
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the mortality due to silicosis is estimated to be 1.3% up to age 65, at an occupational 
exposure level of 100 µg/m3 per 8 h day, as is currently the US Occupational Safety 
and Health Administration (OSHA) Permissible Exposure Limit (PEL) standard for 
quartz 96,124 . The cristobalite form of crystalline silica is thought to be even more 
fibrosing than quartz, although it is much less abundant, and PEL of 50 µg/m3 is set 
for it 124. 
 
Asbestos is also a silicon allotrope and has historically found extensive use in 
industrial, construction and insulation applications until regulatory measures led to 
restriction or banning of its use in developed nations by the 1980s 125. Six types of 
fibrous silicate minerals are defined as asbestos, falling into two classifications; 
serpentine and amphibole. Only chrysotile, a serpentine asbestos, remains 
commercially relevant and is considered less toxic than amphibole asbestos. 
Chrysotile fibres in excess of 20 µm in length can be attacked and cleared by the 
immune system under non-lung overload conditions 126. Chrysotile fibres have a half-
life of approximately 1 day 127 and a potency at least 100 fold less than amphibole 
fibres 120. In contrast, long amphibole fibres are not susceptible to macrophage 
digestion, persisting in the lungs and penetrating the pleural cavity within 7 days. 
While the exact mechanism of toxicity is debated, inhalation of amphibole asbestos 
and very high concentrations of serpentine asbestos is associated with diffuse 
interstitial pulmonary fibrosis, the formation of asbestos bodies, pleural inflammation, 
lung cancer and mesotheliomas 126–129. Symptoms may take up to 40 years to 
develop after the initial exposure, although in up to a fifth of patients abnormalities 
such as diffuse interstitial pulmonary fibrosis may not appear on X-ray 129,130. 
Exposure to amphibole asbestos carries a 5% risk of lung cancer per excess 
fibre/cm3, while chrysotile asbestos carries a 0.5% risk 131. The long lead time, 
variety of asbestos fibre types and different lengths makes it difficult to determine if a 
safe threshold exists for exposure. The US OSHA has determined a PEL of 0.1 
fibres/cm3 over an 8 h/day for fibres that are 5 µm in length and have a 3:1 aspect 
ratio 130. 
 
Metal ores are the target prospect of many large-scale mining operations. As with 
other kinds of pneumoconiosis, metal ore dust is associated with inflammation, 
fibrosis, granulomas and reduced lung function. However, specific metal ores differ 
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in systemic effects such as carcinogenesis, neurotoxicity and other acute toxicities 
unique to the chemistry  of the ore 132–134 (see Table 4, Table 6). For example, 
chronic occupational exposure to manganese over 70 µg/m3 is associated with the 
development of neurotoxic symptoms 135. The variation in ore composition, 
crystallinity and metal speciation arguably require specific determination of risk and 
exposure limit on a mine-site by mine-site basis 20,100,136,137. This is underlined by 
differences in fibrotic potential when workers are occupationally exposed to 
manufactured iron oxides, such as limited findings of fibrosis in welder’s siderosis, 
compared to fibrotic outcomes in haematite miners 17,122,138. Insight into whether 
compositionally driven differences in metal ore toxicity disproportionately alter toxicity 
mediated by physical characteristics alone requires is a key challenge for in-vitro PM 
toxicology. 
 
Table 6: Histopathology of metal-induced disease 132 
Agent Characteristic 
Histopathology 
Other Reported 
Histopathology 
Aluminium Interstitial fibrosis Sarcoidlike granulomas; 
alveolar proteinosis 
Beryllium Sarcoidlike granulomas; 
diffuse interstitial fibrosis 
Tracheitis; bronchitis; 
acute pneumonitis 
Cadmium Acute pneumonitis; 
interstitial fibrosis; 
emphysema 
 
Cobalt Giant cell interstitial 
pneumonia; desquamative 
interstitial pneumonitis; 
fibrosis 
Sarcoidlike granulomas 
Copper Foreign body granulomas; 
fibrosis 
 
Iron Dust macule; 
peribronchiolar collections 
of dust with dust-laden 
macrophages 
Fibrosis 
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Mercury Tracheobronchitis; 
bronchiolitis; pneumonitis; 
pulmonary oedema; 
desquamative interstitial 
pneumonitis (late) 
Proteinuria; acute tubular 
necrosis; neurotoxicity 
Nickel Asthma; epithelial 
dysplasia; chemical 
pneumonitis 
Nasal septal perforation; 
chronic rhinitis; hyper- 
plastic sinusitis; anosmia 
 
2.6 In-Vitro Models of Pulmonary PM Exposure 
2.6.1 Respiratory Structures and PM Interactions 
2.6.1.1 Alveolar Structures  
Knowledge of the cell types and structure of the respiratory surfaces is essential in 
choosing appropriate cell lines for in-vitro models of inhaled PM10 and PM2.5 toxicity 
40. The alveolar surfaces are the thinnest external barrier of the lung parenchyma, 
only one cell layer thick. Type I alveolar epithelial cells are 5 µm thick allowing gas 
exchange, while Type II cells are 15 µm thick and secretory. Type I cells are unable 
to replicate and must be replaced by the differentiation of Type II cells, although this 
process is slow 139. The supporting fibroblast and capillary-rich connective tissue is 
separated from the epithelial layer by the interstitial space 106. Granulocytes, 
monocytes and macrophages can migrate between these tissues 140 (see Figure 3). 
Pulmonary surface tension is reduced by a layer of bronchioalveolar fluid on the 
surfaces of the conducting airways and pulmonary acinus, allowing inflation. This 
‘surfactant’ fluid is composed of large proteins and phospholipids 141. 
 
 
Figure 3: This figure shows the structure of the epithelial layer in the Airways (A) and Alveoli (B). Key: AEPT I: Alveolar 
epithelium type I; AEPT II: Alveolar epithelium type II; ALL: Aqueous lining layer; AM: Alveolar macrophage; BM: Basal 
membrane; C: Capillary; CT: Connective tissue; DC: Dendritic cell; EP: Epithelial cell; P: Particle; S: Surfactant; TJ: Tight 
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junction. Adapted from In vitro models of the human epithelial airway barrier to study the toxic potential of particulate 
matter 40. 
 
2.6.1.2 Bronchioalveolar Fluid Interactions with PM 
Typically studied toxicants are soluble, forming solutions where the compound 
dissolves to a molecular level, as is the case with most pharmacological drugs. 
Poorly-soluble PM however persists as a solid internal phase within a liquid 
continuous phase, and is therefore a suspension. Suspensions differ from colloids in 
that they contain larger particles which undergo sedimentation and potentially 
agglomerate. The effect of bronchioalveolar fluid on particle agglomeration, 
dispersion and solubility is therefore an important area of study, potentially affecting 
effective PM size-distribution and toxicity at the acinar surfaces. 
 
Bronchioalveolar fluid can either be obtained by lavage (BALF) from animals or 
recreated synthetically. Simple synthetic bronchioalveolar fluid can be constituted 
with a combination of biologically active molecules, featuring albumin and 
dipalmitoylphosphatidylcholine (DPPC), the most abundant phospholipid, at a 
physiological alkalinity of pH 7.6 142. More complex synthetic recipes include a 
diverse range of enzymes, antioxidant complexes and other minor surfactant 
phospholipids found in bronchioalveolar fluids 143 (see Table 7), and non-biological 
fluids depending on design philosophy 144. 
 
Table 7: An example of synthetic bronchioalveolar fluid for addition to media (Hank’s balanced salt solution) 143. 
Component Concentration 
Serum albumin 7.4 mg/mL 
 Dipalmitoylphosphatidylcholine (DPPC) 10 mg/mL 
Lysozyme 2.5 mg/mL 
Apotransferrin 0.2 mg/mL 
Ascorbic Acid 50 µg/mL 
Glutathione 50 µg/mL 
Uric Acid 25 µg/mL 
Alpha-tocopherol 1 µg/mL 
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A tenfold increase in serum albumin from 1.5 mg/mL to 15 mg/mL has been shown 
to reduce the average diameter of TiO2 nanoparticles approximately 25% at a stock 
concentration of 2 mg/mL 145. Improved dispersion characteristics are also reported 
for ultrafine carbon particles with Bovine Serum Albumin (BSA) 146,147 (see Figure 4) 
however ultrasonication of the sample is required – a process without biological 
analogue.  While high concentrations of BSA appear to increase particulate 
dispersion characteristics 148, its use is cautioned and qualitative data must be 
evaluated carefully. Concentrations of albumin exceeding in-vivo physiological 
concentrations may cause proteinaceous interference with observed toxicity 149 as 
well as reduce particle uptake 150. Albumin also exhibits antioxidant properties which 
have the potential to diminish redox endpoints 151, although the oxidative interactions 
of transition metals has been reported as similar under either BALF or synthetic 
bronchioalveolar fluid 143. DMSO finds occasional use as a non-biological dispersant 
but has inferior performance and interference with oxidative processes is again an 
issue 147.  
 
 
Figure 4: Ultrafine Carbon Black particles are shown in A: standard Phosphate Buffered Saline; B: Mouse 
bronchioalveolar lavage fluid; C: a sonicated combination of Phosphate Buffered Saline, DPPC and Bovine Serum 
Albumin 146. 
 
The relevance of forcing the disaggregation of fines and nanoparticles is questioned, 
as it is not well substantiated that particles are significantly disaggregated in-vivo 152. 
Theoretical studies indicate that the surfactant properties of DPPC are 2-3 orders of 
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magnitude weaker than the aggregating forces between fine TiO2 particles 153, 
although newer DPPC preparation methods may improve interactions 146,154. DPPC 
may also have effects beyond disaggregation, reducing particle phagocytosis 155. 
Other proteins and phospholipids found in bronchioalveolar fluid such as collectins 
SP-A and SP-D may have important effects to consider when binding to metal 
oxides, such as particle opsonisation, regulation of histamine release by mast cells 
and other immunomodulatory effects 142,156,157. 
 
2.6.2 Lung-Air Interface Systems 
Given the unique air-liquid interface (ALI) of the lungs, replicating toxicological 
exposures using an artificial ALI may more closely resemble in-vivo conditions and 
obviate dosing with particle-media suspensions. The increased oxygenation of cells 
may alter metabolism, the tolerance to oxidative stress, and promote cellular 
differentiation 158. Ideally, ALI exposure systems must be able to deliver aerosol 
doses accurately over time, while keeping cell lines alive. Achieving this in practice 
presents a number of challenges, including determination of actual dose in contact 
with cells, resultant particle-size distribution, addressing perfusion and viability of 
cells, and acquisition of sufficient sample due to deposition efficiencies as low as 2% 
159.  
 
Complex commercial systems exist to perfuse cultures and dose cultures over a thin 
ALI, although no single system dominates 160. These include the Cultex® and  
Minucell® systems 40,159. Depending on requirements, the submersion of cells into 
the media and airflow parameters can be adjusted (see Figure 5). 
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Figure 5: Top: A picture of the Cultex® system exposure hardware. Bottom: A diagram of cell culture methods enabled 
by the Cultex® system. Submersed mode replicates classic culture and enables a coculture to be set up, while lifted and 
dynamic exposure modes allow cell/air interface modelling 161. 
 
The ALI can be modelled more simply using porous membranes inserted into 
multiwell culture plates, allowing cells to grow on an elevated surface much closer to 
the air while still allowing sufficient media for cell growth underneath. While this does 
not model airflow and deposition characteristics, Transwell™ culture inserts may be 
adapted for this purpose and are relatively inexpensive in low-throughput 
applications 162. 
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2.6.3 2D Culture Systems 
Conventional 2D tissue culture assays lend themselves well to multiwell microtitre 
tissue culture plates, for which high throughput dose-response assay protocols are 
well established. In the field of particle toxicology, unique challenges posed by 
poorly-soluble PM10 and PM2.5 require critical analysis and redesign of protocols to 
account for differences in dosing metrics and assay interference from adsorptive and 
optical characteristics 163–166. Successful navigation of these issues will allow 
detailed comparative toxicology of cellular endpoints which fit in with current 
toxicological endpoints. 
 
In choosing cell lines, primary cell lines generally allow responses closer to in-vivo 
exposures to be modelled. Immortal cell lines present advantages over primary cell 
lines in terms of standardisation, and therefore inter-study comparison and cost. 
Culture of human cell lines can be used alongside animal cell lines to differentiate 
responses to PM in humans that may not be evident in animal studies, or to model 
cytokine interactions that may not be completely homologous in animals. To model 
the respiratory surfaces, the A549 epithelial adenocarcinoma cell line is a common 
choice, having characteristics of both Type I and Type II cells and is very resilient 167. 
The CaLu3 cell line is also used to model the epithelial barrier, while BEAS-2B and 
16HBE14o- are popular choices to model the bronchial epithelium 40. Fibroblast cell 
lines are frequently used to represent connective tissue responses, such as LL24 
and IMR-90 168–170. However, connective tissue responses are reactive in nature to 
PM exposure and epithelial cell death in the lungs, making their endpoint selection 
and interpretation more complicated even if cytotoxic effects appear similar in-vitro 
171. 
  
A limited range of macrophage responses including phagocytosis and cytotoxicity 
can also be modelled using 2D cultures. The mouse macrophage RAW 264.7 cell 
line is frequently used because of its ease of culture and immortality. Human 
equivalents such as U937 and THP-1 are cultured as monocytes and then 
differentiated into monocyte-derived macrophages 172. This creates some difficulties 
when using immunological endpoints if the differentiating stimulant, e.g. Phorbol 
Myristate Acetate (PMA), is not washed completely from the culture before assay as 
28 
 
it can continue to stimulate cytokine production. Washing steps are also required to 
minimise particle interference before optical assays, although this can be difficult to 
achieve without altering cell survival if particles have bound to the cell surface 165,166. 
 
2.6.4 3D Culture Systems and Explants 
Animal studies by intratracheal instillation of particles often result in toxicity data 
which is difficult to relate to 2D cell culture models, or may even conflict 173. If the 
discrepancies are not due to improperly adapted assay protocols, the poor 
differentiation of cells in 2D culture may offer an explanation. To remedy this, the use 
of 3D tissue culture systems has been demonstrated to increase cellular 
differentiation 174. 
 
Several systems exist to promote the growth of 3D structures from cellular 
monocultures. The simplest of these is modification of the tissue-culture growth 
surface to prevent adherence of cells, which can be achieved through coating with 
agarose gel, or by using commercially pre-treated surfaces 174. This allows cells to 
self-associate and form 3D spheroids which may differentiate, although the process 
is difficult to control and standardise 175. A similar method utilises the surface tension 
of a small amount of media to form a ‘hanging drop’ when the tissue culture surface 
is inverted. Cell lines within this hanging drop gravitate to the bottom of the drop and 
without a surface to interact with form spheroids 176. The small volume of the drop 
requires humidity to be controlled to prevent evaporation affecting exposure 
concentration during incubation 177. Rotating-wall bioreactors utilize a vessel which is 
constantly in motion, preventing settling of cells so that they adhere to micro-carrier 
beads. On these beads collagen I coatings promote cells within the medium to attach 
and grow into 3D structures 178,179.  
 
Collagen and Extracellular Matrix (ECM) components have been shown to greatly 
enhance cellular differentiation, particularly when structured into a 3D scaffold or 
hydrogel. Scaffold matrices create porous surfaces for cells to adhere to which can 
then degrade away, although this is not necessary, and common active components 
in commercial variants include synthetic peptides, hyaluronic acid, collagen, fibrin 
and reconstituted ECM  180. New tissue culture technologies such as the UpCell® 
29 
 
system allow 3D tissue cultures to be composited from monolayer sheets released 
from culture intact without trypsinisation or other enzymatic means 181. Differential 
effects of 3D scaffolds on tissue culture endpoints such as inflammatory signalling 
present relatively unexplored vistas in particle toxicology 174,180. 
 
Organotypic cultures bridge the gap between in-vivo and in-vitro experiments, 
similarly to explants. Immortalised primary cells are grown on fibroblast-seeded 
collagen I gel which is perfused by media at its base, and can be incubated for up to 
a month, allowing differentiation and exposure to the cell/air interface 182. Figure 6 
depicts this system and differentiated Human Bronchial Epithelial Cells (HBECs). 
 
 
Figure 6: A) Normal human bronchial histology. B) Type I collagen seeded with fibroblasts, contracting as it cools. C) 
Immortalized HBECs attached collagen gel surface. Right: Scanning electron microscope image showing differentiation of 
HBECs on collagen gel into goblet, ciliated and normal cells 182. 
 
A general drawback of 3D tissue cultures in particle toxicology is the inhibition of 
drug penetration, as cells may be protected from complete perfusion within the 3D 
superstructure, especially in spheroidal cultures which resemble tumours 175.  As fine 
particles cannot diffuse through cells, membrane-contact mediated toxicity will be 
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completely inhibited. The greatest challenge of 3D tissue cultures is therefore to 
balance increased complexity with accuracy and sensitivity, in light of reduced cell 
membrane-particle contact. 
 
2.6.5 Co-Culture Systems 
While allowing greater differentiation of cell lines, 3D culture systems may not offer a 
complete picture of complex interactions between unrelated cell-types occurring in-
vivo. This is especially true of the alveolar surfaces of the lung, where chemotactic 
and chemokinetic factors are communicated between the underlying vasculature, 
connective tissue, epithelial cells and immune cells. These communications are 
critical in orchestrating responses to lung injury, and macrophages play a central role 
183–185 (see Figure 7). By establishing cocultures of cell lines representative of these 
components, important aspects of this interplay can be recreated 186. Evidence 
suggests that cocultures of lung epithelial cells and macrophages display differential 
cytokine expression and cytotoxic sensitivity to monocultures of either, in response 
to fine silica and metal oxide particles, and these responses do not necessarily 
proportionally correlate with particle concentration 173,187. Cocultures have also been 
successfully combined with other advanced tissue culture techniques, including ALI 
by Transwell™ insert 186. 
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Figure 7: Interaction between alveolar type II cells and macrophages during inflammation in response to particles 186 
 
2.7 Major In-Vitro Endpoints for Determining and Comparing PM Toxicity 
2.7.1 Particle Characteristics and Toxicity 
2.7.1.1 Particle Size 
Particle airborne half-life and dispersion is governed by particle size, as are 
inhalation characteristics described previously. While higher than TSP, the exact 
toxicity differences between the PM10 and PM2.5 fractions are debatable, and factors 
other than size may take precedence in this range. From a study in Mexico City, TSP 
levels were found to increase the risk of mortality by 5.8% for every extra 100 µg/m3 
in the atmosphere. However PM10 and PM2.5 fractions were found be significantly 
more toxic, increasing mortality by 1.83 and 1.48% per 10 µg/m3, respectively 188. 
This is also reflected in an in-vivo study using PM from six different European cities, 
where the coarse fraction was found to be consistently more inflammatory than the 
fine fraction, although fines caused greater neutrophil accumulation 189. 
 
From an in-vitro toxicology standpoint, decreasing particle size causes the specific 
surface-area to mass ratio to increase, and allows cellular uptake of particles to 
occur more readily. Modern literature explores this relationship frequently 163, finding 
increasing free ion release, cytotoxicity, genotoxicity and redox potential with 
decreasing size within the ultrafine range in metal and metal oxides 173,190–192. In 
contrast, inhalation of PM10 and PM2.5 mining dust is relatively free of particles in the 
ultrafine fraction 20, and therefore the size-dependent toxicity between PM10 and 
PM2.5 is framed by particle composition, lung deposition characteristics and particle 
clearance rates, more so than surface-area dependent reactivity and intracellular 
bioactivity 19. In urban environments, different anthropogenic sources tend to 
produce particles of different sizes, affecting the composition of particles by size 193. 
Table 8 describes the properties of typical urban PM and rate of clearance from the 
human lung. 
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Table 8: Characteristics of anthropogenic PM. Adapted from The Impact of Fine Particles on Health 193 
Characteristics of anthropogenic PM 
Particle Size Solubility Exposure Mechanism 
Coarse thoracic 
particles 
(2.5-10 µm) 
Large numbers of insoluble 
minerals and organic 
material 
Enter the ciliated larger bronchi. 
Cleared within hours or days 
Fine particles 
(< 2.5 µm) 
Majority are highly water-
soluble inorganic salts, 
smaller amount of lipid-
soluble organic compounds 
(PAHs, etc) and insoluble 
soot, organic material and 
minerals 
Enter the small non-cilliated 
bronchi and alveolar sacs. Solid 
particles are cleared over a 
matter of months and 
sometimes years, by 
specialized white blood cells or 
macrophages 
Ultrafine Particles  
(< 0.1 µm) 
Solubility varies, depending 
on nearby emission sources 
and the chemical 
composition of emissions 
(soot, hydrocarbons, 
sulphuric acid) 
Enter the alveolar sacs and the 
bloodstream to some extent. 
Large number but small mass. 
Macrophages do not recognize 
individual ultrafine particles; 
they are either cleared as part 
of the mucous in the 
mucociliary escalator or taken 
into the respiratory epithelial 
cell cytoplasm resulting in very 
slow clearance. 
 
 
A 15 week in-vivo study using radioactively labelled TiO2 as a biopersistent particle 
resistant to physical and chemical breakdown shows that fine (< 2.5 µm) and 
ultrafine (< 20 nm) particles are cleared from rat alveolar surfaces at similar rates. 
However, clearance from the interstitial and lymphatic compartments took much 
longer for ultrafine TiO2, as migration to these spaces was higher and macrophage 
clearance was greatly impaired 194. Macrophage phagocytic activity has been shown 
to be less sensitive to ultrafine particles, while neutrophil recruitment appears to be 
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proportional to the specific surface area of TiO2 dosed when comparing < 2.5 µm 
and < 20 nm particle sizes, and therefore ultrafine particles cause greater 
inflammatory outcomes than macrophage load alone would suggest 137,195. Increased 
access to the vasculature by smaller particles may also affect cardiac diseases, as 
urban epidemiological studies have found ambient fine particle concentrations to be 
associated with early atherosclerosis 196. 
 
In a study of fine and ultrafine metal oxide particles, particle composition determined 
whether a difference was seen between toxicological endpoints. Iron oxides (Fe2O3 
and Fe3O4) were found to differ little by size, having low toxicity. Fine TiO2 was found 
to be more toxic than ultrafine TiO2 causing DNA damage, potentially due to 
differences in crystallinity. Ultrafine CuO was found to be significantly more toxic 
than fine CuO, although both showed markedly cytotoxicity and mitochondrial 
damage than the other samples 197.  
 
2.7.1.2 Particle Shape 
Particle shape has been postulated as central to the toxicity of asbestos, and other 
particles of high aspect ratio which are biopersistent. While rock crushing techniques 
in the mining industry produce highly size-heterogeneous particles, they do not 
generate high aspect ratio particles. It is rather highly foliated rock textures, 
indicating the possible presence of asbestos or other minerals, which break into 
fibrous fine particles upon processing 98.  
 
The size of particles phagocytosed by PAM is limited by cell surface area to ~ 12 
µm, and cannot continue past this point even when there is no shortage of 
phagocytic receptors. If this process fails, PAM may recruit additional monocytes and 
macrophages. Excess monocytes and macrophages allow multinucleated giant cells 
involved in granuloma formation to fuse. Frustrated phagocytosis occurs when 
macrophages enter a continuous state of particle-association which does not resolve 
against fibres longer than ~ 20 µm 30. Sequestration of the particle into the lysosome 
stalls, and the lysosomal protease cathepsin B is released.  This triggers the 
formation of the NALP3 inflammasome which is involved in IL-1β and IL-18 cytokine 
signalling 37,198. TNFα expression is also shown to increase with longer fibres 35.  
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Increased inflammation is consistently observed with long fibres of multiple 
compositions, including asbestos, glass, rigid multi-wall carbon nanotubes (MWCNT) 
and nanoparticles such as TiO2 engineered into fibres over 15 µm in length 37. 
Increased inflammation of this kind in the pulmonary spaces leads to neutrophil and 
lymphocyte recruitment, and also encourages pleural effusions to develop 36,199. 
Pleural inflammation may be linked with the genesis of mesotheliomas. Mechanisms 
to explain this link include epigenetic silencing of tumour suppressor genes and 
TNFα mediated cellular transformation, implying all fibrous particulates stimulating 
TNFα production pose the risk of mesothelioma 200,201. Furthermore, TNFα receptor 
knock-out mice are protected from pulmonary asbestosis; a form of diffuse interstitial 
fibrosis associated with asbestos and formation of ferruginous bodies 130. 
 
While conventional tissue culture techniques lend themselves to studying 
inflammatory endpoints of high aspect ratio particle phagocytosis, successful 
modelling of granulomatous formation using only cell monolayers is doubtful. A study 
of MWCNT and crocidolite asbestos fibres has successfully created 3D spheroids 
demonstrating epithelioid granuloma formation by using bone marrow derived 
macrophages cultured in agarose coated wells. Granuloma formation was 
determined to correlate better with MWCNT length and complexity than surface-area 
and iron content. The development of multinucleated giant cells was also observed  
202. Experiments with MWCNT in-vivo show increased connective tissue thickness in 
the alveolar septa of up to 75% in 56 days, in single aspiration doses as low as 80 
µg in mice 203 , while nanotubes which are not rigid or are tangled may have 
diminished fibrotic potential (see Figure 8) 127. 
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Figure 8: Differences in particle length and rigidity affecting particulate clearance. (left) Successful and frustrated 
phagocytosis of long asbestos fibres; (right) Successful and frustrated phagocytosis of tangled and rigid carbon 
nanotubes. 
 
2.7.1.3 Particle Composition 
Particle composition affects the biochemical interactions available to mediate toxic 
interactions; the formation of adducts with cellular components, adsorption of 
nutrients, disruption of ion channels, interference with metabolism, immunogenicity 
and surface reactivity are dependent on composition 19. For mining dusts, differences 
are likely to arise from the solubility of minerals and speciation of metals in 
bronchioalveolar and lysosomal fluid conditions 204, as well as surface crystallinity 
which influences the catalysis of free radicals 205.  
 
Different mineral crystal structures affect toxicity, and amorphous counterparts are 
generally less toxic. Changes in toxicity are likely to be reflected by oxidative stress 
more than cytotoxicity 206. This is well understood in crystalline silica, the most 
abundant form of which is quartz and most toxic is cristobalite. Surface modification 
of quartz has been shown to reduce toxic effects 207, as free radical generation, 
hydrogen bonding, surface electric charges and silanol functional groups have been 
proposed to explain the interactions of silica with proteins, phospholipids and 
membranes 208. This is also true of TiO2 surface crystallization, where the anatase 
structure has been found to be up to 100 fold more toxic than  the rutile structure 168. 
Differentiating composition mediated effects on cellular endpoints is a strength of in-
vitro toxicology, if appropriate endpoints and methodologies are chosen. Of the 
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common metal oxides found in ores, ZnO and CuO are found to demonstrate 
markedly higher toxicity. The mechanisms are uncertain, including coordination 
effects with protein binding, interference with metal ion proteins, generation of free 
radicals, disruption of homeostasis and the effects of soluble ions (see Figure 9) 209. 
 
Figure 9: Pathways for toxic interactions of CuO and ZnO particles. (a) entry mechanisms into cells through diffusion and 
pinocytosis; (b) effect of ROS on intracellular particles and DNA breaks; (c) coorindation of dissolved Cu2+ and Zn2+; (d) 
non-homeostasis effect caused by Cu2+ 209 
 
2.7.1.4 Particle Solubility 
Solubility is fundamental to observation of differences in toxicity amongst poorly-
soluble mineral and metal-oxide PM sources. For example, soluble barium 
compounds cause nervous system toxicity, whereas the insoluble sulphate of barium 
is ingested in diagnostic medicine with no toxic effect. Silica has been found to be 
partially soluble, allowing dimensions of silica toxicity to result from biochemical 
interactions. The dissolving of silicic acid out of quartz, asbestos and other dusts 
may be enhanced by reactive chemistry occurring at the mineral surface and contact 
with lysosomal enzymes 208. Solubility in this way will be increased with increasing 
particle specific-surface area. The acidic lysosomal fluid compartment of 
macrophages may also liberate cytotoxic metal ions such as copper with greater 
efficiency than more neutral fluid compartments such as bronchioalveolar fluid (see 
Figure 10) 210, and can be detected by inductively coupled plasma mass 
spectrometry, atomic absorption spectroscopy and x-ray fluorescence.  
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Figure 10: Copper release rate per unit surface area from artificial copper patina powder exposed to synthetic biological 
fluids and PBS. Insert shows results on logarithmic scale 210. 
 
2.7.2 Cytotoxicity 
2.7.2.1 Dosing Metrics 
Cytotoxicity is the least sensitive measure of toxicity, though a critical point of 
comparison for assessing other endpoints and data between studies. In measuring 
differences between PM of different compositions and sizes, an appropriate dosing 
metric must be decided upon. For completely soluble or liquid toxicants, 
concentration is usually expressed as solute mass by solvent volume or solute 
volume by solvent volume. Due to the poorly-soluble nature of mining generated 
PM10 and PM2.5, particle mass by cell surface area (e.g. LC50 of ZnO in colon cells is 
15 µg/cm2 for 10 nm particles and 29 µg/cm2 for 44 µm particles 211) and particle 
specific surface-area by suspension volume (e.g specific surface area of TiO2 
ultrafine is ~ 50 m2/g and fine is ~ 6 m2/g 194) may be more appropriate, if the mass in 
contact with cell membranes or surface area dependent reactivity are dominant 
factors in toxicity. Studies have also suggested specific surface area by cell surface 
area exposed allows better comparisons between in-vitro and in-vivo results 212. 
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For PAM, particle volume by PAM number may better correlate with load-dependent 
toxicity, as 60 µm3/PAM is the approximate threshold for lung overloading, with PAM 
mediated particle clearance ceasing near 600 µm3/PAM 22. These dosing metrics 
ease cross-comparisons between studies. For instance, RAW 264.7 rat 
macrophages are reported to be sensitive to ultrafine TiO2 and SiO2, with cell viability 
at 100 µg/mL being 20% and 0%, respectively 213. However, these metrics are 
unlikely to be consistent if the size distribution of particle suspensions is not identical 
or different cell seeding densities are used. When measuring poorly-soluble particles 
of different sizes, sedimentation rates should be considered as this affects particle-
cell contact duration, and gentle centrifuging should be considered. In an in-vivo 
study, the innocuous particle-induced lung overload condition was seen to occur at 
concentrations over 20 mg/m3 at an exposure time of 6 h/day for 20 days in rats 91. 
 
2.7.2.2 Metal and Metal Oxide Cytotoxicity 
The cytotoxicity of poorly soluble metal oxides likely to be found as trace or bulk 
components of mineral ores is usually found to be low when using alveolar cell lines 
such as A549, with exceptions such as ZnO, CuO and anatase TiO2 172,214. Amongst 
carbon, carbon nanotubes and a range of metal oxide nanoparticles (CuO, ZnO, 
TiO2, Fe3O4, Fe2O3, CuZnFe2O4, carbon nanopowder, carbon nanotubes), 
cytotoxicity was found to be less than 10% at a concentration of 40 µg/cm2 on A549 
cells, except for carbon nanotubes, ZnO and CuO. Intracellular ROS was difficult to 
distinguish from control other than TiO2 and CuO. DNA fragmentation was clearly 
distinguishable from controls by CuO, followed by TiO2, CuZnFe2O4 and carbon 
nanotubes 215. Another study focusing on size-dependent differences in toxicity found 
little distinction between fine and ultrafine metal oxides, other than CuO cytotoxicity 
where the ultrafine fraction was more toxic and DNA damage (see Figure 11) 197.  
However, pure metals exhibit higher reactivity and cell membrane disruption than 
oxides 216, reinforcing the importance of testing with lysosomal fluid to see if leaching 
occurs in the PAM intracellular fluid compartment 217. 
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Figure 11: The toxicities of micrometre scale particles (approximately 1 µm) versus nanoscale particles (<0.1 µm) to A549 
cells are shown. A: Cytotoxicity after an 18hr exposure at 40 µg/cm2; B: DNA damage after a 4 h exposure at 40 µg/cm2; 
C: Oxidative DNA damage after 4 h at 40 µg/cm2; D: Mitochondrial damage after a 16h exposure at 40 µg/cm2; E: Dose-
response of mitochondrial depolarization to CuO after 4 h at 40 µg/cm2; F: Comet assays showing DNA damage from 
CuO with and without the Formamido-Pyrimidine DNA Glycosylase (FPG) DNA repair enzyme which forms DNA adducts 
in the presence of O2 after 4 h at 40 µg/cm2. Adapted from Size-Dependent Toxicity of Metal Oxide Particles – A 
Comparison Between Nano- and Micrometer Size 197. 
 
2.7.2.3 Assay Considerations and Particulate Interference 
Colorimetric metabolic assays such as the MTT and Resazurin assays detect the 
enzymatic transformation of a substrate by cellular metabolism. These assays do not 
necessarily distinguish between cellular inhibition and cell death, which may be 
confirmed by trypan blue staining or the LDH assay for loss of cell membrane 
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integrity  and lysis 218,219. If long exposure periods are required, media reperfusion 
and evaporation may make distinguishing small differences in cytotoxicity difficult 
unless corrected in conventional tissue culture incubations. Furthermore kinetic 
assays of cell metabolism are not advised with reagents such as MTT due to the 
formation of cytotoxic crystals 220,221. 
 
The physiochemical characteristics of PM10 and PM2.5 mining dusts interfere with 
colorimetric assays in a variety of ways. The most apparent interference is through 
blockage of light over the entire observed spectrum, resulting in false readings. It is 
also possible that particles catalyse the assay substrate, as demonstrated with diesel 
particles and MTT, producing formazan which is otherwise indicative of cell 
metabolism (see Figure 12). Particle adsorption of protein has been shown to be 
pronounced when assaying soot and oxidised soot particles, resulting in an 85% 
decline in LDH concentration within 5 minutes at 46 µg/mL 166. Adsorption of media 
proteins during incubation may also affect cell growth, although for ultrafine metal 
oxides this effect becomes significant only at concentrations over 1 mg/mL 149. 
Methods of circumventing particulate-assay interference centre on lowering 
concentrations, identifying when interference occurs during the assay procedure and 
appropriate centrifugation and media-transfer steps 165,222. 
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Figure 12: MTT assay interactions with activated carbon, TiO2, soot, oxidized soot and diesel particles after 3 h of 
incubation at 50 µg/mL. a) spectra of particle suspensions and MTT metabolic product (formazan) b) spectra after 
centrifugation for 10 minutes at 115 g. 
 
2.7.2.4 Reflection of Cytotoxic Outcomes and Pulmonary Pathology 
Cytotoxicity may correlate to apoptosis in lung injury and fibrosis, although 
decreased cytotoxicity does not necessarily indicate milder pathological outcomes. 
For epithelial, fibroblast and PAM coculture combinations, the immunologically 
mediated pathways are of particular significance as cell types can differ in their 
resistance to these signals, and high resistance of fibroblasts to apoptosis is a factor 
in fibrotic pathogenesis 171. Incubation of A549 cells with 250 µg/mL ultrafine iron 
oxide and silica over 72 h was found to induce apoptosis in approximately 15% to 
20% of cells measured by annexin V-FITC (green) binding assay 214. Hyperplasia of 
Type II epithelial cells is also a pulmonary remodelling response characteristic of 
42 
 
pulmonary disease 139, implicating increased cell proliferation to be as much a 
hallmark of disease processes in the lungs as cytotoxicity. Given the complexities 
affecting cytotoxicity, unexpected results should be expected but investigated, and 
always accompanied by other cellular endpoints. 
 
2.7.3 Immune Mediated Clearance 
2.7.3.1 Physiology of PAM-Mediated Particle Clearance in the Lungs 
Mechanisms of insoluble particulate matter clearance from the tracheobronchial tree 
differ in the upper respiratory tract and conducting airways to the acinar surfaces. In 
the upper respiratory tract, the airways are lined with ciliated epithelium which impels 
a thick, dual-phase mucous fluid layer towards the oropharynx. The cilia move within 
a low-viscosity hypophase mucosal layer, on which rests a high-viscosity epiphase 
layer, responsible for removal of most particulate matter from this region. In the 
bronchioles the bronchioalveolar fluid is composed of only the low-viscosity 
component and has surfactant properties. The non-ciliated acinar surfaces of the 
lungs depend on PAM to return particulate matter to the mucociliary escalator, 
otherwise particles may be collected by PAM after migration into the interstitial 
spaces and moved to the lymphatic system. Failing this, particles may enter the 
capillary vasculature spontaneously – particles < 10 nm may diffuse through the air-
blood barrier directly 24. 
 
An experiment on healthy volunteers inhaling 0.2 µm radiolabelled sulphur colloid 
aerosol found at 100 minutes post exposure macrophage recruitment peaked at 92% 
of immune cells in sputum, the remainder being neutrophils, monocytes and 
lymphocytes. It was found that after 40 minutes, collection of sputum cleared ~ 50% 
of the PM load, although remaining particles had a long half-life 223. This long-term 
retention of particles is associated with the proportion of particles which enter the 
acinar surfaces of the lungs and are not phagocytosed; while there is rapid 
mucociliary clearance of PM within 48 h, particles which have not been cleared are 
sequestered. The mechanism of this sequestration is not fully understood but may 
be related to immobilized particle-laden macrophages in connective tissue, lymphoid 
foci and other areas 27. Specifically, ~ 60 % of inhaled fused aluminosilicate particles 
< 4 µm in were found to be retained in the lungs of healthy volunteers after 7 days, 
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with a second clearance phase then following a much longer half-life of ~ 500 days 
25. 
 
2.7.3.2 Cellular Mechanisms of PAM-Mediated Particle Clearance 
PAM, which typically measure ~ 12 µm, can engulf particles slightly larger in 
diameter than themselves, a process enhanced by opsonisation 30. The frequency 
macrophages associate with particles drops with increasing particle size from 300 
nm to 3 µm, slowing clearance of larger particles 224. The PAM pool of the lung 
respiratory surfaces have a limited capacity to clear particulates based on maximum 
carrying volume per cell (~ 60 µm3/PAM 22). Lung overloading also slows down 
particle clearance, and if severe creates an inflammatory cycle of apoptosis and 
recruitment 225, and cessation of clearance at ~ 600 µm3/PAM 22. The most 
significant problem in overload conditions is the dramatic increase in PAM 
sequestered particle translocation to the interstitial space, encouraging the 
development of interstitial granulomas  18,33,226. In an animal study of ultrafine (20 
nm) and fine (250 nm) TiO2 particles, it was found that while particle retention in the 
alveolar spaces was similar between the particle sizes, ultrafine TiO2 exhibited 
increased interstitial retention, inflammatory activity, greater induction of Type II 
alveolar epithelial cell proliferation and greater total PAM recruitment to the alveolar 
surfaces during the exposure phase 194. 
 
2.7.3.3 Intracellular Interactions between PAM, Epithelial Cells and Particles 
The intracellular fluid compartment represented by macrophages has properties 
distinct from bronchioalveolar fluid, attacking particles at an acidity of pH 4.5. A study 
of metal and metalloid solubility using ambient PM10, PM2.5 and PM1 acquired from a 
high-volume sampler found Pb, Cu, As, V and Sb trace metals were markedly more 
liable to leaching in artificial lysosomal fluid than Gamble’s solution, increasing 
bioavailability of metal ions 217. Dissolution can be significant and rapid. Ultrafine 
ZnO will not dissolve in bronchioalveolar fluid at pH 7.4, but dissolution of ~ 90% of 
the ZnO mass occurs within 24 h of exposure to artificial lysosomal fluid 204.   
 
The intracellular accumulation of ultrafine metal-oxides by in lung epithelial cell lines 
has been demonstrated by Transmission Election Microscopy (TEM) using A549, 
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with observations as short as 6 h post-exposure showing translocation of < 100 nm 
TiO2 into the cell cytoplasm 227,228 (see Figure 13). This is larger than < 10 nm size 
limit thought to allow diffusion through the alveolar epithelium, indicating pinocytosis 
of particles. Ingestion of quartz particles < 2 µm in size by A549 cells has also been 
observed 229. Epithelial particle ingestion is theorised to play a significant role in 
particle migration to the interstitial space, and is enhanced under conditions of lung 
overload 229. 
 
 
Figure 13: TEM images of A549 cells, x80000 zoom. A: Unexposed cells; B: TEM image demonstrating TiO2 nano-particle 
uptake at 100 µg/mL. Nu denotes the nucleus, NP denotes the particle 227. 
 
2.7.4 Inflammatory Signalling and Fibrosis 
2.7.4.1 Cytokines in the Genesis of Fibrosis 
Inflammation and tissue remodelling are tightly linked processes in the repair of lung 
injury, and the disruption of homeostasis between these processes by chronic 
exposure to mining dusts greatly increases the likelihood of lung fibrosis; the 
pathological growth of connective scar tissue with an accumulation of fibroblasts and 
a reduction or elimination of the epithelium 171. Failure of the immune system to 
resolve inflammatory processes, or hypersensitive induction of inflammatory 
processes, are thought to underlie most kinds of fibrosis, including those with 
idiopathic, autoimmune and foreign material causes. The lung presents as two 
distinct immunological environments, where inflammation in either is not necessarily 
intertwined; the bronchial space where inflammation from asthma and bronchitis 
does not cause changes in the lung interstitum, and the pulmonary space where 
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interstitial inflammation such as sarcoidosis does not affect the bronchial wall. These 
compartments are independently vascularised 140.  
 
During pulmonary inflammation from PM10 and PM2.5, epithelial and macrophage 
cytokine signalling drive the rapid recruitment and activation of monocytes, 
granulocytes and  lymphocytes. Once cells are recruited, the signalling environment 
of lungs during becomes complex, creating cytokine networks which under 
dysregulated chronic inflammatory conditions initialise pulmonary fibrosis. It is 
postulated that there are at least two kinds of effector cytokine networks involved, 
Type 1 (non-fibrotic) and Type 2 (fibrotic). In Type 1 inflammation, IFN-γ expression 
leads to mononuclear cell activation, clearing the antigen while mediating 
antiproliferative and antifibrotic effects. In Type 2 inflammation, IL-4/IL-3 expression 
leads to effector cell activity encouraging fibroproliferation and matrix deposition 230. 
 
A wide variety of cytokines drive cell migration, activation, proliferation, apoptosis 
and extracellular matrix deposition (see Table 9). Particles contacting lung epithelial 
cells are found to influence the expression of interleukins IL-8 (also known as 
CXCL8) and IL-6 which have pro-inflammatory and anti-inflammatory effects, 
respectively, as well as C-Reactive protein and TNFα 231. Macrophages can also 
express these interleukins. Increased expression of IL-8 is found in patients suffering 
from idiopathic pulmonary fibrosis and is chemotactic to neutrophils 29. Neutrophils 
do not normally account for a large fraction of cells in bronchioalveolar fluid, however 
exposure to PM10 in-vitro has been shown to allow neutrophils to accumulate and 
make up to 15% of cells in bronchioalveolar fluid within 6 h 232. 
 
Comparisons of PM2.5 metal-oxides against nanoparticle metal-oxides (Al2O3, CeO2, 
Fe2O3, NiO, SiO2 and TiO2) in bronchial epithelial cells have been shown to elicit 
weak IL-6 and IL-8 expression changes in lung epithelial cells at concentrations 
where there is no significant cytotoxicity with the exception of micron and nano SiO2. 
A 3-fold induction of IL-8 resulted from SiO2 exposure at 58 µg/cm2, while IL-6 
expression was nominal. However, it was demonstrated that low serum 
concentration below 3% allowed nanoparticle interference to deplete the 
concentration of an IL-6 standard significantly, raising questions about the accuracy 
of low induction results 233. Other studies have shown epithelial cell production of 
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both IL-8 and IL-6 in response to silica particles being strongly induced 229,231,234, 
while coculture with macrophages has  been shown to further enahance IL-8 
expression. In these cocultures, epithelial cell cytokine expression appears to be 
regulated by macrophage expression of IL-1β, rather than TNFα 234,235. Mineral PM10 
induction of cytokine expression in macrophages has been shown to occur 
independently of apoptotic potential, depending on mineral compositon 206. 
 
Table 9: The effects of cytokines in lung tissues, cytokine network type given where available 
Cytokine Effects in Lung Tissue Type  230 
PGE2 Anti-inflammatory 140  
TGF-β1 Anti-inflammatory. Myofibroblast resistance to cell death 
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TNFα/TNF Pro-inflammatory responses, regulation of neutrophil 
chemotaxis (adhesion molecule ICAM-1 and Eselectin 
upregulation)  140, associated with macrophage activation 
183, induction of apoptosis, induction of matrix 
metalloproteinases 237, eosinophil recruitment 238 
 
Type I IFN Associated with macrophage activation 183  
IGF-1 Proliferation of fibroblasts and myofibroblasts, increased 
collagen matrix synthesis  239 
 
IFN-γ Macrophage priming 183, suppression of IGF-1 and 
fibroblast proliferation and activity 239 
Type 1 
IL-1 Regulation of neutrophil chemotaxis (adhesion molecule 
ICAM-1 and Eselectin upregulation) 140 
 
IL-1β Associated with macrophage activation 183, pro-
inflammatory responses, collagen deposition, fibroblast 
proliferation 29, A549 cell migration, induction of matrix 
metalloproteinases 240 
 
IL-1ra Down-regulation of neutrophil chemokine MIP-2 183  
IL-4 Activation of granulocytes in allergy 140, stimulation of IGF-
1 239 
Type 2 
IL-5 Activation of granulocytes in allergy 140  
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IL-6 Anti-inflammatory 140, inhibition of fibroblast proliferation 
241, epithelial response to fine particles 233 
 
IL-8 Neutrophil chemotactic 29,185, epithelial response to fine 
particles 233 
 
IL-10 Inhibition of granuloma formation and Th1 recruitment 242, 
opposes inflammatory action of TNF, activated during 
fibrosis 243, suppression of Type 1 cytokines 230 
Type 2 
IL-13 Macrophage priming 183, stimulation of IGF-1 and 
fibroblast proliferation and activity 239 
Type 2 
IL-12 Inducer of of IFN-γ 244 Type 1 
 
2.7.4.2 Modelling Fibrosis 
Fibrosis as a result of high ambient PM inhalation or high occupational exposures 
often takes years to develop. Bleomycin induced lung injury is often used to model 
interstitial fibrosis, and develops rapidly in-vivo; increased collagen deposition is 
visible 8 days after exposure in histologically stained lung sections 245. Dendritic cells 
and macrophages have been suggested to play key roles in bleomycin induced 
fibrosis, and other forms of fibrosis. Dendritic cells accumulate in fibrotic diseases 
and may drive damaging effector cell activity in the lungs, as the fibrotic response to 
bleomycin diminishes when dendritic cells are inactivated in-vivo 246. Mice deficient in 
macrophage colony-stimulating factor (M-CSF), or treated with IL-12 (an IFN-γ 
inducer) also experience diminished fibrotic response to bleomycin 171,244. When 
used in-vitro, bleomycin has been shown to cause lung epithelial cell apoptosis, as 
modelled by A549 cells, as a result of increased free radical production. This 
damages mitochondrial DNA and nuclear DNA 247. 
 
2.7.4.3 Tissue Remodelling During Fibrosis 
Tissue remodelling during fibrosis involves proliferative and apoptotic processes that 
create non-functional scar tissue in place of healthy pulmonary tissue. Accumulation 
of immune cells is accompanied by cellular apoptosis of the alveolar epithelium Type 
I cells and hypertrophy of Type II cells, characterising denudation of the alveolar 
surface. Meanwhile, collagenases and matrix metalloproteases degrade the 
extracellular matrix allowing it to be reshaped by fibroblast activity which respond to 
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inflammatory signals by resisting apoptosis, causing remodelling of the interstitium 
171, and enhanced epithelial cell migration 248. The expression of IGF-1 and TGF-β1 
by macrophages and monocytes is known to activate fibroblast anti-apoptotic 
pathways and induce production of matrix metalloproteases 239,249. The leakage of 
plasma into damaged alveoli containing lysophosphatidic acid may activate fibroblast 
migration into the alveolar spaces during fibrosis. Mice deficient for the 
lysophosphatidic acid-1 G-coupled receptor, which is expressed on the alveolar 
epithelium, were less affected by bleomycin induced fibrosis than control 250. 
 
 
2.7.4.4 Signalling Models 
The role of the macrophage is multifaceted, and depends upon the mode of 
activation. Once circulating monocytes are attracted to the site by cytokines and 
chemokines, they differentiate into macrophages and are activated by a range of 
factors; immune complexes, lymphocytes, damaged extracellular matrix, opsonised 
particles and bacterial moieties. The method of activation determines the ‘type’ of 
resulting macrophage (see Table 10). Classically activated macrophage types tend 
to express higher levels of cytokines and chemokines, and generate more free 
radicals. This leads to apoptotic cell death, anti-microbial activity, phagocytosis of 
opsonised particles and immune complexes and matrix degradation. Alternatively 
activated macrophages tend to express anti-inflammatory cytokines. This leads to 
matrix stabilisation, cell survival and proliferation, angiogenesis and antigen 
presentation. Both classically and alternatively activated macrophages show 
enhanced phagocytosis of debris and apoptotic cells. In progressive fibrosis, 
classically activated macrophages are implicated in causing excess apoptosis. 
Excess or prolonged activity of alternatively activated macrophages is implicated in 
TGF-β1 mediated fibrosis 251. 
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Table 10: Factors stimulating either classical or alternative macrophage activation 251. 
Mφ 
activation 
Stimulus 
Classical IFN-γ 
Bacterial lipoproteins (TLRs) 
Bacterial DNA (TLRs) 
Parasitic proteins/carbohydrates (TLRs) 
Opsonized particles (FcR, CR) 
Hypoxia 
Abnormal matrix 
Alternative IL-4 
IL-10 
IL-13 
TGF-β 
Glucocorticoids 
 
 
The balance of macrophage activation states is important in the coordination of the 
overall inflammatory response, having downstream effects on both immunological 
and parenchymal cell types in the lungs. After acute inflammatory activity, 
macrophages must inhibit neutrophil and monocyte chemotaxis and initiate 
parenchymal repair processes. These include repair of gaps in the acinar epithelium, 
stabilisation of connective tissue and angiogenesis 183 (see Figure 14). 
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Figure 14: Targets of macrophage participation in the termination of acute inflammatory activity and coordination of 
repair processes in the pulmonary acinus. Recruitment of polymorphonuclear cells (PMN) such as neutrophils and 
monocytes such as macrophges is inhibited and cell proliferation and repair processes are activated 183.  
 
2.7.5 Free Radical Generation 
Particulate air pollution has repeatedly been shown to increase alveolar epithelial 
cellular oxidative stress in-vitro, and this is linked with increased TNFα expression 
peaking in the short term (5 h) and increased IL-6 expression peaking in the longer 
term (72 h) 252. Decreased concentration of the antioxidant glutathione has also been 
observed in-vivo in response to intratracheal PM10 instillation in as little as 6 h 232. 
Redox imbalance can occur in a variety of ways, both directly due to particle 
chemistry and surface interactions, and from oxidative bursts by macrophages as 
part of their antimicrobial defenses which may vary depending on particle surface 
characteristics 195. The overall redox imbalance on cells ranges from insults that can 
be resolved spontaneously, to irreversible cellular DNA damage and ultimately cell 
death (see Figure 15) 66. 
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Figure 15: Hierarchical oxidative stress model showing response tiers related to PM exposure. (Tier 1) Antoxidant 
enzyme activity restores cellular redox homeostasis. (Tier 2) Proinflammatory responses are induced. (Tier 3) Cellular 
apoptosis-necrosis is induced. GSH (Glutathoine); GSSG (Oxidized Glutathione); NF-κB (Nuclear Factor κB); MAPK 
(Mitogen Activated Kinase); AP-1 (Activator protein 1)  66. 
 
The nature of contact between particulate matter and epithelial cell membranes likely 
makes lipid peroxidation an important player in cellular membrane disruption and 
cytotoxicity. It has been proposed that cell membrane interference activates the 
protein MKK1 which stimulates an ERK1,2 cascade activating both cPLA1 and 
sPLA1 proteins, hydrolyzing phospholipids and producing arachidonic acid. This in 
turn  is an additional source of cellular redox imbalance 253. However, measurements 
of free radical damage should extend beyond the Thiobarbituric Acid Reactive 
Substances (TBARS) test for lipid peroxidation to other oxidation products 254.  
 
Metal-oxides with low cytotoxic effect are also shown to increase oxidative stress, 
which is associated with microvascular and endothelial permeability 255. For fine ZnO 
particles, free radical generation and DNA oxidation has also been cited in lung 
epithelial cells as the leading toxicological endpoint, and distinctly mediated by the 
oxide compound whereas equivalent Zn2+ exposure resulted in less redox activity 192. 
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A study on the differential effects of fine and ultrafine TiO2 particles on RAW 264.7 
rat macrophage cells found no significant difference in cytotoxicity between 0 and 
200 µg/mL suspensions of the particles after 24 h, however 1.5 to 2.5 fold inductions 
of free radicals were observed at 4 h 218. Free iron ions in inhaled particulate matter, 
Fe2+ and Fe3+, are found to increase hydroxyl radical production and DNA oxidation 
products through the Fenton reaction: 
 
Fe2+ + H2O2 → Fe3+ + .OH + OH- 
Fe3+ + H2O2 → Fe2+ + .OOH + H+ 
 
The presence of metal-oxides and free transition metal ions therefore presents a 
source of oxidative stress in addition to free radicals associated with inflammation, 
and may be complicated by cross-reactivity in transition metal mixtures as found in 
particulate matter 256–259. However, results may vary depending on the type of 
oxidative stress assay employed. Using iron oxide and silica ultrafines on A549 cells, 
dihydrodichlorofluorescein diacetate (H2DCF-DA) assay fluorescence was found to 
only differ by only ~5% from 126-600 µg/mL 214, while comparisons between ultrafine 
TiO2 and fine silica also observed little difference up to 200 µg/mL 227. It is important 
to note that the H2DCF-DA assays requires either activity by cytochrome c, or both 
the presence of H2O2 and redox-active transition metals such as iron ions 260. A 
study comparing ultrafine TiO2 effects on fibroblast redox balance found greater 
sensitivity; concentrations of 300 µg/mL increased H2DCF-DA assay fluorescence 
50% and depleted glutathione by 25% compared to control. Between 3-600 µg/mL, 
GSH levels responded in the clearest dose-dependent fashion 261.  
 
The downstream effects of redox imbalance and resulting oxidative stress initiate 
cellular responses, affecting overall gene expression within the cell (see Figure 16). 
It is proposed that ultrafine particle stimulation of oxidative stress can cause 
disruption of redox homeostasis resulting in positive feedback, as intracellular Ca2+ 
both signals macrophage superoxide radical and nitric oxide production and is 
increased by these free radicals. The expression of TNFα may also be indicative of 
intracellular Ca2+ concentration 262. 
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Figure 16: The proposed effect of transition metals and Polycyclic Aromatic Hydrocarbons (PAH) combustion products on 
cellular redox homeostasis and gene expression. Increased inflammation and cell proliferation may affect chronic 
obstructive pulmonary disease (COPD), asthma, cardiovascular disease and cancer 262. 
 
2.7.6 Genotoxicity and Carcinogenicity 
Genotoxicity bioassays determine a cell’s ability to successfully replicate and 
indicate whether a toxin is mutagenic, carcinogenic or both. Oxidative potential and 
free radical generation are genotoxic mechanisms, and gentotoxicity can similarly be 
tested by acellular assays as well as in-vitro and in-vivo, with the added possibility of 
biomarker studies in humans. Genotoxicity can therefore occur directly because of 
particle inhalation (primary), or as a result of inflammation (secondary). Therefore, 
any particle resulting in an inflammatory response, especially those arising from NF-
κB regulated pathways, may cause secondary tumours to develop, but some 
particles may have a primary genotoxic component which can manifest at a low or 
sub-chronic dose 136,201 (see Figure 17). 
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Figure 17: Inflammatory networking in cancer. Cytokines dependent on NF-kB activation pathways are involved in 
numerous cancer pathways, including genes confering chemoresistance and increased proliferation and metastatic 
ability 161.  
  
As reviewed by Borm et. al. 118, it has been shown that poorly soluble particulates 
such as TiO2, carbon black and coal mine dust can cause tumours in-vivo. While 
fibrosis is considered a precursor of lung cancer, it has been shown that tumours 
arise independently. Furthermore, the type of squamous tumour appeared to differ in 
frequency based on particle size and particle type. The observed tumours were 
squamous cell carcinoma (SCC), non-keratinizing non-cystic tumour (NKCT), 
squamous keratinizing cyst (SKC), bronchio-alveolar carcinoma (BAC) and 
bronchioalveolar adenoma (BAA). Amorphous silica was found to be largely non-
tumorigenic. Fine TiO2 caused mostly SCC, SKC and BAA in mostly equal measure 
that showed a dose-response relationship. Ultrafine TiO2 exposure resulted in SKC, 
BAA and BAC but these did not appear to follow a strong dose-response 
relationship. However, SCC maintained a dose-response relationship increasing with 
increasing specific-surface area dosed, in line with fine exposures. Fine carbon black 
showed a strong dose-response relationship from BAA and BAC, but SKC and SCC 
responses, while induced, were not as clear. Ultrafine carbon black did not result in a 
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clear dose-response relationship for any of SKC, SCC, BAA or BAC and seldom 
resulted in NKCT. Taken together, the results between fine and ultrafine particles 
indicate there are either problems in dosing ultrafines accurately in-vivo, or other 
effects are at play such as particle agglomeration or particle redistribution away from 
the interstitial spaces. Despite this, it is informative that insoluble fine inorganic 
particles are tumorigenic 118. 
 
In a study of ultrafine anatase TiO2 and Fe2O3, intracellular uptake was observed in 
fibroblasts and bronchioepithelial cells, but not nuclear, mitochondrial or ribosomal 
uptake. It was found that lung fibroblasts were more sensitive to cytotoxic and 
genotoxic effects from both particle types. The mechanism of action for TiO2 
appeared to be through generation of free radicals, while Fe2O3 was able to cause 
DNA strand breaks directly at concentrations of 50 µg/cm2 in both fibroblasts and 
bronchioepithelial cells, but required reducing conditions to generate high levels of 
free radicals 169. 
 
The measurement of gene expression profiles is also informative of cellular response 
pathways to particulate matter, providing information about the mode of toxicity and 
defense mechanisms employed by the cell. One study has found that environmental 
PM10 particles and metal-oxide standards differentially induce cytokine and 
chemokine gene expression based on particle source, size and composition, and 
that fine particles did not induce changes in gene expression, using bronchial 
epithelial cells 231. 
 
It has been shown that environmental PM2.5 and PM10 increase the expression of 
fos/jun family proto-oncogenes involved in sarcoma and non-small cell lung 
carcinomas several fold. Over a 2 h time period, gene expression was most elevated 
in lung epithelial cells exposed to PM2.5, however over a 24 h time period, gene 
expression was most elevated in cells exposed to PM10 263. 
 
2.7.7 Relationship of Pulmonary Models with Cardiovascular Models In-Vitro  
Many epidemiological studies have associated PM inhalation with increased 
cardiovascular risks, indicating it as one of the most important risk factors for 
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population health at ambient concentrations alongside pulmonary and cancer risks. 
Furthermore, these risks are evident at much lower concentrations than previously 
believed possible 90. Estimates vary, however many studies show a 1% or greater 
increase in relative risk of cardiovascular mortality per 10 µg/m3 of daily ambient 
PM10 exposure, although some studies on PM2.5 indicate the risk to be as high as 
14% 15,73. 
 
Bai et al. 264 have identified from the literature five biological pathways to 
mechanistically explain the association of ambient PM10 exposure to cardiovascular 
outcomes; 1) the systemic effects of pulmonary inflammation affecting the 
vasculature, 2) ultrafine fraction translocation to the vascular and activation, 3) 
generation of free radicals which enter circulation and affect cardiac function, 4) 
interference of endothelial function by inflammatory mediators or soluble 
components of PM, 5) cardiac function changes altered by central nervous system 
response to PM10  264. 
 
Of the pathways identified, in-vitro endpoints discussed in this review are informative 
of aspects in pathways 1 (PAM and inflammatory endpoints), 2 (particle size 
endpoints), 3 (free radical generation and oxidative stress endpoints), and 4 
(solubility endpoints). Therefore in screening PM10 sources for pulmonary toxicity 
and fibrogenicity, samples with high activity in these pathways may also be identified 
as warranting specific investigation against cardiovascular endpoints.  
 
During inflammation, high alveolar permeability allows pro-inflammatory factors to 
enter the blood stream and cause endothelial dysfunction in the vasculature and 
hypercoagulability of the blood which has follow-on negative effects on heart function 
and health, such as increased risk of infarction 73. This may also be directly mediated 
by particle uptake into the lungs and into the circulatory and lymphatic systems 164. 
 
Well-designed comparative in-vitro models must be able to distinguish the nuances 
of inflammatory and oxidative stress markers which indicate systemic effects able to 
reach the heart. As the differential influence these factors have on cardiovascular 
risk has not been quantified, in-vivo validation would be required to extrapolate 
cardiovascular risk from a chosen lung parenchyma model. However, there is clearly 
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utility for vascular epithelial and myocardial cell lines in addition to erythrocyte lysis 
and blood coaguability tests. 
 
2.8 Discussion 
Without a satisfactory mechanistic understanding of why PM10 and PM2.5 influence 
morbidity and mortality, epidemiologists have begun to pursue ultrafine particulate 
fractions, supported by some evidence that PM2.5 health impact correlations are 
stronger than PM10, and that PM2.5 is dominated by a variety of toxic combustion 
products in urban environments. However, differential effects between PM10 and 
PM2.5 do exist, and PM2.5 correlations are not universally accepted as more powerful 
49,51,53,62,89,189. This is especially evident from the pulmonary morbidity associated 
with increases in coarse fraction mineral PM10-2.5 during dust storms 60,61, which have 
similarities to mining dusts. This is a key insight that gives weight to the need for 
specific monitoring of PM10 produced at different mining sites. Given the knowledge 
PM10, PM2.5 and ultrafine particles have different kinds of interaction with the lungs, it 
becomes apparent that all three fractions have a place in the monitoring paradigm 
and cannot yet replace one another. 
 
Environmental regulators around the world are currently in a difficult position. There 
is increased pressure for risk assessment vs. screening, and the lowest effect levels 
to ensure the public is free of risk have been determined as extremely low or non-
existent. Furthermore the validity of a linear dose-response relationship which is 
somewhat interpolated from epidemiological studies requires a mechanistic 
understanding to validate, yet in the past inflection points of reduced proportionality 
of risk for particles such as smog above a certain concentration have been observed 
195. These considerations raise the question of what ‘acceptable’ public risk is in the 
face of increasing compliance costs. It is therefore imperative that in-vitro toxicology 
techniques be marshalled for effective bulk data generation to aid risk assessment in 
monitoring effect levels on a source-apportioned basis. 
 
While occupational exposure limits exist, they cannot be directly applied to AAQS 
due to differences in design; such safety standards assume a minimum level of 
employee personal protective equipment be worn, that employees are not of rare but 
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vulnerable- population groups and that exposures be time-weighted, following the 
work week schedule. They do however make excellent points of comparison for 
poorly-soluble metal-oxide dusts. 
 
It is clear that PM10 and PM2.5 inhalation present risks to health through many 
different mechanistic pathways, none of which may clearly dominate overall due to 
interdependencies 15. In determining the factors relevant to in-vitro determination of 
PM10 and PM2.5 toxicity, inter-study variability is a distinct problem which further 
cloud the nature of these interdependencies. Differences in sample preparation, 
particle size-distribution, crystallinity and dosing metrics can make in-vitro 
comparisons complicated, even when the same compounds, cell types and assays 
are being used 34. Standardisation is the greatest strength of in-vitro experiments, yet 
the field of particulate toxicology has had a difficult time in validating results in-vivo 
well enough to settle upon standards 173.  
 
Critical questions that must be answered to resolve these difficulties centre on 
whether the impacts of PM10 and PM2.5 can be predicted using simple tissue culture 
methodologies, without introducing even greater complexities associated with 
advanced exposure systems and 3D tissue culture methodologies. More 
fundamentally this question resides in whether the major in-vitro endpoints discussed 
deliver enough understanding of particulate toxicity, including their relationships with 
macroscopic pathological outcomes, and how these outcomes are prioritised by 
concentration of exposure.  
 
A large amount of poorly-soluble metal-oxide toxicity in the lungs can be understood 
through inflammatory effects, after accounting for more readily determinable 
cytotoxic/metabolic, genotoxic and oxidative effects from soluble factors. It is 
therefore important to understand whether ‘nuisance’ dusts mediate toxicity through 
a pulmonary alveolar macrophage ‘overload’ effect and can thus be predicted by 
acinar accumulation alone, or if overload is not a physiologically relevant concept in 
humans and inflammatory risks depend on immobilised interstitial accumulation. 
 
Once such mass-load questions are addressed, inflammatory dependencies of 
specific-surface area exposed naturally follow, as does the importance of surface 
59 
 
crystallinity and related power of oxidative/genotoxic stressors. Measurement of 
relevant gene expression profiles offer a unique perspective on this problem, where 
the activation of differential pathways produce unique signatures of many 
upregulated and down-regulated genes which may survive systematic particle 
interference effects that cast doubts on traditional endpoints.  
 
The overabundance of cytotoxic mediators in fibrosis occurs in parallel with 
macrophage inability to resolve inorganic particles load resistant to break-down and 
detoxification, and indeed toxicants rendered soluble by the phagocytic response. 
The acidic pH conditions of the lysosome should therefore receive as much, if not 
more, attention than the surfactant properties of lung fluid, as the particle dispersion 
paradigm lacks merit on its occurrence in-vivo and its relevance to the clearance 
process. 
 
The cytokine interactions between co-cultures of lung epithelial cells and 
macrophages presents an opportunity to dissect the inflammatory system within the 
lungs in greater detail beyond the interleukins typically produced by epithelial cells 
alone. There are nevertheless many variables to consider, including greater time-
course resolution to track acute and longer term inflammatory cytokine release as 
well as the differential effects of classically and alternatively activated macrophages. 
The ratios between cytokine expression networks are also important, as it appears 
that while suppression of anti-inflammatory cytokines enhances alveolar damage, 
over expression of anti-inflammatory cytokines in the longer term may be a principle 
mediator of fibrotic cell proliferation – which is less intuitive. 
 
Based on the information collected, we propose in-vitro methodologies may be able 
to discern toxicity of poorly-soluble particulate matter comparatively to materials with 
occupational exposures that have similar physical variables, following a hierarchy of 
effects which terminate in dominant health outcomes (see Figure 18).  
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Figure 18: Proposed heirarchy for poorly-soluble coarse particulate matter toxicity 
 
Using such a hierarchy, after adjusting for inflammatory activity due to particle load 
(assuming the ultrafine component which escapes macrophage uptake is low), 
current occupational exposure standards that are applicable include, but are not 
limited to: Low solute toxicity, fine SiO2 standards; High solute toxicity, fine CuO 
standards; High particle specific-surface area, ultrafine ZnO; Low particle specific-
surface area, fine ZnO; Low particle aspect ratio, fine Fe2O3 standards; High particle 
aspect ratio, amphibole asbestos. 
 
The proposed hierarchy would therefore ignore the aspect-ratio of chrysotile 
asbestos, classifying it as mediating toxic effects through soluble/break-down 
components, while amphibole asbestos toxicity would still be mediated by particulate 
length. Development and validation of such hierarchal particulate toxicity systems 
may allow comparative high-throughput in-vitro monitoring of particulate toxicity in 
the future, and meaningful contributions to AAQS. 
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3. Improving Toxicological Assessment of Poorly-Soluble Coarse 
Fraction Particulates Relevant to Pulmonary Health In-Vitro  
 
3.1 Introduction 
Comparative toxicology requires the accurate assessment of cellular endpoints in-
vitro. For this to occur, the toxicological model must be relevant to the target organ 
system from which observed health outcomes are to eventuate, and the comparative 
standards chosen based on similar modes of toxicity. In this regard, when assessing 
the impact of iron-rich ore particle inhalation on human health, the most immediate 
concern is damage to lung tissue and inflammatory responses which may lead to 
asthma, bronchitis, increased respiratory hospital admissions and in severe cases 
the development of obstructive pulmonary diseases and fibrosis 62. While there is 
evidence for systemic cardiovascular risks, it is unclear how they are mediated 
requiring more investigation in-vivo before modelling this phenomenon toxicologically 
can be validated 73. Nevertheless, modelling particle interaction with the lungs is also 
fraught with caveats and complications. With dozens of different cell types, complex 
3D structures, airway dynamics affecting particle deposition characteristics by size, a 
unique air-biofluid interface and a complex immunological environment, the lung far 
outstrips the ability of current cell culture technology to mimic all factors important in 
the particle-lung interaction 108,140. It is therefore not surprising that in-vitro toxicology 
end-points are often thought to correlate poorly with in-vivo experimental endpoints 
265. Furthermore, the driving factors behind particulate toxicity of size, shape, 
composition and crystallinity are not well defined in general 213,265, with the 
differences in toxicity between coarse, insoluble metal-oxides of different 
compositions especially unclear, despite some agreement they are able to cause 
inflammatory responses 34,212. Concern over the toxicity of the metal species content 
in urban PM10 is also reflected in epidemiological data 259. 
 
The ambiguities associated with modelling the lungs in-vitro as well as the toxic 
mechanisms of poorly soluble metal-oxides themselves leave the field of in-vitro 
inhalable particulate toxicology in an exploratory state, despite decades of 
advancements. In reflection of this, several exposure concentration ranges, dosing 
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metrics, particulate standards and culture techniques have been trialled throughout 
the project in search of increased accuracy and greater differentiation between 
samples. The problems requiring immediate attention include the interference of 
particulates on assay protocols themselves, which can cause conflicting results 
between different assays and either exacerbate or reduce perceived particle toxicity 
unless accounted for 166,222. Particular care was taken to adapt colorimetric 
cytotoxicity assays to avoid particle interference, as guaranteeing the similar 
cytotoxicity profiles between different endpoints is essential to their calibration and 
interpretation. 
 
Size dependent toxicity effects between micron and nano-size particles were 
investigated, as well as the effect of lung surfactant proteins on particulate toxicity 
which may aid particle disaggregation effects. It is possible that disaggregated 
particles expose a larger surface area to mediate toxic effects, and have enhanced 
transmembrane penetrative capability. To assess the effect of cellular differentiation, 
3D tissue culture techniques were also employed, and cell contact mediated toxicity 
assays attempted. As the samples used are of environmental origin, the PM10 
extraction methods have also been refined to increase yield, and sterilisation 
techniques adapted to reduce changes to surface chemistry which may determine 
some component of toxicity. However, gentler approaches to sterilisation require 
caution; environmental samples contaminated with endotoxins may greatly influence 
toxicological results obtained 266. 
 
The samples received from the ChemCentre WA for toxicological analysis are 
sourced from the stockpiles of mining sites producing many megatons of ore per 
annum and are thus significant sources of PM10 and PM2.5 pollution in the immediate 
region and shipping ports distal to the mines. Mining Area C (MAC, 42 mtpa), the 
Yandi mine (41 mtpa) and Newman Hub Mt. Whaleback (Newman) mine (37 mtpa) 
are represented. These mines are all located in the Pilbara region of Western 
Australia. BHP Billiton owns a majority stake in these mines (85%) and employs 
some 8,000 people in the region. The town of Newman is adjacent to the Mt. 
Whaleback mine and is populated by 4,245 residents. Table 11 shows satellite 
imagery of these mines. Samples directly obtained from BHP Billiton in 2009-2012 
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were tested, however were suitable for method development only as BHP Billiton 
could not guarantee the source and purity of the samples. 
 
Table 11: Satellite imagery of mining sites. Elevation emphasis x3. Supplied by Google Earth, Newman 2005, Yandi 2011, 
MAC 2011, Pilbara 2012. 
 
Newman Hub Mt. 
Whaleback Mine 
(Newman) 
 
 
Yandi Mine (Yandi) 
 
Area C Mine (MAC) 
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Overview of Pilbara 
region and mines. 
Newman is 350 KM 
from Port Hedland and 
approximately 87 KM 
from Yandi and MAC 
mines. Yandi and MAC 
are approximately 25 
KM away from each 
other. 
 
3.2 Materials and Methods 
3.2.1 Cyclone Separation 
Sampling the air for PM10 and transferring this into lab based experiments is the 
most direct method to obtain PM10 and PM2.5. However, investigation into the 
feasibility of these processes for supplying the project revealed that it presented a 
major bottleneck, and the Ecotech HIVOL samplers at BHP Billiton would only be 
able to supply several dozen micrograms of sample per week which would not be 
sufficiently rapid to sustain all experiments. 
 
Cyclone separation was instead used to extract aerodynamic PM10 and PM2.5 from 
ore samples prior to 2012. A tangential flow cyclone separator traditionally used as a 
wearable device for occupational exposures was adapted to extract respirable 
fraction particles at an airflow rate of 4.21 L/min and 1.61 L/min to extract thoracic 
fraction particles (see Figure 19). Samples were continually turned over every 30 
minutes to ensure the surface mixture contained extractable PM10 and PM2.5, and 
filter papers were generally saturated and ready for collection after 4-6 h. Samples 
were brushed off filter paper into collection tubes for autoclaving before suspension 
in media, providing some 250-500 µg of sample per week when continuously run. 
This created delays of several weeks between sample reception and assay. 
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Figure 19: Outline of cyclone separation apparatus operation and collected sample. 
 
3.2.2 Ultrasonic Sieving 
Despite improvements over atmospheric sampling, the rate of sample collection by 
cyclone separation remained a limiting factor in the experimental process. Sieving 
was deemed to be a superior technique for acquiring PM10 rapidly. However, 
traditional sieving techniques are best suited to acquiring samples only as small as 
45 µm.  To sieve below 10 µm, an Ultrasonic Sieve Ring and shaker tower were 
acquired by 2012, along with custom 10 µm electroformed sieves (Precision 
Eforming LLC, New York, USA). The ultrasonic burst interval, intensity and shaker 
intensity were adjusted to provide optimal extraction efficiency and avoid sieve 
damage. Any sieve damage which occurred was repaired by epoxy resin to avoid 
collecting unintended size fractions. Placement of the ultrasonic ring below the 
electroformed sieve and above the collection plate was found to decrease damage to 
the electroformed sieves. The optimised operation of the apparatus was able to 
supply 1-2 mg of PM10 over a 6 hour period of completely automated operation (see 
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Figure 20). This allowed samples to begin the assay process one day after 
reception. 
 
 
Figure 20: Sieve shaker and ultrasonic ring (left) with ultrasonic wave generator (right). 
 
Ultrasonic sieving was used to extract PM10 from < 45 µm iron ore samples sieved 
and characterised by ChemCentre WA from the MAC, Yandi and Newman mines as 
well as Iron-Ore A and B samples. During the sieving procedure, aluminium foil was 
used to line the collection tray to allow easier transfer of dusts into collection tubes 
by brushing and prevent contamination from the brass collection tray, while the top 
sieve was also covered in aluminium foil to avoid dispersion of inhalable material into 
the laboratory environment. Once sieved onto the collection tray, the sample was 
brushed off into 5 mL Falcon tubes (BD Biosciences, USA) and fractionally sterilised 
(see section 3.2.3) for mixture with media or biofluid.  
 
3.2.3 Fractional Sterilisation 
Steam autoclaving of samples (121 °C, 15 psi, 15 mins) has the potential to solvate 
adsorbed toxicants on PM samples, while dry autoclaving (170 °C, 60 mins) also has 
the potential to volatilise adsorbed toxicants. In an effort to reduce changes to 
surface chemistry, radiative methods such as UV were tested, but penetrated the 
sample mass insufficiently to guarantee sterilisation. Fractional sterilisation 
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(tyndallisation) methods were found to be optimal, and introduced to the MAC, Yandi 
and Newman samples which were ultrasonically sieved. The sample collection tubes 
(50 mL, BD Biosciences, San Diego, USA) were heated to 60 °c for an hour and 
allowed to cool each day for three consecutive days. The cooling time allows 
bacterial and fungal spores surviving the heat sterilisation to germinate and be 
destroyed by the subsequent sterilisation round, while avoiding extreme changes in 
heat and humidity brought about during the autoclaving process. 
 
3.2.4 Chemicals and Reagents 
Poorly-soluble oxide particulate standards (Sigma Aldrich, USA): Copper(II) Oxide 
<50 nm, Copper(II) oxide <5 µm, Iron(II,III) Oxide <5 µm, Iron(II,III) Oxide <50 nm, 
Iron(III) Oxide <5 µm, Silicon(IV) Oxide <10 µm, Titanium(IV) Oxide <50 nm. Soluble 
iron compounds (Sigma Aldrich, USA):  Iron(II) Lactate Hydrate, Iron(III) Sulphate 
Hydrate, Iron(II) D-Gluconate Dihydrate,  Iron(III) Chloride on Silica. Other standards: 
Carbon Black <150 nm powder was obtained from US Research Nanomaterials, Inc., 
USA. Samples: Iron Ore A and B PM10 (obtained in 2009-2011, deprecated after 
BHP Billiton informed these car dumper samples may be contaminated in exchange 
for samples MAC PM10, Yandi PM10, Newman PM10 used in subsequent chapters).  
 
Differentiation of U937 to a mature macrophage-like morphology can be induced by 
exposure to phorbol esters 267. For this purpose, differentiation was induced during 
the seeding period by exposure to 30 ng/mL of Phorbol Myristic Acid (PMA) for 48 h. 
 
Dipalmitoylphosphatidylcholine (DPPC) (#P5911-250MG, Sigma Aldrich, USA) was 
employed as a surfactant additive in creating a synthetic biofluid, which has been 
described as successful in dispersing ultrafine carbon black when used in 
combination with albumin 146. DPPC was prepared in 100% ethanol stock and added 
to media for a final concentration of 10 µg/mL (0.1% ethanol v/v), with bovine serum 
albumin (BSA) 2 mg/mL. 
 
For 3D spheroid culture experiments, 96-well plates were prepared with a mixture of 
1.5% v/v agarose gel and F-12K media, 50 µL per well, and allowed to set for 1 hr 
prior to seeding. 
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Cell viability was analysed by the 3-(4,5-Dimethylthiazol-2-yl)-5(3-
carboxymethonyphenol)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) assay, 
marketed as the the CellTiter 96® Aqueous Non-Radioactive Cell Proliferation Assay 
(#G5430, Promega, USA) 
 
3.2.5 Cell Culture 
Cell types cultured: A549 pulmonary type I/II-like epithelial adenocarinoma (ATCC 
CCL-185), LL24 pulmonary normal fibroblast (ATCC CCL-151), U937 monoblastic-
like histiocytic lymphoma (ATCC CRL-1593.2).  
 
The A549 and LL24 cell lines were cultured in F-12K medium (#21127, Life 
Technologies, USA) supplemented with 10% foetal bovine serum (FBS), 100 IU/mL 
penicillin, 100 µg/mL streptomycin, and 10 mg/mL amphotericin B (#A9528-50MG, 
Sigma Aldrich, USA). U937 was cultured in RPMI 1640 medium (#72400, Life 
Technologies, USA) supplemented with 10% foetal bovine serum (FBS), and 100 
IU/mL penicillin, 100 µg/mL streptomycin, 10 mg/mL amphotericin B (#A9528-50MG, 
Sigma Aldrich, USA), 2mM L-glutamine, 1mM Sodium pyruvate and 10mM HEPES 
buffer. 
 
Cells were cultured in 75 cm2 tissue culture treated flasks (Corning, USA) at 37 °C in 
humidified 5% CO2, 95% air atmosphere. A549 and LL24 medium was changed 
every 2-3 days and split every 5 days. As they are adherent, cells were harvested for 
seeding using trypsinization and washing in Phosphate Buffered Saline (PBS). U937 
were cultured in suspension and maintained in at 2 x 105 to 1 x 106 cells/mL by 
passage every 4 days. 
 
For seeding incubation, cells were plated in clear flat bottom 96-well plates (BD 
Biosciences, USA) at 70% confluency (100 µl/well, 2x105 cells/mL) and incubated for 
24 h prior to the particle exposure time period at 37 °C under Breath Easier sealing 
membrane for multiwell plates (#Z763624, Sigma Aldrich, USA). 
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For cell contact experiments, 1 µm polycarbonate pore Transwell™ 6 well plate filter 
inserts (#Z681814, Sigma Aldrich USA) were inserted into 6-well plates (BD 
Biosciences, USA) after cell incubation, and particulate sample added above the 
insert.  
 
3.2.6 Cytotoxic Endpoint Development 
3.2.6.1 Particle Interference in Spectroscopic Assays 
The testing of insoluble particles for cytotoxicity rather than soluble chemicals poses 
many technical challenges. Both cell surface area exposure to particles as well as 
the concentration of the suspension must be considered, and the particle number 
which may vary greatly depending on the weight and size distribution of the particles. 
Once these are accounted for, traditional bioassays may require substantial 
adaptation to work with particles. Cell proliferation assays are a major endpoint for 
cytotoxicity, apoptosis and quiescence. By measuring the metabolic activity of an 
exposed group of cells against an unexposed control, the loss of metabolism due to 
exposure is proportional to the loss of cell number or cell function. 
 
A mainstream method to measure cell proliferation is the colorimetric MTS assay, a 
derivation of the well-established 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay. It was initially determined this assay which detects the colour 
change of a substrate as it is metabolized (MTS+PMS formazan) should be used 
on the 96 well assay plates to construct a dose-response relationship using a serial 
dilution of sample. 
 
Work to optimise the experimental concentrations and durations revealed problems 
in the MTS assay for cell proliferation in assessing coarse particle toxicity, as well as 
physical problems in pipetting particle suspensions, preventing the collection of 
interpretable data. In initial assays, the unmodified MTS assay showed increasing 
cell proliferation with increasing dose, rather than increasing toxicity with increasing 
dose as would be expected. As increased absorbance indicates increased cell 
survival in the MTT assay, absorption or blocking of light by the insoluble iron-ore 
samples and particulate standards was determined to be the cause of these results. 
This was confirmed by light microscopy observation, showing that while copper oxide 
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dispersions did indeed lead to cell apoptosis, iron compounds did not necessarily 
cause significant cell death at concentrations that were high enough to interfere with 
visible light (see Figure 21). 
 
 
Figure 21 Light microscopy 200x magnification of A549 and LL24 cells exposed to CuO and Fe3O4 over 48 h using micron-
size standards. 
 
To remedy this, cells were washed prior to assay in PBS to free them of particulate 
interference. The effect of the washing step was effective in trending the dose-
response relationship along the correct gradient, although results varied significantly 
between experiments and failed to show any correlation with particle composition. 
Light microscopy of 6 well plates before and after the washing step revealed that at 
high concentrations, particles became embedded in all cell lines and therefore could 
not be washed away without destroying cells (see Figure 22). Trypan blue staining 
indicated A549 survival rates of at least 85% when exposed to 390 µg/cm2 of Iron 
ore A and B samples over 24 h, sans washing step. Therefore cell destruction during 
the washing step was implicated in the dose-response curves observed, confounding 
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the determination of coarse particle toxicity. Dramatic macroscopic patterns were 
also observed at high particulate loads over longer time periods of 96 h, owing to 
cell-particle interaction characteristics (see Figure 22). In the A549 cell line 
exposures particle distribution remained similar to that of empty wells, while the cells 
themselves appeared largely unaffected by the presence of particles and adherent. 
In contrast the polar and self-aligned growth characteristics of the LL24 cell line was 
observed to produce a mottled pattern with particulate matter clumping along axes of 
fibroblast growth. In the U937 cell line a more uniform and granular appearance 
resulted. This was microscopy observed to be the clearance and concentration of 
particles by macrophages into clumps, possibly facilitated by phagocytosis to the 
point of cell overloading and death.  
 
 
Figure 22: View of A549, LL24 and U937 cells in 6 well plates exposed to 390 µg/cm2  Fe2O3. Top row: 96 h post exposure 
1X; Bottom Row: Immediately after PBS wash 200x magnification. 
 
3.2.6.2 96 Well Plate Layout 
In response to these effects, the arrangement of replicates and controls (Figure 23) 
was designed to compensate for particle interference no longer controlled by a 
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washing step, by including both traditional no-exposure controls and exposure no-
cell controls. 
 
 
Figure 23: A typical 96-well plate plan for the MTS assay  
 
Two sample rows exposed to cells (row mean = As) at 1x104 cells/well with a third no 
cell exposure (Ab) form one sample bracket and help counteract the effects of 
particle opacity while a control bracket of three rows with cells and no exposure (row 
mean = Ac) form the control measurement which is measured against. Three of 
these plates are used for accuracy (6 replicates at each data point). Survival rate 
calculation: 
 
 Survival rate (%) =
As−Ab
Ac−Ab
.  
 
Conversion from mg/mL suspension concentration (Cs) to mg/cm2 surface area 
concentration (Ca) is shown below where Vws is sample volume in well and Wa is well 
area. It is assumed particle settling time is negligible over the exposure period. The 
resulting figure is multiplied by a thousand for expression as µg/cm2: 
 
Ca =  
Cs×Vws
Wa
  
 
3.2.6.3 Adapted MTS Assay 
The final adapted MTS assay carries improvements over the standard protocol to 
minimise collateral cell death due to particle abrasion and reduce uneven 
evaporation in multiwell assay plates by using appropriate controls and sealing 
membranes, a problem that has been previously recognised affecting longer 
duration, low toxicity exposures 268. The assay was continued normally without a 
Experiment Tpe Date
ID # # µl/well Cell Line Cells/well Seed # h Exposure # h Notes
Friday
 # μg/ml stock 1 2 3 no cell 4 6 5 no cell 7 8 3 no cell 10 11 12
1 in 2 A
1 in 2 B
1 in 2 C
1 in 2 D
1 in 2 E
1 in 2 F
1 in 2 G
1 in 2 H
Sample 1 Sample 2 Sample 3 Controls
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washing step until the MTS incubation step with the sample was completed. The 
reaction was then stopped with ethanol and 75% of the well volume supernatant 
transferred to a new clean 96 well plate (see Figure 24). This allowed live cells to 
metabolise the assay substrate normally, and due to the settling properties of the 
particles, the extracted supernatant for measurement remained low in particulate 
interference in experimental exposures longer than 24 h. This was corroborated by 
control rows of particulate matter in serial dilution without cells to be subtracted as 
described (see section 3.2.6.2), which showed no measurable increase in opacity 
with higher concentrations. 
 
 
Figure 24: Terminal procedure for adapted MTS assay to avoid particulate interference with absorbance assays 
 
The importance of aligning all sample endpoints by cytotoxicity is underscored by the 
unknown mode of toxicity for a given PM sample. Repeating these experiments 
across different laboratories by other alignments, such as mass by suspension 
volume or mass by surface area, provide less of a guarantee downstream endpoints 
will bear any relationship because the toxicological action of particulate samples 
could be mediated either through contact or soluble factors – the ratio of which can 
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change depending on size distribution and total reactive surface area, extraction 
method, assay format, media type and reagents used. 
 
Concentrations ranging from 5 mg/mL to 0.1 mg/mL for a 1:2 serial dilution into 96 
well plates were used to determine initial cytotoxic parameters. The preferred stock 
concentration subsequent to initial experiments was found to be 1 mg/mL, with the 
exception of copper oxide stock at 0.25 mg/mL due to its much greater toxicity. 
 
3.3 Monolayer Cytotoxicity Results 
The toxicity of the iron ore samples (Iron Ore A, B, and MAC, Yandi and Newman 
samples) were measured against several standards. The SiO2 < 10 µm standard 
was chosen to compare against silica dusts, which are abundant in many industrial 
activities as silica compounds compose 28% of the earth’s crust. The U.S. 
Occupational Safety and Health Administration’s permissible exposure limit is 100 
µg/m3 in an 8 h work day, to protect against known pulmonary disease outcomes 95. 
Iron is also abundant, composing 5.6% of the earth’s crust. The CuO < 5 µm 
standard was chosen as a relatively cytotoxic control given its use as a sterilising 
agent 216 and the CuO < 50 nm standard for determination of size-dependent toxicity 
190. The Fe3O4 < 5 µm and Fe2O3 < 5 µm standards were used as magnetite and 
haematite iron oxide references with the Fe3O4 < 50 nm sample also being used for 
size dependent toxicity tests. The TiO2 < 50 nm standard was chosen for reference 
to existing in-vitro literature where it is extensively studied in relation to nanomaterial 
containing consumer goods 269. 
 
While soluble iron compounds were assayed, comparing solubilised weight to 
volume ratios of the various soluble iron compounds to particulate matter was not 
found to produce informative comparisons. As the particulate samples assayed were 
highly insoluble in nature, the weight to cell surface area exposed convention was 
adopted. This more accurately reflects changes in cell behaviour mediated by 
particulate surface contact with the cell membrane as the particles rapidly settle 
within the exposure well, and is applied in the literature for in-vitro PM10 and PM2.5 
exposures 202,229,233,270,271, although the w/v relationship holds proportionally so long 
as the well area and media volume are constant. 
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3.3.1 LL24 Monolayer Toxicity 
Analysis of cytotoxicity using the adapted MTS assay showed that insoluble PM had 
very little effect on cell viability despite high concentrations used. Once a maximum 
effect level was reached, likely indicating saturation contact of cells with PM, 
cytotoxic changes were minimal and did not follow a traditional dose-response 
relationship. Standards Fe3O4 < 5 µm, Fe2O3 < 5 µm, TiO2 < 50 nm, Iron Ore A < 10 
µm, and Iron Ore B <10 µm were tested. Over 24 h, neither of the micron-size iron 
oxide standards, iron ore samples, nor TiO2 achieved an IC50 value in the LL24 cell 
line (see Figure 25) 
 
 
Figure 25: LL24 24 h particle toxicity, using iron ore samples and reference compounds. From a 1:2 serial dilution over 
12-1562 µg/cm2. 
 
Over a 48 h long exposure period, the maximum cytotoxicity is increased (see Figure 
26). However, the nature of this increase in cytotoxicity may be confounded by 
adsorption of protein and obstruction of media diffusion in addition to direct cytotoxic 
effects 166. 
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Figure 26: LL24 48 h particle toxicity, using iron ore samples and reference compounds. From a 1:2 serial dilution over 
12-1562 µg/cm2. 
 
Over a 96 h long exposure period (see Figure 27), the dose-response relationships 
had largely moved through the IC50 toxicity level. However, there was remarkably 
little movement in the maximum cytotoxicity despite increased separation between 
sample toxicities. 
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Figure 27: LL24 96 h particle toxicity, using iron ore samples and reference compounds. From a 1:2 serial dilution over 
12-1562 µg/cm2. 
 
 
3.3.2 A549 Monolayer Toxicity 
The A549 cell line responded similarly to the LL24 cell line in terms of the ranking of 
toxicity of particulates, showing greater divergence in the 24 h period (see Figure 
28). Interestingly, the Iron Ore A and TiO2 sample were again found to have a similar 
toxicity, approaching an IC50 of 390 µg/cm2 after 24 h, while Iron Ore B and the 
micron-size iron oxides remained largely indistinguishable and less cytotoxic. The 
similarity of the Fe3O4 and Fe2O3 standards allows to the former to be substituted for 
the latter if room is required for additional standards to be compared on the same 
plate. 
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Figure 28: A549 24 h particle toxicity, using iron ore samples and reference compounds. From a 1:2 serial dilution over 
12-1562 µg/cm2. 
 
Over a 48 h long exposure period, the maximum cytotoxicity is increased and some 
differentiation of the particulates occurred at the lower concentrations (see Figure 
29). For this reason, the 48 h interval was considered optimal for differentiation of 
particle cytotoxic effect while minimising error due to evaporative and other effects 
accruing over time. 
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Figure 29: A549 48 h particle toxicity, using iron ore samples and reference compounds. From a 1:2 serial dilution over 
12-1562 µg/cm2. 
 
Over a 96 h long exposure period, the maximum cytotoxicity responded in an 
inelastic fashion in comparison to lower dose exposures, although greater 
differentiation also occurred at the lower doses (see Figure 30). This differentiation 
appeared maximum within a range of 24-94 µg/cm2. 
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Figure 30: A549 96 h particle toxicity, using iron ore samples and reference compounds. From a 1:2 serial dilution over 
12-1562 µg/cm2. 
 
The dose-response relationship between low and high cytotoxic effects of the 
particle exposures suggest that a return on effect diminishing towards zero 
approached in the toxicity mode active at the upper end of the dose range. While the 
level of agreement between the A549 and LL24 cell lines added to the robustness of 
the observed effect, the sensitivity limit of the assay appears to be inadequate to 
truly differentiate the insoluble metal-oxide samples types observed at lower doses 
which would be of greater physiological relevance. 
 
3.3.3 Lung Surfactant and Size-Dependent Effects 
The addition of DPPC 10 µg/mL and BSA 2 mg/mL to culture media was used to 
create a synthetic biofluid with lung surfactant and disaggregation effects described 
by experiments in the literature 148,154, for assessing whether such biofluids alter 
cytotoxicity. Surfactant added media was used in both sample suspension and assay 
culture. Prior to dosing, sample tubes were ultrasonicated for 30 minutes and 
vortexed immediately before pipetting. The TiO2 < 50 nm, Fe304 < 50 nm, CuO < 50 
nm and CuO < 5 µm samples were used in the cytotoxicity analysis, and compared 
to identically prepared samples without DDPC or increased BSA concentration using 
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the A549 cell line. CuO and Fe304 was also compared in the LL24 cell line (see 
Figure 30). 
 
 
 
Figure 31: A549 (right) and LL24 (left) experiments examining differences in cytotoxicity when the lung surfactant 
protein and BSA were used together in combination with ultrasonication against regular media suspensions of 
particulate matter. 
 
The results indicate there is very little or no effect as a result of the addition of 
surfactant protein and ultrasonication steps as no significant differences were 
observed between the exposure groups. Evidence in the literature supports this 
finding, as it has been calculated the force required to overcome particle aggregation 
cannot be overcome by the protein-particle interactions which occur in the production 
of surfactant effects 153. This is emphasised by the relatively modest difference 
between the toxicity of nanoscale and micron size CuO particles, which was not 
enhanced by the surfactant proteins. If disaggregation were a significant effect, it is 
presumed cytotoxicity would be increased by increased specific surface area of 
particulate exposed to cells. Furthermore, under light microscopy no surfactant 
mediated disaggreagative effects were distinguishable from controls. 
 
While albumin concentrations as high as 15 mg/mL are shown to be required to 
stabilise some nanoparticle suspensions 145, the resulting increased specific surface 
area of the suspension may be counteracted by reduced catalytic activity in the 
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generation of ROS. Such concomitant effects are undesirable, compounded by the 
questionable physiological relevance of such high albumin concentrations. It has 
been shown using BSA that albumin carries antioxidant effects, which may interfere 
with the oxidative stress mechanism of cellular damage 151, and further reduce 
intracellular nanoparticle uptake 150. 
  
3.4 3D Cytotoxicity Results 
3.4.1 A549 Spheroid  
Cytotoxicity studies were performed to establish the utility of spheroid cell culture 
methodology as a suitable 3D cell culture system. Seeding of cultures was 
performed at normal 2D culture densities, onto well surfaces coated with a 1.5% 
agar-media mix which had been allowed to set and brought to room temperature 
(see Figure 32). 
 
 
Figure 32: Diagram of 3D spheroid structure within microtitre 96 well plate. 
 
Different cell lines were examined for the construction of the spheroid, shown in 
Figure 33, panels A-D, after 48 hours of incubation. The regularity in shape of 
spheroid clusters was dependent on cell type. Monocyte differentiated macrophages 
(U937) were found to be incompatible with spheroid culture techniques, as they were 
unable to form spheroids through self-adherence and hence remained settled on the 
well surface.  
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A  
 
B 
  
C 
  
D  
 
Figure 33: Images of spheroid cultures after 48 h post seeding: A: A549 cells tended to cluster in a tight spheroid on agar. 
B: LL24 cells tended to form more diffuse spheroids on agar. C: A549+LL24 cells tended to form very diffuse cell masses 
on agar. D: A549 cells cultured conventionally on the well surface shown for reference. Magnification 200x.   
 
In particle exposure experiments, the A549 spheroid system demonstrated reduced 
sensitivity compared to 2D systems. However the nature of this reduced sensitivity 
was helpful in determining the transmission of cytotoxic action for a given particulate 
sample; as spheroids reduce the cell surface area available for contact with particles 
for a given cell number, it is expected that particles with soluble toxic components 
will maintain cytotoxic power better than those solely exerting cytotoxicity through 
cell contact or uptake. If so, this most clearly supported by the observation of CuO 
exposures compared to the other particles. At a dose of 0.138 mg/mL (24.5 µg/cm2) 
a toxicity of 24% continues to be exerted where no significant toxicity is observed in 
the other sample types at 0.276 mg/ML (49 µg/cm2), as show in Figure 34.  
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Figure 34: A549 3D spheroid, 96 h particle toxicity, Fe3O4 and Iron Ore A at 390-49 µg/cm2. Concentration of CuO at 195-
24.5 µg/cm2, shown in brackets. 
 
As particles settle over the 96 h exposure period, the surface area of the spheroid in 
contact with particles will be far less in practice, as most particles will rest at the well 
bottom not in contact with the spheroid. The potency of CuO cytotoxicity at the 
lowest dose therefore suggests that the catalysis of ROS or effusion of a soluble 
intermediate occurs. While CuO is considered insoluble, limited production of soluble 
species may still occur and the concomitant cytotoxic activity of these species has 
previously been intimated in the literature 133,272.  
 
3.5 Cell Contact Cytotoxicity Results 
3.5.1 Insert Culture 
To further investigate the role of cell contact, 1 µm pore filter inserts were used to 
investigate whether cytotoxicity could be mediated without direct contact using 6-well 
plates. This was achived by separately layering the particulate exposure material on 
top of inserts after cells had been seeded at the bottom of the well normally (Figure 
35). Using the 6 well plates posed additional challenges , causing particles to settle 
in the middle of the well rather than disperse evenly, increasing the error of results. It 
can be observed however that CuO is able to mediate toxicity similar to positive 
controls despite insert separation, and this further supports the possibility that 
soluble species, redox catalysis or to a lesser extent (given the 2 mL well volume), 
nutrient adsoprtion affects cell survival. 
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Figure 35: LL24 and A549 Transwell™ insert, 6 well plate culture assay. CuO micron size particles assayed. 
 
 
3.6 Discussion 
The experiments in this chapter reflect adaptations towards dealing with particulate 
matter in a manner that is aware of the limitations in directly applying current 
biochemistry and cell biology methodologies to poorly soluble micron-size particles. 
Similar investigations in the literature in-vitro increasingly are finding that once 
effective endpoints and metrics of toxic interactions with lung cells are found, the 
epidemiological assumptions about toxicity as a function best predicted by particle 
size and inhaled mass are inadequate to explain toxicity 222. The wide range of toxic 
interactions requires comprehensive analysis of biological endpoints, while 
accounting for adsorbed toxicants and immunological interactions as well as size-
distribution 163. As found in the cell proliferation experiments, dose response curves 
become difficult to construct when dealing with poorly soluble particulates such as 
metal oxides where cytotoxicity can range from high, as seen in the CuO standard, 
to having a maximum cytotoxic effect, as seen with other samples. Yet, particle 
number alone can begin to overwhelm the immunological clearance of particles 
independent of cytotoxicity in chronic exposures 91. At the size ranges investigated, 
differences between micron and nanometer size particles were also difficult to 
distinguish, driven by the effect of agglomeration. Particle size differences at these 
ranges may require dynamic immunological interactions to effectively observe, 
otherwise constrained by strong agglomeration 266. 
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Attempts to elicit more dynamic effects through emulating a more complex lung 
structure or increasing cellular differentiation also have a limited impact on 
discriminating which toxic modes a given poorly soluble particle is active in. The 
spheroid experiment may offer clues to a particle’s solubility, however this may be 
redundant as insolubility is indicated by particles with an apparent maximum level of 
effect in monolayer experiments and filter based experiments offer a more targeted 
way to approach this problem. A typical spheroid 1.4 mm in diameter has an 
approximate surface area of 6.2 mm2, compared to a surface area of 25 mm2 for an 
80% confluent 96 well microplate monolayer. This is some 3 fold less surface area 
exposed. If cytotoxic responses were mediated solely by surface interaction, it 
follows that a sphere would exhibit only a fraction of the effect. Spheroids are also 
unsuitable to high sensitivity or long term assays and develop necrotic cores if 
exceeding 400 µm in diameter. Their non-adherent nature also poses additional 
challenges in serial dilutions or other exercises requiring media transfer. 
 
Despite these problems, determining the cytotoxicity of a particle is not a problem 
that can be ignored, as it has traditionally been a source of discrepancies between 
in-vivo and in-vitro experiments of haematite dusts 273. Given the variability of the 
effect of other measures of differentiating particles including size-distribution and 
particle number, to reasonably expect downstream endpoints to be comparable such 
as oxidative stress and cytokine signalling profiles, cell death must be matched as 
closely as possible. It must also be expected that many insoluble particulates will be 
poorly distinguishable in effect 167, even when acting through a multitude of pathways 
205. However, the general findings presented in this chapter suggesting a toxicity 
hierarchy of CuO > TiO2 > Fe2O3 and iron ore samples is consistent with similar 
experiments in the literature 214,215. 
 
A newer reagent, PrestoBlue (Life Technologies) resazurin based assay, replaces 
the MTS assay (Promega) in subsequent chapters, based on the findings in this 
chapter. The MTS assay requirement for two 96 well plates to complete one assay 
increased error due to multiple pipetting steps. The difficulty of obtaining IC50 data 
also led to high concentrations of particulate sample being used. These experiments 
have established that the amount of sample required to reach IC50 is not only 
physiologically irrelevant to environmental exposure but brings about model specific 
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limitations not present in the biology. For example, it is possible the particle layer 
affecting diffusion of media to cells may have been a major contributor to the IC50 
values found. Therefore, the IC20 concentration data is more relevant. For these, 
exposures are started at 1000 µg/ml (312 µg/cm2 for 100 µl 1:2 dilutions in a 0.32 
cm2 well) and therefore less optically dense. The IC20 concentrations while still high 
in mass terms, allow comparative toxicology of oxidative stress and cytokine 
responses to scale on a more accurate measure of interaction 212. Secondly, 
laboratory upgrades from the FLUOStar Optima to the FLUOStar Omega (BMG 
Labtech) allow multiple measurements per well in an orbital track and the opportunity 
to perform top-down fluoresce measurements.  
 
Given that the resazurin assay responds in both absorbance (600 nm) and 
fluorescence (excitation 540-570 nm, emission 580-610 nm) ranges, the selection of 
the fluorescence measurement and top-down optic emission reading provides the 
advantage of being less susceptible to the interference of particles, where individual 
particles or agglomerations obscure the bottom reading optic absorbance 
measurements. In the FLUOStar Omega, top-down a xenon flash lamp provides the 
excitation emission which passes through a filter into the clear bottom well. The 
diffuse light of this flash is blocked only by the average opacity of the suspended 
dust in the well and causes the fluorescence emission to occur throughout the 
media. When the top-down optic measures the fluorescence, there is little or no 
impact on the measurement from particles as they are at the bottom of the well.  
 
Another significant advantage presented by the resazurin based assay as opposed 
to the MTS assay is that it is minimally cytotoxic by comparison, subsequently 
allowing downstream assays. The MTS-formazan product in the MTS assay is 
insoluble in water, causing purple needle shaped crystals to form in the cells unless 
an organic solvent is part of the assay kit, and the test is somewhat cytotoxic. 
PrestoBlue can therefore be used prior to both the Cytometric Bead Array Human 
Inflammatory Cytokines Kit (CBA HICK, BD Biosciences, USA) and the Luciferase 
assay (Promega) used to detect oxidative stress in AREc32 cells. Assay multiplexing 
in this way allows cell viability to be tied directly with these endpoints so that values 
can be normalized.  
 
88 
 
4. In-Vitro Comparative Toxicology of Inhalable Iron-Rich 
Particles from Mining Industry in Western Australia 
 
4.1 Introduction  
Australia exported approximately 505 million tonnes (Mt) of iron ore in 2012, placing 
it as the world’s largest exporter. The industry’s scope and growth has significant 
economic and environmental ramifications, largely affecting Western Australia where 
exports have doubled over the last five years to 2012 and continued growth is 
projected. In towns associated with iron ore export activity in Australia, fugitive dust 
has become a prevailing air quality hazard owing to semi-arid conditions and 
encroachment of housing development toward high volume shipping terminals. The 
town of Port Hedland is one such settlement, home to over 15,000 residents and is 
the region’s largest port by tonnage, exporting 240 Mt per annum of material mined 
from the productive Pilbara region. Iron-rich particles account for up to 93% of total 
suspend particulates (TSP) in the town by volume 2,4. 
 
The current regulatory framework adopted by leading international bodies including 
the World Health Organization (WHO), US Environmental Protection Agency 
(USEPA) and the EU makes few distinctions between the health burdens of aerosols 
and liquids, nor their respective compositions bar a select few pollutants; ozone, 
nitrous oxides and sulphuric oxides. The focus has instead been to stratify 
particulate matter (PM) by size and set guideline limits governing the acceptable 
mean daily and annual concentrations. This format works well for urban air pollution 
and is targeted at the minimum concentration at which health effects are observable 
to a 95% confidence interval, known as the Air Quality Guideline (AQG) which is set 
by the WHO, although a threshold value which eliminates health burdens entirely 
may not exist 12,48. 
 
Meta-analyses of urban epidemiological studies serve as the basis for the AQG, and 
show smaller particles are more clearly associated with morbidity and mortality than 
larger fractions. The Australian Ambient Air National Environmental Protection 
Measure (NEPM) specifically governs PM10 and < 2.5 µm diameter particles (PM2.5) 
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separately. PM10 is not to exceed a 24 h mean concentration of 50 µg/m3 and the 
PM2.5 component is not to exceed a 24 h mean concentration of 25 µg/m3, nor a 
mean of 8 µg/m3 per annum. Because of difficulties meeting these requirements, 
especially in proximity to the port facilities, the WA state government has proposed 
an interim lifting of site-specific PM10 limits to 70 µg/m3 in Port Hedland 4. 
 
Increasing the annual mean PM 2.5 concentration by 10 µg/m3 may be expected to 
increase pulmonary, cardiovascular and all-cause morbidity and mortality by up to 
10%, whereas the same mean increase limited to a 24 hour period can be expected 
to increase morbidity and mortality just 1% 15. While dust storms occur with regularity 
in Port Hedland requiring exceptions in the NEPM air quality guidelines for natural 
events, the fibrotic potential of iron-rich particles must be assessed for residents and 
authorities to be aware of health risks mediated by ambient fine particulate matter. 
Lung fibrosis and obstructive diseases 15,28,95,96,122,194,274, inflammatory responses 
189,212,232,275,276 and cardiovascular 45,73,117,277,278  implications have all been 
associated with PM10 and PM2.5 inhalation, although prediction of long term health 
outcomes remains unclear by any other metric than size, though various factors 
have been proposed as indicators of fibrotic potential 57,73,196,279. Inorganic transition 
metal such as iron may have unique modes of action and catalytic potentials 132. 
New toxicological data specific to the area benefits both prediction of long term 
health outcomes and may shed light on contributors to acute toxicity to vulnerable 
populations, as well as rationalise dust mitigation actions which have their own 
environmental and economic costs 80. 
  
Before personal protective equipment was commonplace in the workforce, 
occupational lung disease, or siderosis, had been well associated with iron ore 
mining for the better part of a century 17,122, and similar afflictions were also seen in 
steelmakers and welders 138,280,281. Surface miners were found to be less afflicted by 
lung diseases than underground miners, whom inhaled extremely high quantities of 
dust when pneumatic drills came into use 17. Unlike air pollution in large urban 
centres, epidemiological associations between industrial air pollution and morbidity 
and mortality in the general population have been harder to establish 70,282, hindered 
by small population sizes and confounding factors such as smoking 82,282.  
 
90 
 
This study aims to comparatively assess the in-vitro effects of iron-rich PM10 derived 
from three major Pilbara mines; Newman, Mining Area C (MAC) and Yandi which 
deliver crushed ore to Port Hedland. Commercially available < 5 µm Iron(II,III) Oxide, 
Copper(II) Oxide, < 10 µm Silicon(IV) Oxide, < 50 nm Titanium(IV) Oxide,  and 150 
nm carbon black (CB) have been chosen as standards to compare against existing 
literature 172,209,283. Benzo[a]Pyrene (B[a]P) ]has been included in cytotoxicity studies, 
being a potent aerosol carcinogen 284 and having the potential to be adsorbed onto 
particles 285 from industrial combustion sources 286. Four human cell lines bearing 
relevance to the development of pulmonary disease were selected to carry out 
toxicity tests; the A549 lung epithelium-like adenocarcinoma, LL24 fibroblast like 
normal cell line, U937 monoblastic-like histiocytic lymphoma and the AREc32 
transfected Antioxidant Response Element (ARE) reporter adenocarcinoma.  
 
The development of high-throughput in vitro models that can predict pulmonary 
disease is sought after to supplement conventional analytical techniques that predict 
toxicological characteristics based on chemistry and minimise animal use 162. In-vitro 
modelling is advantageous in its standardisation, use of human cell lines, cost-
effectiveness and speed in comparison to animal studies and epidemiological 
studies. However, inconsistencies observed between in-vitro and in-vivo literature 
require some form of resolution 91. To this end, we construct in-vitro experiments 
focusing on the limitations of modelling the lung parenchyma and associated 
phagocytic and inflammatory activity in response to long term particle residence. We 
find sensitivity is key in attempting to bridge the interpretation of cellular level 
biochemistry to tissue level disease using comparative toxicology, and that 
proliferative effects should be investigated more thoroughly. It is anticipated further 
data collection by high throughput bioassays with this understanding can allow 
meaningful risk assessment of ambient inorganic particulates with reduced 
ambiguity. 
 
4.2 Materials and Methods 
4.2.1 Chemicals and Reagents 
As standard compounds the following from Sigma Aldrich, USA were obtained: 
Copper(II) oxide <5 µm, Iron(II,III) Oxide <5 µm, Iron(III) Oxide <5 µm, Silicon(IV) 
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Oxide <10 µm, Titanium(IV) Oxide <50 nm. Carbon Black < 150 nm powder was 
obtained from US Research Nanomaterials, Inc., USA. Benzy[a]Pyrene (B[a]P) 
(#B1760-100MG, Sigma Aldrich, USA) was used as a carcinogenic potentially 
adsorbed combustion product standard. Tert-Butylhydroquinone (TBHQ) (Sigma 
Aldrich, USA) was used as the NRF2 (Nuclear factor (erythroid-derived 2)-like 2) 
positive control in oxidative stress experiments. The S9 male rat liver enzyme mix 
(Sigma Aldrich S2067-1VL) was used to emulate normal metabolism of PAH 
compounds. 
 
The PrestoBlue reagent (#A-13261, Life Technologies, USA) was obtained for cell 
viability experiments. The Luciferase Assay System experimental reagents were 
acquired as kit (#E4030, Promega USA) for identifying response to oxidative stress 
in the AREC32 cell line. The Human Inflammatory Cytokine Kit was used to detect 
interleukin expression (#551811, BD Biosciences, USA). Cells were fixed in 
glutaraldehyde prior to electron microscopy (Sigma Aldrich, USA). 
 
4.2.2 Particle Extraction and Sterilisation 
Representative iron ore stockpile samples were supplied from three major mining 
sites in the Pilbara region in Western Australia courtesy of BHP Billiton; Newman 
Hub Mine (Newman), Mining Area C (MAC) and Yandi Mine (Yandi). The supplied 
samples were sieved to < 45 µm by ChemCentre WA (CCWA). To sieve the samples 
further down to PM10, an ultrasonic sieve tower and accompanying custom 10 µm 
electroformed sieve was used (Precision Eforming LLC, New York, USA). 
 
To preserve as much surface chemistry as possible while reducing bacterial and 
fungal interference, sterilization was carried out based on fractional sterilization 
methodology. Sieved material was collected into 50 mL Falcon conical tubes (BS 
Biosciences, USA) and heated to 60 °C for 15 minutes before being allowed to cool 
at room temperature for 24 hours, repeated over three successive days. This 
negates the need for high temperature, pressure and moisture conditions under 
traditional autoclaving which may remove VOC and or other organic compounds. 
However, experiments conducted at CCWA show VOC are unlikely to remain 
adsorbed onto the iron ore samples naturally. 
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4.2.3 Particle Size Distribution Analysis 
Particle size profiles for the sieved PM10 iron ore samples were obtained on a 
Malvern Mastersizer 2000 (Malvern, UK) located at the Department of Chemical 
Engineering, The University of Queensland. Approximately 200 mg of PM10 was 
dispersed in water and a particle Refractive Index of 2.94 and Absorption of 0.1 
assumed. Size measurement ranged between 0.02 and 2000 µm. 
 
4.2.4 Particle Solubility Analysis 
To assess particulate solubility in culture medium and the effect of cell type on metal 
ion leaching, particulates were exposed to cell cultures before extraction of media for 
measurement. Cells were plated at 70% confluence in 6 well plates over 48 h in 400 
µL of media, at a concentration of 45 µg/mL for copper (II) oxide and 180 µg/mL for 
all other samples. A 1 mL sample of media was then extracted using a 0.22 µm filter 
and diluted to 5 mL with PBS. Inductively coupled plasma mass spectrometry (ICP-
MS) was then performed to analyse for free metal ion isotopes. The isotopes 
detectable by this method were 48Ti, 56Fe, 57Fe, 63Cu and 65Cu. 
 
4.2.5 Electron Microscopy  
Cells were grown on 12 well plates and incubated for 96 hours with samples. Media 
was drained from the cells and fixed with glutaraldehyde. Post fixation cells were 
cured with osmium tetroxide and baked in resin for four hours, then left to solidify 
overnight. Resin was then mounted and cut on an ultramicrotome (Lecia UC61, 
Germany) to 40 nm for observation by transmission electron microscopy (JEOL 
1010, Japan) on 400 square mesh copper grids (ProSciTech, Australia).  
 
4.2.6 Electron Density Spectroscopy 
The local chemistry of the particle microstructures were investigated by Energy-
dispersive X-ray spectroscopy (EDS) using an FEI Tecnai-F20 FEG TEM equipped 
with a Gatan image filter. Particles were suspended in ethanol and ground with a 
mortar and pestle to achieve fines small enough for analysis. The particles were then 
transferred to lacey carbon grids for analysis. 
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4.2.7 Cell Culture 
The A549 pulmonary type I/II-like epithelial adenocarinoma (ATCC CCL-185), LL24 
pulmonary normal fibroblasts (ATCC CCL-151) and U937 monoblastic-like histiocytic 
lymphoma (ATCC CRL-1593.2) were used to represent lung epithelial, connective 
and immunological cells, respectively. A transgenic cell line to indicate electrophilic 
and oxidative potential in vivo was also employed; AREc32 (CXR Biosciences, 
Scotland), a transgenic Nrf2 mediated Antioxidant Response Element (ARE) 
luciferase reporter, based on the MCF7 mammary adenocarcinoma cell line. 
 
The A549, LL24 and AREc32 cell lines were cultured in F-12K medium (#21127, Life 
Technologies, USA) supplemented with 10% foetal bovine serum (FBS), 100 IU/mL 
penicillin, 100 µg/mL streptomycin, and 10 mg/mL amphotericin B (#A9528-50MG, 
Sigma Aldrich, USA). U937 was cultured in RPMI 1640 medium (#72400, Life 
Technologies, USA) supplemented with 10% foetal bovine serum (FBS), and 100 
IU/mL penicillin, 100 µg/mL streptomycin, 10 mg/mL amphotericin B (#A9528-50MG, 
Sigma Aldrich, USA), 2mM L-glutamine, 1mM Sodium pyruvate and 10mM HEPES 
buffer. 
 
Cells were cultured in 75 cm2 tissue culture treated flasks (Corning, USA) at 37 °C in 
humidified 5% CO2, 95% air atmosphere. A549 and LL24 medium was changed 
every 2-3 days and split every 5 days. As they are adherent, cells were harvested for 
seeding using trypsinization and washed in Phosphate Buffered Saline (PBS). U937 
was cultured in suspension and maintained in at 2 x 105 to 1 x 106 cells/mL by 
passage every 4 days. 
 
For seeding and exposure incubation, cells were plated onto opaque flat bottom 96-
well plates (Becton Dickinson, USA) at 70% confluency (100 µl/well, 2x105 cells/mL) 
and incubated for 24 h prior to the particle exposure time period at 37 °C under 
sealing film (Corning, USA). 
 
Differentiation of U937 to a mature macrophage-like morphology can be induced by 
exposure to phorbol esters 267. For this purpose, differentiation was induced during 
the seeding period by exposure to 30 ng/mL of Phorbol Myristic Acid (PMA) for 48 h. 
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4.2.8 Cell Proliferation Assay 
Cytotoxicity of particulate matter was measured using a cell survival resazurin assay, 
PrestoBlue. After seeding incubation, cells were exposed to a 2 x serial dilution of 
particulate matter suspension down 8 rows. To achieve the first well concentration 
expressed as 312.5 µg/cm2 (unless CuO, at 78.1 µg/cm2),100 µL of 2 mg/mL (CuO, 
0.5 mg/mL) suspension was added to 100 µl of media per well of an area 0.32 cm2. 
Incubation with particulate matter was then continued until measurement for up to 96 
h, again under sealing film. For measurement, 10 µL/well of PrestoBlue reagent was 
added to the plates and incubated for 1 h (LL24) or 30 minutes (A549, U937) at 37 
°C. Spectrophotometric analysis was then conducted using the FluoStar Omega 
microplate reader (BMG Labtech, Germany), using the top-down fluorescence optic 
(540 nm excitation, 580 nm emission) configured to average 8 pulses in a circular 
pattern per well.  
 
This particular method was developed to minimize particulate matter interference. 
The elimination of washing reduced toxicity false-positive effects caused by the 
mechanical abrasion of cells by the particulate matter during washing. To negate 
optical interference by dusts, the top down fluorescence approach avoids the 
requirement for a clear optical path through the bottom of the plate, where particulate 
matter effectively settles due to the extended exposure times. This is described in 
Figure 36. 
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Figure 36: Depiction of strategy to avoid optical interference of particles by using top down cytotoxic measurement of a 
96-well plate and settled particulate matter. 
 
4.2.9 Oxidative Stress Assay 
Gently, cell media was removed from the 96 well sample plate. Cells were rinsed in 
PBS and 20 µL/well of Luciferase Assay System lysis agent was added and 
incubated at room temperature for 10 minutes. Briefly, 100 µL of luciferase assay 
reagent was then added to the wells and immediately analysed on the FluoStar 
Omega plate reader in fluorescence mode. 
 
4.2.10 Flow Cytometric Cytokine Quantification 
Cytokine standards were prepared as follows; each vial of lyophilized Human 
Inflammatory Cytokine Standards was reconstituted with 0.2 mL of Assay Diluent to 
prepare a 10x bulk standard. This was equilibrated for at least 15 minutes before 
making dilutions. Dilutions were mixed by pipetting. Serial dilutions were then 
performed from 1:1 through 1:256 in a 2x serial dilution, starting with 900 µL of 
Assay Diluent and 100 µL of 10x bulk standard in the Top Standard tube and 300 µL 
transferred to successive tubes thereafter. 
 
After cytotoxic measurement, 20 µL was taken from each sample well on the 96-well 
microplate into Eppendorf tubes. This was mixed with 8 µL per sample of CBA beads 
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comprised of the 6 detection bead types, after an equal amount of PE detection 
reagent to the CBA beads was added and vortexed. The mixture was then incubated 
at room temperature away from light for 3 hours. 150 µL of wash buffer was then 
added to each sample and centrifuged at 400 x g for 3 minutes. Precipitate was 
resuspended in 200 µL wash buffer. This was then analysed on the Accuri C6 flow 
cytometer to count over 1,000 events. Data was then processed on BD’s FCAP 
Array v3 software. 
 
4.3 Results 
4.3.1 Sample Size Distribution 
Ultrasonically sieved iron ore samples (MAC, Yandi and Newman) were analysed for 
particle size distribution. The sieving method was found to be effective in extracting 
PM10, particles of 7-10 µm made up the bulk of the sample, while sub-micrometre 
particles were present in all samples (Figure 37) and most numerous. This indicates 
both PM10 and PM2.5 mediated effects are present in the ore samples.  
 
 
Figure 37: Distribution of particles ultrasonically sieved with a 10 µm electroformed mesh obtained on a Malvern 
Mastersizer 2000.  
 
4.3.2 Sample and Standard Electron Microscopy 
Electron microscopy was performed on the Fe3O4 < 50 nm sample, and ore samples 
with cells. Large size heterogeneity is apparent in all the particle standards, and the 
ore samples as is expected from size distribution analysis. No fibre-like 
morphologies were seen in the ore samples, indicating the sieving process is less 
likely to cause significant distortions in inertial aerodynamic settling of particles which 
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differ in higher aspect ratio particles. Particles under 1 µm begin to be dominated by 
diffusive effects and are unaffected by aerodynamic shape 26. 
 
The interaction between the Fe3O4 standard and the lung epithelial A549 cell line in 
Figure 38 and lung fibroblast LL24 cell line in Figure 39 show particles intersecting 
with the cells and being internalised into the cytoplasm. Figure 38, top left, shows 
opacities around a particle within the cell, possibly indicating a vesicle. The most 
common observation is as seen in Figure 38, right, where particles become 
entrapped by elongated membrane structures. Similar results with haematite 
particles have been regarded as cytoplasmic uptake in the literature 187. 
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Figure 38: TEM images of A549 cells after 96 h exposures to the  Fe3O4 < 50 nm . Top Left, potential uptake of particles 
into the cytoplasm. Microvilli and particles are also visible outside the cell. Scale bar 1 µm. Top Right, horizontal 
membrane structure entrapping clusters of iron ore. Scale bar 2 µm. Bottom: extensive apical surface membrane 
development and possible internalisation of particulate agglomerates. 
 
In the LL24 cells, similar membrane structures where particles intersect the cells 
were observed but how this process occurs is ambiguous, as seen in Figure 39. 
However, this form of uptake still likely to be driven by membrane bound endosomes 
if it is not membrane extension around the particles, with little resultant biochemical 
interaction 287. The recurrent development of this structure supports literature 
findings that particulate loads stimulate apical membrane extension in epithelial lung 
cells and may also apply to fibroblasts 288. 
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Figure 39: TEM image of LL24 cells after 96 h exposures to  Fe3O4 < 5 nm samples. Top Left, apical membrane extension 
interacting with particle agglomerations. Top Right, complex membrane bound inclusions of particles. Scale bars 1 µm. 
Bottom staining reduces visibility of particle interactions however highlights the rough and complex surface of the LL24 
cell membrane surface. Scale bar 3 µm . 
 
Exposure of A549 cells to MAC, Yandi and Newman ores and TiO2 is shown in 
Figure 40. The ore sample sizes varied containing considerably larger somewhat 
irregular chunks than the standards. These agglomerated particles were nonetheless 
found to interact closely with the cell membrane, although fewer clear examples of 
cytoplasmic internalisation could be found. 
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Figure 40: TEM image of A549 cells after 96 h exposures to Yandi (Top Left) and Newman (Top Right) and MAC (Bottom 
Left) PM10 and TiO2 < 50 nm (Bottom Right), showing complex apical membrane interactions including internalisation of 
particulate agglomerates.  Scale bar 1000, 2000 nm. 
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4.3.3 Sample and Standard Solubility 
Solubility analysis was carried out on samples using ICP-MS which had been 
exposed to cell lines for 96 h, and then resuspended in PBS for analysis. This helped 
determine if intracellular compartment conditions played a role in the solubilisation of 
metal oxides. Samples prepared with A549 cells showed that TiO2 and CuO were 
the only samples tested with an appreciable free-ion component (see Figure 41), 
once isotope counts were normalised by abundance and background concentrations 
subtracted. 
 
 
Figure 41: ICP-MS detection of free 48Ti, 56Fe, 57Fe 63Cu and 65Cu ions using MAC, Yandi, Newman Iron ores, Fe(II,II)O < 5 
µm and TiO2 < 50 nm at 180 µg/mL, CuO < 5 µm at 45 µg/mL. Incubated with A549 cells 37 °C 96 h.  
 
The solubility of TiO2 and CuO did not change when cultured with LL24 cells, with 
differences being within limits of differences caused by the error in cell proliferation 
and viability (Figure 42).  
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Figure 42: ICP-MS detection of free Ti, Fe and Cu ions using MAC, Yandi, Newman Iron ores, Fe(II,II)O < 5 µm and TiO2 < 
50 nm at 180 µg/mL, CuO < 5 µm at 45 µg/mL. Incubated with LL24 cells 37 °C 96 h.  
 
Incubation of particles with U937 cells, while failing to liberate any iron ions, 
dramatically increased the release of Cu ions by 230%, relative to A549 (see Figure 
43). This implies immunological activity towards CuO inhalation would greatly 
increase the toxicity of the compound, independent of effects caused by biofluids. 
Moreover, the solubility of TiO2 and iron oxides was unaffected, making this form of 
screening useful in discriminating against particulates which may unexpectedly be 
solubilised in the lysosomal environment of the macrophage. 
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Figure 43: ICP-MS detection of free Ti, Fe and Cu ions using MAC, Yandi, Newman Iron ores, Fe(II,II)O < 5 µm and TiO2 < 
50 nm at 180 µg/mL, CuO < 5 µm at 45 µg/mL. Incubated with U937 cells 37 °C 96 h. 
 
The sparing solubility demonstrated by CuO and TiO2 in culture media is 
appreciable, though still far lower than quartz and its polymorphs which range from 
3-40 mg/L 289. Nevertheless, it is a significant finding, as in water CuO is insoluble at 
physiological temperatures and pressure 290. While occasionally observed, the 
solubility of CuO in media is often not addressed 210.  
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4.3.4 Elemental Analysis 
EDS was carried out to ascertain the composition of particles seen to interact with 
cells under TEM (see Figure 44). Elemental analysis aids in confirming particle 
identity, where images may contain interfering materials with similar electron density 
291. The sharper imagery of the FEI Tecnai-F20 in comparison to the JEOL 1010 also 
allowed better visualization of the particles. One or more points were scanned by 
EDS to identify the bulk material as opposed to silica and other minor compounds. 
 
MAC Yandi Newman 
   
   
   
Figure 44: TEM images of iron-ore samples. Scale Bar: Top Row: 2000 nm; Middle Row 200 nm, Bottom Row: EDS Sample 
points. 
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The spectra produced by the EDS measurement indicated a very similar iron oxide 
composition for all three samples, with minor compounds of aluminosilicates and 
cupric oxides as would be expected from rock samples (see Figure 45). 
 
 
Figure 45: EDS of MAC, Yandi and Newman ore samples. Differences in spectra height are not necessarily related to 
stoichiometry, and reflect penetration through the bulk sample. 
 
4.3.5 Cell Proliferation 
The interference of particulate matter in the proper functioning of in-vitro assays is 
quickly becoming a recognized problem 165,166,222, however the development of 
mitigation strategies is still to gain traction in nano and micron-size particle in-vitro 
research. Failure to take interference into account leads to problems, in the form of 
overestimated toxicity in formazan MTT assays and underestimation in Lactate 
Dehydrogenase (LDH) assays 166. 
 
The iron ore samples and other particulate standards were found to interfere with 
optical assays, presenting opaque solid phase agglomerations blocking correct 
absorbance values in the popular formazan MTT assay. The inextricability of particle 
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agglomerations and cells shown in TEM (Figure 38-Figure 40) provided evidence 
that washing steps would not able to remove particles without destroying the cell 
membrane, creating false positives. Instead, a 96 well plate format resazurin based 
fluorescence assay was used with modifications. The washing step was discarded, 
and the wells assayed directly using only the top-down fluorescence optic. This 
ensured particulate matter settled at the bottom of the well did not block excitation 
and emission light in the upper volume of the well. Plate sealers were also used 
during cell culture incubations to eliminate evaporative edge effects over long 
exposure periods, which was found to impact sensitive assays over 24 h. This 
method allowed high sensitivity despite maintaining a high throughput measurement 
process in long exposure, high PM concentration conditions.  
 
There is ongoing discussion about suitable dosing metrics for nano and micrometr 
size particles, as which metric is chosen depends on how toxicity is assumed to be 
mediated. For completely soluble compounds, the relationship between mass by 
volume concentration and toxicity remains constant. For insoluble particles, this is 
not necessarily the case if toxicity is mediated by particle-cell contact. Assuming 
even distribution is achieved, mass by cell surface are exposed can rectify this to 
some degree, though significant surface adsorption/desorption kinetics and catalytic 
effects can make material surface area by cell surface area the most desirable 
measure for a given material. For the purposes of this study µg/cm2 is used, 
providing sufficiently consistent relationships between samples and particle 
standards. Using particle mass by surface area also provides a compromise in 
comparing cell biochemistry mediated interactions to macrophage phagocytic 
interactions, which are influenced by mass load, and enhances throughput for 
biomonitoring purposes where the impact of airborne PM10 and PM2.5 particulate 
surface areas may not be cost effective to characterise. 
 
The particle standards used were Fe3O4 < 5 µm, TiO2, < 50 nm, SiO2 < 10 µm and 
carbon black < 150 nm (CB). CuO < 5 µm was also compared as a standard at ¼ the 
given concentration of the other standards. Ultrasonically sieved PM10 iron ore 
samples MAC, Yandi and Newman were tested alongside. The same samples and 
standards were used in conjunction with exposure to B[a]P, a carcinogenic 
Polycyclic Aromatic Hydrocarbon (PAH), to understand the toxicity of potentially 
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adsorbed organic combustion products. Samples were prepared in media as 
suspensions, before serial dilution in 96 well plates. 
 
It was found that low acute cytotoxicity was elicited by all samples and particulate 
standards, in comparison to typical mass concentrations for soluble toxicants. 
Despite different morphogical and metabolic characteristics, similar profiles were 
obtained both from LL24 (Figure 46) and A549 cells (Figure 48). Amongst the 
samples, the iron-ore samples, Fe3O4 and TiO2 toxicity was mediocre at this dose 
range, with SiO2 demonstrating some 50% greater toxicity. CuO exhibited an order 
of magnitude higher cytotoxicity and was therefore compared at a quarter of the 
standard concentration of the other particulates.  
 
  
Figure 46: LL24 48 h particle toxicity. CuO 39 µg/cm2, 156 µg/cm2 other particulates. 
 
Cytotoxic response is increased similarly across all particles in LL24 in response to 
coexposure with 50 µM B[a]P, shown in Figure 47. There does not appear to be any 
difference in interaction specifically tied to a given particle. 
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Figure 47: LL24 48 h + 50 µM B[a]P particle toxicity. CuO 39 µg/cm2, 156 µg/cm2 other particulates 
 
The differences in cytotoxicity between samples remained similar in the A549 cells, 
although greater sensitivity to CB was observed. SiO2 demonstrated up to 90% 
greater toxicity than the iron-ore sample, TiO2 and Fe(II,II)O band (see Figure 48). 
The toxic response to CuO was marginally less. 
 
 
Figure 48: A549 48 h particle toxicity. CuO 39 µg/cm2, 156 µg/cm2 other particulates 
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The metabolic activity of A549 cells is limited, and it has been shown that 
metabolites are an important factor in B[a]P mediated toxicity, therefore 5% S9 rat  
liver enzyme mix was added. While S9 has been previously shown not to increase 
the toxicity of iron oxide nanoparticles 292, its presence has been shown to enhance 
the DNA damage potential of organics in airborne particulate matter 293. It appeared 
that CuO toxicity was enhanced to a similar level shown by the LL24 cell line (Figure 
49), however the iron-ore samples and SiO2 remained relatively unchanged. 
 
 
Figure 49: A549 48 h + 50 µM B[a]P + 5% S9 mix particle toxicity. CuO 39 µg/cm2, 156 µg/cm2 other particulates 
 
The monocyte derived macrophage cell line, U937 behaved in a similar fashion to 
the LL24 and A549 cell lines. The dynamics between the monocytes to 
macrophages differentiation process may play a role, if the process can continue to 
occur after seeding. Controls help to account for differences in particle number 
accrued by non-adherent monocytes being transferred from well to well during 
sample serial dilution, but does not counteract differences stimulated by macrophage 
cytokine signalling during phagocytosis – if this is a contributing factor. In the dose 
range tested, SiO2 showed a highly positively proliferative effect across a wide range 
of concentrations. Carbon black caused an even greater positively proliferative effect 
(down to -20% toxicity) until 156 µg/cm2, after which the cytotoxic effect prevailed 
increasing to 28% at 312 µg/cm2. This form of response may be a result of 
phagocytosis induced proliferative signalling or differentiation of remaining 
monocytes, then cytotoxic overloading. However, it masks cytotoxicity, requiring 
0
10
20
30
40
50
60
70
80
90
100
CuO MAC Yandi Newman SiO2
To
xi
ci
ty
 (
%
)
A549 + B[a]P + Cell Viability - 48 h PM Exposure
110 
 
U937 cell viability assays be used in conjunction with other cell lines to help 
ascertain the extent of this effect.  
 
 
 
Figure 50: U937 48 h particle toxicity. CuO 39 µg/cm2, 156 µg/cm2 other particulates 
 
The effect of B[a]P on U937, paradoxically tended to equalize toxic effects (Figure 
51). This confounds what toxic effect co-inhalation of both particulate matter and 
B[a]P will have, at the least suggesting immune recruitment will be enhanced. 
However, the proliferative effect of CB remained very strong at the lower doses, 
reaching -27% toxicity at 10 µg/cm2. Both enhanced cytotoxicity and enhanced 
immune recruitment are signs of increased inflammatory activity and fibrotic 
potential. 
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Figure 51: U937 48 h + 50 µM B[a]P particle toxicity. CuO 39 µg/cm2, 156 µg/cm2 other particulates. 
 
4.3.6 Oxidative Stress 
To preface the antioxidant reporter element (ARE) luciferase reporter activation test 
in AREc32 cells, cytotoxicity tests were conducted to ensure that it responded 
similarly to the lung cell lines and to ensure testing occurred near the IC20 level for 
each of the particulates, minimizing the effect of cell death on expression of the 
reporter. The AREc32 system was chosen as it is a measure of intracellular 
activation of antioxidant response pathways, which are often linked with the Nrf2 
transcription factor, and as a more robust method less vulnerable to artifacts 254. 
AREc32 was found to respond to particles similarly to lung cell lines, and Figure 52 
graphs the toxicity of the samples and standards at 156 µg/cm2 as described for the 
other cell lines, and 39 µg/cm2 as chosen for the AREc32 luciferase reporter assay. 
While not strictly part of the lung cells examined for cytotoxic effect, the electrophile 
sensitisation of the AREc32 cell appeared to make it particularly vulnerable to CuO 
and SiO2 toxicity, while leaving the iron-ore samples and Fe3O4 and Fe2O3 
responding similarly to LL24 and A549. 
-20
0
20
40
60
80
100
Fe3O4 CuO TiO2 MAC Yandi Newman SiO2 CB
To
xi
ci
ty
 (
%
)
U937 + B[a]P Cell Viability - 48 h PM Exposure
112 
 
  
Figure 52: AREc32 48 h particle toxicity. CuO 39/10 µg/cm2, 156/39 µg/cm2 other particulates, TBHQ 25 µM/6.25 µM 
 
Aside from tert-Butylhydroquinone (TBHQ) as the positive control, the AREc32 
luciferase reporter assay showed activation highest with CuO followed by SiO2, 
followed by TiO2 and Fe2O3, described in Figure 53. The iron ore samples had 
reduced oxidative potential in comparison. Surprisingly, while TiO2 did not play a 
major role in cytotoxicity, it caused almost the equivalent Nrf2 mediated activation as 
SiO2. 
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Figure 53: ARE element activation as measured by a luciferase reporter in AREc32 cells 48 h exposure, positive control 
TBHQ 6.25 µM, CuO 10 µg/cm2,  others 39 µg/cm2  
 
4.3.7 Inflammatory Cytokine Induction 
 
The nature of inflammatory cytokine signalling is complex, and often the ratio of a 
range of cytokine signals ultimately determine inflammatory outcomes in extension to 
sheer concentration. In choosing the experimental process to pursue it was therefore 
important to measure as many cytokines as possible. While ELISA is a popular 
choice, it measures a single interleukin at a time. The Human Inflammatory Cytokine 
cytometric bead assay kit (BD Biosciences) was chosen as it simultaneously 
measures 6 inflammatory cytokines and eliminates inter-experiment variability 
individual ELSIA measurements of cytokines would introduce, so that the ratios 
between interleukins are accurate. Quantitatively, IL-6 and IL-8 were most strongly 
expressed in LL24 (see Figure 54). Simplistically, on the left inflammatory cytokines 
are represented (IL-8, TNF, IL-1β) and on the right anti-inflammatory cytokines are 
represented (IL-10, IL-12p70 and IL-6) 237,241, although the actual impact of cytokine 
activity is highly varied. While induction was overall mild, the iron ore samples 
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appeared to clearly induce cytokine induction similar to SiO2, although CuO and SiO2 
engendered the greatest IL-8 response, closely followed by the MAC sample.  
 
 
Figure 54: LL24 inflammatory cytokine expression. CuO, at 5 µg/cm2, others 156 µg/cm2. 
 
IL-8 is typically reported as being expressed in A549 cells 185, allowing immune 
recruitment to epithelial cells in airways experiencing injury. Commensurate with this, 
A549 expressed IL-8 in higher quantities than LL24 cells, and interestingly also 
showed the most potent TNF, IL-1β and IL-12p70 expression on average. IL-1β has 
also been associated with fibroblast proliferation 294. IL-12p70 expression is 
associated in the development of Th1 lymphocytes and is suppressed in dendritic 
cells by fibroblasts 295.  IL-10 expression was near that of U937. IL-10 is thought to 
be a respiratory sensitiser, leading to humoral immunity and allergic responses 186. 
Elevated IL-10 has also been suggested as a key diagnostic factor in patients with 
idiopathic pulmonary fibrosis (IPF) 243. The Yandi and Newman samples appeared to 
repress most interleukins, other than IL-6 in which expression was induced, possibly 
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having elicited an anti-inflammatory feedback mechanism (see Figure 55). SiO2, CB 
and the MAC sample however appeared to be inflammatory and induce IL-8.  
 
 
Figure 55: A549 inflammatory cytokine expression. CuO, at 5 µg/cm2, others 156 µg/cm2. 
 
Quantitatively, U937 was found to express the highest quantity of IL-8 and IL-10, and 
appeared to express as much TNF as A549, although the addition of PM appeared 
to greatly suppress TNF expression, and other interleukins (see Figure 56). TNF has 
been shown to orchestrate many types of other inflammatory responses including 
cancer 201. Suppressed TNF expression, with the exception of SiO2, would suggest 
an anti-inflammatory effect, however an alternative explanation would be that culture 
conditions without stimulus affecting the control samples were relatively pro-
inflammatory. Nevertheless, this effect highlights SiO2 represented as being 
especially pro-inflammatory, leading to increased TNF expression. The unusually 
high induction of IL-6 by TiO2 also suggests it may be problematic to immune 
function. 
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Figure 56: U937 inflammatory cytokine expression. CuO, at 5 µg/cm2, others 156 µg/cm2. 
 
 
4.4 Discussion 
At the particle loads illustrated (Figure 46-Figure 51), the overall order of cytotoxicity 
is determined to be CuO > SiO2 >Newman PM10 = MAC PM10 = Yandi PM10 >TiO2 
= CB > Fe3O4, although the differences vary between cell types. While CuO presents 
the greatest concern all around being highly cytotoxic, the responses to SiO2, CB 
and TiO2 present as compounds with tangential toxic aspects more sinister than the 
Fe3O4 sample. The strong proliferative effect of SiO2 and CB on U937 monocyte 
differentiated macrophages suggests greater inflammatory potential, reflected by 
potent induction of IL-8 in A549 cells. SiO2 also prominently induced IL-8 in LL24 
cells and TNF in U937 cells. High TiO2 induction of IL-6 in U937 and IL-8 in A549 
was also unexpected given the relatively low toxicity of the compound. The iron-ore 
samples themselves displayed some of the most dynamic induction of IL responses, 
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with the MAC sample being highly represented in IL-8 induction in A549 and LL24 
cells, while the Newman and Yandi samples displayed peculiar suppression of 
interleukins bar IL-8 in the LL24 sample and potently induced IL-6 along with the 
MAC sample. It is of note that the environmental iron-ore samples may carry 
endotoxins or other organic matter, influencing cytokine responses towards them. 
 
The addition of B[a]P showed an additive affect to the inorganic particulates, and its 
bioavailability may be limited rather than enhanced by inorganic particulate 
adsorption 296. The effect of B[a]P on U937 was also unexpected, and may hint at 
changes in cell metabolism in U937 cells when undergoing stress, or stress caused 
by control overgrowth compared to sample exposures where particle uptake activity 
may limit growth. Oxidative stress results showed correlation with CuO and SiO2 
cytotoxicity, but implicated TiO2 to have more oxidative stress potential than Fe3O4 
and the iron-ore samples. 
 
The experimental results show that proliferative, or inverse cytotoxic interactions in-
vitro, can affect cell lines in the investigation of lung fibrosis and inflammation. While 
hyperplasia is frequently noted in histological in-vivo samples, it is discussed 
infrequently in in-vitro toxicology or dismissed as an artefact caused by effects such 
as protein adsorption 266,273. In these experiments, particulate interference of this 
kind fails to explain differences between cell lines observed, and biological 
explanations are better suited to answering questions such as why U937 is 
disproportionately affected. The interpretation of proliferative effects of low toxicity 
particles may therefore be a source of discrepancy in translating in-vitro research to 
in-vivo outcomes.  
 
Determining such effects requires high sensitivity and tolerance to noise and error, 
as the lack of cytotoxicity creates difficulty in distinguishing between systematic error 
and actual responses, which are always clearer with the CuO standard having been 
shown to have a soluble cytotoxic component giving it much greater toxicity that 
follows a traditional dose-response relationship 289. The high toxicity of CuO has 
been noted previously in the literature in comparison inorganic particulates and 
carbon based particles 215, and has been shown to cause increased oxidative stress 
and cytotoxicity relative to iron oxides and SiO2, which this study confirms 283.  
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Despite limited cytotoxicity of the iron-ore samples, extensive work in analysing 
particulate burden in vivo over the past three decades 18,22,24,25,27,225,274 has shown 
that even inert particles can cause obstructive and fibrotic changes if the particle 
clearance limit of pulmonary alveolar macrophages is reached 280, and can occur 
over time as the half-life of particles reaching the acinar surfaces of the lungs is long; 
some 500 days 25. An important characteristic of particle uptake underscoring the 
need for particle shape characterisation by electron microscopy is that particle 
uptake is also morphology dependent, and high-aspect ratio particles such as 
asbestos, glass fibre and multi-walled carbon-nanotubes (MWCNT) have been 
repeatedly shown to induce frustrated phagocytosis 30,35,127,213. Incomplete 
phagocytosis of long particles leads to ineffective clearance, prolonged inflammation 
and potentially penetration into the mesothelium, causing carcinogenic effects 35,127. 
Successful particle uptake is also able to liberate metal ions, as demonstrated by 
ICP-MS, making the immunological compartment of cell uptake even more 
significant. A limitation of the ICP-MS technique is that it was not able to detect Si 
ions for this comparison. 
 
The uptake of silica particles by U937 monocyte differentiated macrophages has 
previously been shown to occur through binding of immunoglobulin to plasma treated 
silicates and internalization via FcγRI – a known trigger of cellular ROS production 
297. This has the potential to aggravate pulmonary inflammation. The AREc32 
transgenic reporter relies on activation by the Nrf2 transcription factor, and this 
pathway has been shown to be involved in oxidative stress caused by atmospheric 
pollutants 298. This establishes the pathway as relevant to in-situ oxidative stress 
measurement within the cell, in response to particulate matter. Cytotoxicity is often 
attributed to redox catalytic properties in metals and metal oxides 167,172,222,233,261,299–
303. Whether or not ROS or cytotoxicity itself is a key driver for all metal oxide 
mediated lung disease, the assessment of standards and samples using AREc32 
provides an additional way to rank particle hazard and bore resemblance to 
inflammatory cytokine comparisons. 
 
Taken together, from our experiments it can be seen regulating airborne particulate 
in Port Hedland matter solely on the basis of dimensional fractions carries an 
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inherent assumption that limits are protective against the net toxicity of any size 
distribution and chemical composition reasonably expected to occur within a given 
fraction. However, given the nature of epidemiological studies on which regulations 
are based, arguments can be made for and against the stringency of current 
standards in all scenarios, based on the perceived statistical strength of associations 
and that no distinction is made between particulate types 80. For this reason, the low 
solubility and concomitant weak acute toxicity of the studied iron-ore PM10 may place 
it within the bound of these regulations.  
 
In this study, cytotoxic differences between SiO2 and the iron-ore samples are shown 
to be minimal, however proliferative effects, increased oxidative stress and increased 
inflammatory properties point to SiO2 as having a fibrotic potential. This is consistent 
with occupational exposure data showing chronic exposure to silica over 45 years 
still poses unacceptable mortality risk (6/1000) 96. Nevertheless, the iron-ore samples 
are not shown to be inert, and cellular responses towards them indicate they should 
be treated as an equal hazard. 
 
In practice, an informed balance between public health risk and cost-effective dust 
mitigation strategies must be achieved; a requirement complicated by the volume of 
material handled and the scarcity of fresh water for wetting based dust suppression 
or the environmental impact of chemical methods 94. 
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5. Comparative Toxicology of Inhalable Particulate Matter to 
Human Lung Cell and Macrophage Cocultures  
5.1 Introduction  
As inflammatory activity is a central mediator of fibrosis, further investigation into the 
scope and breadth of immunological reactions to iron-ore PM10 and standards was 
required. To achieve this simply without creating further uncertainties to account for 
when comparing data, coculture methods were developed based on combining two 
cell types at half their monolayer seeding volume and proceeding with the monolayer 
methodologies established.  
 
This effectively allows some of the immunological cell to cell communication inherent 
in the in-vivo system to occur in-vitro. As each cell type (A549 lung epithelial, LL24 
fibroblast, U937 monocyte derived macropage) has been found to have different 
cytokine responses when challenged with particulate matter, it is possible that 
coculture can provide immunomodulatory feedback and grant some clues as to the 
dysregulation of this process during respirable particle challenges. Dysregulation of 
the inflammatory cycle could result in continued inflammation and prevent a return to 
homeostasis, leading to fibrosis, and is dependent on input from both lung 
parenchymal cells and immune cells 140.  
 
Furthermore, the uptake of particles into U937 monocyte differentiated macrophages 
was crucial to examine, based on the importance of the lysosomal compartment of 
the macrophage. The acidic environment of the lysosomal compartment may play a 
crucial role in liberating metal ions, and when combined with increased 
immunological recruitment, create positive feedback. This could in turn create 
bioavailability conditions which exceed those that would otherwise be determined 
from pH 7.4 lung biofluid experiments alone, when examining otherwise insoluble 
metal-oxides. Electron microscopy of U937 macrophages to observe the extent of 
particle uptake and loading was therefore performed. 
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5.2 Materials and Methods 
5.2.1 Chemicals and Reagents 
As standard compounds the following from Sigma Aldrich, USA were obtained: 
Copper(II) oxide <5 µm, Iron(II,III) Oxide <5 µm, Iron(III) Oxide <5 µm, Silicon(IV) 
Oxide <10 µm, Titanium(IV) Oxide <50 nm. Carbon Black < 150 nm powder was 
obtained from US Research Nanomaterials, Inc., USA. Representative iron ore 
stockpile samples were supplied from three major mining sites in the Pilbara region 
in Western Australia courtesy of BHP Billiton; Newman Hub Mine (Newman), Mining 
Area C (MAC) and Yandi Mine (Yandi)  
 
The PrestoBlue reagent (#A-13261, Life Technologies, USA) was obtained for cell 
viability experiments. The Human Inflammatory Cytokine Kit was used to detect 
interleukin expression (#551811, BD Biosciences, USA). Cells were fixed in 
glutaraldehyde prior to electron microscopy (Sigma Aldrich, USA). 
 
5.2.2 Particle Extraction and Sterilisation 
The supplied iron ore samples were sieved to < 45 µm by ChemCentre WA (CCWA). 
To sieve the samples further down to PM10, an ultrasonic sieve tower and 
accompanying custom 10 µm electroformed sieve was used (Precision Eforming 
LLC, New York, USA). 
 
The prepared samples were sterilised using fractional sterilisation. Sieved material 
was collected into 50 mL conical Falcon tubes (BS Biosciences, USA) and heated to 
60 °C for 15 minutes before being allowed to cool at room temperature for 24 hours, 
repeated over three successive days.  
 
5.2.3 Electron Microscopy  
Cells were grown on 12 well plates and incubated for 96 hours with samples. Media 
was drained from the cells and fixed with glutaraldehyde. Post fixation cells were 
cured with osmium tetroxide and baked in resin for four hours, then left to solidify 
overnight. Resin was then mounted and cut on an ultramicrotome (Lecia UC61, 
Germany) to 40 nm for observation by transmission electron microscopy (JEOL 
1010, Japan) on 400 square mesh copper grids (ProSciTech, Australia).  
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5.2.4 Cell Culture 
The A549 pulmonary type I/II-like epithelial adenocarinoma (ATCC CCL-185), LL24 
pulmonary normal fibroblasts (ATCC CCL-151) and U937 monoblastic-like histiocytic 
lymphoma (ATCC CRL-1593.2) were used to represent lung epithelial, connective 
and immunological cells, respectively. 
 
The A549, LL24 and AREc32 cell lines were cultured in F-12K medium (#21127, Life 
Technologies, USA) supplemented with 10% foetal bovine serum (FBS), 100 IU/mL 
penicillin, 100 µg/mL streptomycin, and 10 mg/mL amphotericin B (#A9528-50MG, 
Sigma Aldrich, USA). U937 was cultured in RPMI 1640 medium (#72400, Life 
Technologies, USA) supplemented with 10% foetal bovine serum (FBS), and 100 
IU/mL penicillin, 100 µg/mL streptomycin, 10 mg/mL amphotericin B (#A9528-50MG, 
Sigma Aldrich, USA), 2mM L-glutamine, 1mM Sodium pyruvate and 10mM HEPES 
buffer. 
 
Cells were cultured in 75 cm2 tissue culture treated flasks (Corning, USA) at 37 °C in 
humidified 5% CO2, 95% air atmosphere. A549 and LL24 medium was changed 
every 2-3 days and split every 5 days. As they are adherent, cells were harvested for 
seeding using trypsinization and washed in Phosphate Buffered Saline (PBS). U937 
was cultured in suspension and maintained in at 2 x 105 to 1 x 106 cells/mL by 
passage every 4 days. 
 
For seeding and exposure incubation, cells were plated onto opaque flat bottom 96-
well plates (Becton Dickinson, USA) at 70% confluency (100 µl/well, 2x105 cells/mL). 
In an effort to mitigate the effects of inflammatory activity by the PMA induced U937 
differentiation step and minimise variance, cell cultures were left to incubate and 
settle for twice the normal duration. Cells were incubated for 48 h after seeding, prior 
to the particle exposure time period at 37 °C under sealing film (Corning, USA). 
 
Differentiation of U937 to a mature macrophage-like morphology can be induced by 
exposure to phorbol esters 267. For this purpose, differentiation was induced during 
the seeding period by exposure to 30 ng/mL of Phorbol Myristic Acid (PMA) for 48 h. 
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5.2.5 Cell Proliferation Assay 
Cytotoxicity of particulate matter was measured using a cell survival resazurin assay, 
PrestoBlue. After seeding incubation, cells were exposed to a 2 x serial dilution of 
particulate matter suspension down 6 rows. To achieve the first well concentration 
expressed as 156 µg/cm2 (unless CuO, at 39 µg/cm2),100 µL of 1 mg/mL (CuO, 0.25 
mg/mL) suspension was added to 100 µl of media per well of an area 0.32 cm2. 
Incubation with particulate matter under sealing film was then continued until 
measurement. For measurement, 10 µL/well of PrestoBlue reagent was added to the 
plates and incubated for 30 minutes at 37 °C. Spectrophotometric analysis was then 
conducted using the FluoStar Omega microplate reader (BMG Labtech, Germany), 
using the top-down fluorescence optic (540 nm excitation, 580 nm emission).  
 
5.2.6 Flow Cytometric Cytokine Quantification 
Cytokine standards were prepared as follows; each vial of lyophilized Human 
Inflammatory Cytokine Standards was reconstituted with 0.2 mL of Assay Diluent to 
prepare a 10x bulk standard. This was equilibrated for at least 15 minutes before 
making dilutions. Dilutions were mixed by pipetting. Serial dilutions were then 
performed from 1:1 through 1:256 in a 2x serial dilution, starting with 900 µL of 
Assay Diluent and 100 µL of 10x bulk standard in the Top Standard tube and 300 µL 
transferred to successive tubes thereafter. 
 
After cytotoxic measurement, 20 µL was taken from each sample well on the 96-well 
microplate into Eppendorf tubes. This was mixed with 8 µL per sample of CBA beads 
comprised of the 6 detection bead types, after an equal amount of PE detection 
reagent to the CBA beads was added and vortexed. The mixture was then incubated 
at room temperature away from light for 3 hours. 150 µL of wash buffer was then 
added to each sample and centrifuged at 400 x g for 3 minutes. Precipitate was 
resuspended in 200 µL wash buffer. This was then analysed on the Accuri C6 flow 
cytometer to count over 1,000 events. Data was then processed on BD’s FCAP 
Array v3 software. 
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5.3 Results 
To understand the effects of coculture on cell proliferation and cytokine signalling, 
experiments were performed with 1:1 combinations of A549:LL24, U937:A549 and 
LL24:A549. Parallel monolayer cultures of A549, LL24 and U937 cells alone were 
exposed to identical conditions and examined concomitantly, to ensure the accurate 
interpretation of the coculture results. 
 
The U937:LL24 combination was chosen for cytokine investigation, to provide the 
most direct information about the cytokine signalling responses of fibroblasts to 
inflammatory activity. These results were compared to U937 and LL24 cytokine 
signalling alone. 
 
Electron microscopy investigations were carried out on U937 monocyte differentiated 
macrophages to show the effectiveness of the differentiation process and examine 
uptake activity, apoptosis and self-recruitment on a range of particulate standards. 
 
 
5.3.1 Cell Proliferation 
The following set of cell proliferation assays are presented as stacked bar graphs in 
this chapter. This provides more information across the concentration ranges 
exposed than single concentration bar charts. Scatter plots, while useful in observing 
dose-response relationships, are less able to convey the nature of low maximum 
toxicity exposure information across dose ranges by exhibited by the insoluble 
particulates examined. Furthermore, proliferative effects were are easily interpreted 
in this format, which may be indicative of hyperplasia potential in-vivo. The CuO < 5 
µm, and PM10 MAC, Yandi, Newman and SiO2 samples and standards were used. 
As the CuO sample is ¼ the concentration of the other particulate standards, 
conversions are provided on Table 12. 
 
Table 12: Conversion for other particulate concentration to CuO in µg/cm2 
Other CuO 
156 39 
78 20 
125 
 
39 10 
20 5 
10 2 
5 1 
 
The cumulative toxic effect across the dose range on A549 monoculture cells 
showed high cytotoxicity from CuO as expected, while the MAC and SiO2 samples 
narrowly exceeded the toxicity of Yandi and Newman ores (see Figure 57). 
 
 
Figure 57: A549 cumulative toxicity of particles across 5-156 µg/cm2 dose range, and 1-39 µg/cm2 dose range for CuO, 
over 48 h. 
 
The LL24 monlayer culture showed similar relationships between the toxicity of 
samples and standards to the A549 cell line, and simialar sensitivity in Figure 58. 
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Figure 58: LL24 cumulative toxicity of particles across 5-156 µg/cm2 dose range, and 1-39 µg/cm2 dose range for CuO, 
over 48 h. 
 
While the cumulative toxic effects of samples and standards on the U937 monolayer 
showed similar relationships in comparision to LL24 and A549 (see Figure 59), the 
toxic effect reversed at lower concentrations becoming a proliferative effect. It is 
possible that this is caused by induction of undifferentiated U937 monocytes to more 
metabolically active macrophages in response to cytokines produced during the 
phagocytosis of particulate matter, or that it is related to greater metabolic activity 
within the cells. 
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Figure 59: U937 cumulative toxicity of particles across 5-156 µg/cm2 dose range, and 1-39 µg/cm2 dose range for CuO, 
over 48 h. 
 
Interaction between the epithelial layer of the pulmonary acinus and macrophages 
forms represents the acute immunological recruitment phase in response to particle 
contact with the respiratory surfaces of the lung. This was modelled as U937 in 
coculture with A549 cells. Relative to the monolayer responses, this drastically 
altered the toxicity profile, causing all samples other than CuO and MAC to show 
large proliferative effects (see Figure 60). As the cumulative cytotoxicity of CuO was 
reduced relative to the monolayer cultures, a possible explanation for this 
phenomenon is that the control samples have not performed as well as the exposure 
samples, although it is unclear what could cause this effect systematically. It would 
also be expected that underperforming control samples would not differentially affect 
the sample types. Alternatively, the presence of or uptake of particles and their 
characteristics may have a modulatory effect on A549 proliferation and U937 
differentiation. In this regard, it appears that SiO2 is the most potent inducer of 
proliferation for this coculture. 
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Figure 60: U937+A549 coculture cumulative toxicity of particles across 5-156 µg/cm2 dose range, and 1-39 µg/cm2 dose 
range for CuO, over 48 h. 
 
The coculture of A549 and LL24 represents investigation of connective tissue 
proliferation in response to epithelial layer signalling, or vice versa, during particle 
exposure. The toxicity profile of this coculture resembled the U937+A549 coculture 
more than any of the monolayer experiments (see Figure 61). However, the effect of 
SiO2 was not as extremely proliferative, and higher doses showed a slight return to 
toxicity. The toxicity of MAC also remained resistant to reversal, while Yandi and 
Newman samples showed very low but somewhat reversed toxicity.  
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Figure 61: A549+LL24 coculture cumulative toxicity of particles across 5-156 µg/cm2 dose range, and 1-39 µg/cm2 dose 
range for CuO, over 48 h. 
 
The coculture of U937 and LL24 examines a crucial slice of the immunological 
puzzle. Dysregulation of fibroblast growth by inflammatory mediators from the 
immune response to particulate matter is implicated as a major factor in fibrotic 
disease 171. The cumulative toxic effects and relationships of particulates and 
standards resembled monoculture experiments more closely than the other coculture 
experiments Figure 62. At low doses, a proliferative effect was still observed. The 
weakness of this effect suggests it is mediated by the U937 response alone and 
does not greatly affect LL24 proliferation, unlike the U937+A549 coculture 
experiment. 
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Figure 62: U937+LL24 coculture cumulative toxicity of particles across 5-156 µg/cm2 dose range, and 1-39 µg/cm2 dose 
range for CuO, over 48 h. 
 
The LL24+U937 coculture toxicity response to samples and standards was charted 
alongside the mean response of the individual LL24 and U937 cultures at 156 
µg/cm2 (CuO 39 µg/cm2). The comparison shows little difference in toxicities 
between these two culture methods at the given concentration (see Figure 63). 
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Figure 63: Right: LL24+U937 coculture (denoted CC) toxicity of particles. Left: Geometric mean of monoculture LL24 and 
U937 toxicity values. Exposure shown 39 µg/cm2 for CuO and 156 µg/cm2 for other particles, over 48 h. 
 
5.3.2 Interleukin Data 
 
Interleukin expression was measured at 39 µg/cm2 for particles other than CuO, 
which was measured at 1 µg/cm2, in order to detect any changes in expression near 
concentrations where particulate proliferative effects may dominate over cytotoxic 
effects (see Figure 64). While the cell monolayer toxicity profiles largely corroborated 
with monolayer toxicity profiles presented in Chapter 4, the cytokine induction is 
markedly different, potentially due to higher concentrations used previously (156 
µg/cm2 for particles other than CuO at 5 µg/cm2) and shorter seeding incubation 
times. The expression profile of LL24 was muted in comparison, although differences 
in the overall profile are also emergent. Expression of IL-8 was highly attenuated, 
whereas IL-10 expression remained comparable. IL-6 showed the greatest 
inducibility, responding with a two-fold increase upon SiO2 exposure. 
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Figure 64: LL24 inflammatory cytokine expression. CuO, at 1 µg/cm2, others 39 µg/cm2.  
 
Changes in the expression profile of U397 were also evident, and with induction of 
IL-1β and IL-10 becoming prominent (see Figure 65). Overall repression of other 
cytokines remained in the same order of magnitude, translating to a relatively more 
dynamic expression pattern than the previous experiment for the concentration. A 
two-fold increase in IL-6 expression was stimulated by MAC exposure. 
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Figure 65: U937 inflammatory cytokine expression. CuO, at 1 µg/cm2, others 39 µg/cm2.  
 
The U937+LL24 coculture experiment showed near complete suppression of 
cytokine responses to particles (see Figure 66). Although quantitatively compared to 
the monocultures, IL-8 expression was close to mean, U937 TNF expression was 
completely inhibited, U937 IL-1β expression was inhibited, IL-10 expression was 
inhibited, IL-12p70 expression did not occur in either the monolayer cells or 
coculture, and IL-6 expression was enhanced. 
 
Why particle responses are not apparent despite continued expression of some 
cytokines may be due to experimental factors. This includes the 48 h time of assay 
being too delayed to detect a brief inflammatory reaction, or the balance of cell types 
being too far weighted in U937 representation. In such a scenario, the anti-
inflammatory response by LL24 to too many U937 cells may be overriding any other 
response, mediated by IL-6. Expression of TNF-α on lung endothelial cells has been 
shown to have a repressive effect and also induce IL-6 234, therefore it is possible 
constitutive expression levels of TNF by U937 are causing a similar suppressive 
feedback effect. 
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Figure 66: U937+LL24 inflammatory cytokine expression. CuO, at 1 µg/cm2, others 39 µg/cm2. 
 
5.3.3 Macrophage Uptake 
Previous TEM of A549 cells and LL24 cells revealed that while by light microscopy, 
cells appeared to take up particles into the cytoplasm, this was not necessarily the 
case and significant amounts of particulate matter were associated with cells but 
were outside the cytoplasm. Light microscopy of differentiated U937 cells confirmed 
particulate uptake, and unique clearance patterns (see Figure 67). The efficacy of 
particle uptake and macrophage behaviour was further evaluated using TEM. 
 
 
Figure 67: Cell lines exposed to 156 µg/cm2 of Fe3O4 oxide over 96 h, 200x magnification 
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Panel one shows the particle standards, cultured in 12 well plates for 96 h. 
Ultramicrotomy of the U937 resin samples was complicated by the hardness of the 
material chipping the glass knife, exacerbated by dense accumulations of particulate 
matter accrued by the macrophage cells. This led to thick resin sections being 
required reducing contrast and streaks from glass knife damage were usually visible. 
However, the image quality is sufficient to reveal particle-cell interactions. The 
carbon black sample presented with few intact macrophage cells, where instead 
remains of cells filled with blocky accumulations of carbon black were frequent. The 
low electron density made free carbon black otherwise difficult to detect. 
Macrophages interacting with metal-oxide particulates tended to accumulate 
particles around themselves, and this activity appeared to attract large clusters of 
macrophages. Complex cytoplasmic extensions and fine processes were seen to 
reach out in exploration or mediating some form of particle-cell or cell-cell contact. 
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Figure 68: TEM of macrophage standard uptake in 12 plates after 96 h culture at 40 µg/cm2. Scale bar 5 µm. 
 
Panel two shows U937 differentiated macrophages interacting with iron-ore PM10 
standards (see Figure 69). The large size of the particles tended to recruit very large 
masses of cells in response. Finer particles were also present and possibly 
accumulated cytoplasmically. The increased difficulty of particles larger than ~2 µm 
attracting these accumulations may implicate differential responses to the respirable 
fraction particulates than the fine fraction particulates which could influence toxicity. 
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Figure 69: TEM of macrophage standard uptake in 12 plates after 96 h culture at 40 µg/cm2. Top: Scale bar 10 µm. 
Bottom: Scale bar 5 µm. 
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5.4 Discussion 
In the cell proliferation data, while the parenchymal cells cultured alone reinforce the 
message of a toxicity profile for insoluble particulates that is characteristic of being 
limited to cell membrane contact, the phagocytic cell line and different coculture 
combinations present an unexpected mix of new information. The shift towards a 
proliferative effect at concentrations of sample below 20 µg/cm2 in the U937 cell line 
is interesting although unlikely to be a true proliferation as only the monocyte 
progenitor is known to undergo cell division in this cell line, although it may stimulate 
other lung cells to proliferate 251. Hence, the effect is mild and likely tied to increased 
differentiation of remaining undifferentiated monocytes, or metabolic and cytoplasmic 
expansion related to macrophage phagocytic activity. At higher concentrations, the 
exhaustive and cytotoxic effect of phagocytosis appears to override any proliferation. 
When the U937 cell line is paired with the LL24 cell line, the proliferative effect 
continues to be limited to what is observed of the U937 cell line alone and therefore 
this coculture pair appears to have no alternate modulation of cytotoxicity. However, 
when the U937 cell line is paired with the A549 cell line, dramatic increases in cell 
proliferation are observed. This enhanced proliferation is furthermore discriminative, 
not affecting CuO or MAC exposures, yet being highly responsive to Yandi, MAC 
and SiO2 exposures. When the A549 and LL24 cell lines are paired, the cell 
proliferation profile most closely resembles the U937 and A549 pairing, albeit with 
proliferative effects roughly halved. This pattern suggests that only in the presence of 
cytokine signalling from either the U937 or LL24 cell lines, A549 cells will undergo 
cell proliferation at moderate particulate concentrations if exposed to certain 
particulates, and the strength of this effect is modulated by cytokine expression 
differences between U937 and LL24. Immunomodulatory effects between lung 
epithelial cells and monocyte differentiated macrophages have been previously 
observed in the literature, causing differential IL-6 and IL-8 signalling when in 
coculture to quartz particles 186. 
 
While such observations are too limited to draw absolute conclusions of the 
interaction between lung epithelial, fibroblast and macrophage cells, they do show 
that cocultures in combination with accurate cell proliferation profiling are powerful in 
discriminating against the toxicity of different particulates. It has long been 
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understood that hyperplasia is a response to foreign material in-vivo, however the 
recognition of such effects in-vitro are investigated infrequently as this conflicts with 
the acquisition of an IC50 value. Indeed, such a situation juxtaposes opposite values 
as equitable measures for toxicity; while it is clear that the cytotoxicity of CuO 
micron-size dusts will cause cytotoxic harm to the lung parenchyma upon inhalation 
283, it is also known that prolonged SiO2 PM10 inhalation causes lung fibrosis and this 
is proliferative harm 21. 
 
Investigation of immunomodulatory effects using the LL24 and U937 cell line 
combinations were unable to derive a universal pattern of dysregulation attributable 
to metal-oxide microparticle exposure. Nevertheless, monoculture experiments show 
CuO and SiO2 which are particulates of greater concern leave distinct and differential 
signatures, eliciting some of the strongest cytokine inductions. By the same token, 
the MAC and Yandi samples also left competitive signatures. It is possible that minor 
changes in experimental procedure can cause marked differences in cytokine 
expression in situations where the cytotoxicity profiles remain similar. The down-
regulation of cytokines in the presence of macrophage cells also suggest that self-
limiting regulatory systems may have been activated in the fibroblast-macrophage 
combination. There are many variables that can affect the cytokine representation of 
particle induced dysregulation. Of greatest concern are the method of U937 cell 
differentiation, presence of extracellular matrixes, exposure duration and 
measurement time, and which cytokines are observed 163. Compounding these 
uncertainties, as cytokine signalling is a highly acute and transient phenomenon, 
marrying cytokine signalling profiles in long exposure experiments to mechanistic 
effects is a necessarily difficult task. In monoculture and coculture scenarios in which 
dysregulation is occurring it is therefore most important to look for patterns of 
abnormality to flag particle compositions of concern, then corroborate particle 
characteristics and other bioassay results in determining the toxicity driver until these 
issues can be resolved. 
 
Macrophage activity is a key driver of pathological responses to particulates that 
occurs vigorously, independent of the poor cytotoxicity characteristics of insoluble 
metal oxide particles. The observation of macrophage behaviour under electron 
microscopy shows that the U937 monocyte differentiated macrophages are indeed 
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highly active against micron-size insoluble particulate matter, and will both engorge 
particulates until cell death occurs and recruit more macrophages while doing so, 
without the need for mediation by an intermediate cell type. This behaviour is 
associated with a slowing of particle clearance in-vivo 304.The overall nature of this 
activity and recruitment appeared similar amongst the different metal-oxide samples. 
Such particles accrued in agglomerations of similar size that were both internalised 
and spatially clustered to a high degree. The carbon black nanoparticles produced a 
minor differential effect, packing more diffusely into the macrophage cells. Once 
particles had been accumulated by groups of macrophages, recruitment activity 
continued resulting in large numbers of surrounding cells. If this process is 
extrapolated to an in-vivo setting, it could be expected that pulmonary alveolar 
macrophages are likely to cause prolonged inflammatory activity against particulate 
matter if concentrations are high enough or aggregations large enough to prevent 
rapid clearance to the lymphatic system – a model which is supported in in-vivo 
literature findings 186,251.  
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6. Comparative Toxicity of Acute Inhalation of Respirable Iron-
Rich Particles from Mining Industry In-Vivo 
6.1 Introduction 
Validation of in-vitro data through an in-vivo experiment was sought to guide 
interpretation of the data and the most valuable endpoints to follow. Using mice and 
for intratracheal installation of iron oxides to measure lung fibrosis is an established 
technique from which biochemical and histological results from which fibrotic 
potential can be determined 305. Although developing dose-response relationships in 
an animal model requires hundreds of animals, as only a comparative assessment of 
fibrotic potential is required as few as 56 animals were necessary in these 
experiments. 
 
Selected samples of particulate matter (CB < 150 nm, Fe3O4, CuO < 5 µm, MAC, 
Yandi, Newman and SiO2 PM10) and bleomycin were instilled in a single acute dose 
in 56 female C57BL/6J mice intratracheally. The mice were then observed for a 28 
day period. The length of exposure was chosen to allow the development of fibrotic 
responses after instillation for observation 28. Instillation was delivered by a DP-4M 
Dry Powder Insufflator™ (PennCentury, USA) to two groups; 10 mg/kg and 50 
mg/kg. This method was chosen as it did not require a liquid bolus for aerosolization, 
and therefore has a more symmetrical dispersion profile to the right and left lungs, 
allows administration of larger doses and reduces the risk of asphyxiation. Lung 
tissue was harvested and split into three parts for histology (fixed in formalin), 
homogenisation and biochemistry (cryogenically stored in liquid nitrogen), and lastly 
electron microscopy (fixed in glutaraldehyde). Heart, kidney and liver tissues were 
also stored in formalin. At least 300 µL of blood was taken and stored cryogenically. 
Histological staining was performed on the mouse lungs using Masson’s Trichrome 
for detecting collagen deposition as a marker of fibrosis. Due to time constraints and 
the sufficiency of histological data for comparative purposes, further experimental 
work was not integrated. However, lung biochemistry and blood work are available to 
future investigations. Specifically, these are the corroboration of histological lung 
fibrosis with lung homogenate collagen content through the hydroxyproline assay, 
analysis of systemic inflammation from blood using the Mouse Inflammation Kit 
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cytometric bead assay (BD, USA) and electron microscopy of particle-lung 
interaction in-situ. 
 
6.2 Materials and Methods 
6.2.1 Particulates and Reagents 
Particle standards: Carbon Black < 150 nm, Fe3O4 < 5 µm, CuO < 5 µm, MAC PM10 , 
Yandi PM10, Newman PM10, SiO2 PM10. Positive control: bleomycin. Particulate 
vehicle: fine cornflour. Belomycin vehicle: PBS. Anaesthetic: ketamine. Electron 
microscopy fixative: glutaraldehyde. Biochemistry reagents: Hydroxyproline 
(#MAK008-1KT, Sigma Aldrich), Mouse Inflammation Kit (552364, Sigma Aldrich). 
 
6.2.2 Animal Selection and Handling 
The use of animals in this experiment was approved by the Queensland Health 
Animal Ethics Committee. Female 6 week old C57BL/6J mice were purchased from 
Cerberus Sciences, Australia. The mice were acclimatised for 1 week before 
separation into cages of 6 by groupings. 
 
6.2.3 Animal Dosing 
Animals were restrained on a Mouse Intubation Platform (Penn-Century, USA) and 
anesthetised with intraperitoneal injection of ketamine before intratracheal instillation 
of sample. Dosage was calculated to meet specification (10 mg/kg or 50 mg/kg) 
using cornflour as a bulking agent, according to their initial weight (see Table 13). 
The Dry Powder Insufflator™ (Penn-Century, USA) was loaded with 3.5 mg of 
vehicle and sample mixture and connected to the hand driven air pump. The vehicle 
mixture dosage were calculated in recognition of an estimated efficiency of 0.8 mg of 
solid material dosed per 200 µL air volume puff of the device. A small animal 
laryngoscope (Penn-Century, USA) was used to open the mouth for dosing. Only 
one puff was used per mouse before reloading. 
 
After dosing, the animals were left to recover, with special observation made three 
times per day for 3 days to ensure no adverse effects were occurring. Thereafter, the 
animals were maintained as per usual for 28 days before sacrifice. 
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Table 13: Animal designation, dosage and weights 
Material Dosage Designation Initial Weight End Weight 
Carbon Black 10 mg/kg CB-1B 18.32 21.1 
Carbon Black 10 mg/kg CB-2B 17.66 19.89 
Carbon Black 10 mg/kg CB-3B 19.92 22.12 
Carbon Black 50 mg/kg CB-1R 18.48 22.02 
Carbon Black 50 mg/kg CB-2R 18.75 21.67 
Carbon Black 50 mg/kg CB-3R 17.58 22.76 
Iron(II,III) 
Oxide 
10 mg/kg Fe-1B 18.46 20.63 
Iron(II,III) 
Oxide 
10 mg/kg Fe-2B 19.02 20.35 
Iron(II,III) 
Oxide 
10 mg/kg Fe-3B 17.27 21.16 
Iron(II,III) 
Oxide 
50 mg/kg Fe-1R 18.28 21.71 
Iron(II,III) 
Oxide 
50 mg/kg Fe-2R 19.68 21.63 
Iron(II,III) 
Oxide 
50 mg/kg Fe-3R 19.92 22.28 
Newman 10 mg/kg NM-1B 18.15 21.62 
Newman 10 mg/kg NM-2B 18.11 20.28 
Newman 10 mg/kg NM-3B 17.16 21.06 
Newman 50 mg/kg NM-1R 18.54 21.88 
Newman 50 mg/kg NM-2R 17.71 18.68 
Newman 50 mg/kg NM-3R 18.61 21.51 
MAC 10 mg/kg MC-1B 18.94 21.3 
MAC 10 mg/kg MC-2B 19.13 21.09 
MAC 10 mg/kg MC-3B 17.68 20.21 
MAC 50 mg/kg MC-1R 20.56 23.46 
MAC 50 mg/kg MC-2R 18.86 20.73 
MAC 50 mg/kg MC-3R 19.52 22.3 
Yandi 10 mg/kg YN-1B 18.95 20.35 
Yandi 10 mg/kg YN-2B 17.07 20.46 
Yandi 10 mg/kg YN-3B 19.03 20.86 
Yandi 50 mg/kg YN-1R 19.15 23.53 
Yandi 50 mg/kg YN-2R 17.88 20.1 
Yandi 50 mg/kg YN-3R 18.82 21.46 
Silicon Dioxide 10 mg/kg Si-1B 18.33 21.52 
Silicon Dioxide 10 mg/kg Si-2B 18.58 20.84 
Silicon Dioxide 10 mg/kg Si-3B 18.82 20.22 
Silicon Dioxide 50 mg/kg Si-1R 19.85 23.46 
Silicon Dioxide 50 mg/kg Si-2R 19.86 22.88 
Silicon Dioxide 50 mg/kg Si-3R 17.26 21.62 
Copper Oxide 10 mg/kg Cu-1B 18.4 21.36 
Copper Oxide 10 mg/kg Cu-2B 18.35 19.67 
Copper Oxide 10 mg/kg Cu-3B 19.09 20.6 
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Copper Oxide 50 mg/kg Cu-1R 17.69 20.67 
Copper Oxide 50 mg/kg Cu-2R 17.71 20.65 
Copper Oxide 50 mg/kg Cu-3R 17.76 21.3 
Bleomycin 5 mg/kg BL-1B 18.83 20.56 
Bleomycin 5 mg/kg BL-2B 18.84 21.19 
Bleomycin 5 mg/kg BL-3B 19.54 22.48 
Bleomycin 10 mg/kg BL-1R 19.68 21.05 
Bleomycin 10 mg/kg BL-2R 19.04 20.43 
Bleomycin 10 mg/kg BL-3R 17.2 19.69 
Vehicle 
Control 
10 mg/kg VC-1B 18.92 20.52 
Vehicle 
Control 
10 mg/kg VC-2B 20.53 21.6 
Vehicle 
Control 
10 mg/kg VC-3B 18.83 20.23 
Blank Control 0 mg/kg NO-1R 18.02 23.26 
Blank Control 0 mg/kg NO-2R 18.91 22.18 
Blank Control 0 mg/kg NO-3R 17.75 21.36 
 
 
6.2.4 Animal Sacrifice 
Animals were sacrificed using O2:CO2 overdose at a 50:50 ratio to first anesthetise 
the animal, before 100% CO2 was applied after 5 minutes to ensure death had 
occurred. 
 
6.2.5 Histological Methods 
Lung histology was carried out on right lobe lung tissue fixed in formalin and 
paraffinized using the Masson’s Trichrome stain. Approximately 275 slides were 
prepared (5 slides per lung) with 4 sections each, allowing the statistical power of 
analysis to be increased if necessary. Slides were recorded digitally on an Aperio 
slide scanner. Aperio ImageScope v11 was used to calculate the positive pixel count 
values. The settings used were: Positive Pixel Count v9 Algorithm, Hue 0.936 (red, 
not used), Hue 0.536 (blue/green), Hue Width 0.5, Color Saturation Threshold 0.04. 
 
6.3 Results 
6.3.1 Lung Histology 
The lung histological sections obtained show that the vehicle control (cornflower) did 
not appear to cause any fibrotic changes above the no exposure control (see Figure 
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70). However as the lungs were not filled with agarose prior to fixing to preserve lung 
biochemistry and net weight, morphological changes are difficult to gauge as some 
collapse of structure is apparent. This may also be affected by the sacrifice method, 
causing interference with breathing and lung function. The appearance of the Fe3O4 
sample is similar to the vehicle control, while significant increases in collagen 
deposition from the CuO exposure are visible, affecting the bronchioles and alveoli. 
  
 
Figure 70: 28 day exposure, control, Vehicle Control, Fe3O4, CuO. C57/BL6 lung histology, Masson’s Trichrome 200x. 
 
Increases in collagen deposition in the lungs using Masson’s Trichrome has been 
described in the literature previously, showing increases in collagen deposition by 
SiO2 at 10 mg/kg and 50 mg/kg and TiO2 only at 50 mg/kg after 28 days 28. This 
corroborates well with observations in this study, as collagen staining is visibly higher 
in the SiO2 samples. A pervasive increase in collagen deposition is observed both in 
the bronchiole walls and in the alveolar spaces. The appearance of collagen in the 
iron-ore samples is less, similar to the control and Fe3O4 standard (see Figure 71).  
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Figure 71: 28 day exposure, MAC, Newman, Yandi, SiO2. C57/BL6 lung histology, Masson’s Trichrome 200x. 
 
The pulmonary and systemic inflammatory properties of carbon black 306 are well 
studied, as are the fibrotic effects of bleomcyin from both in-vivo and clinical studies 
due to its use as a cytotoxic antineoplastic drug 246. The effects of these particles are 
demonstrated clearly in the observed increase of collagen deposition (see Figure 
72). 
 
 
Figure 72: 28 day exposure, Carbon Black, Bleomycin. C57/BL6 lung histology, Masson’s Trichrome 200x. 
 
A computational analysis of the higher effect dosage of sample on mouse lung 
staining is shown in Figure 73. Areas not containing bronchial structures were 
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chosen for analysis, with 3 different sections per sample used and the mean of the 3 
replicates taken. While the short time period produced a very mild fibrotic effect, 
improvements to the hue values selected in the colour matching algorithm may be 
able to strengthen the results. The results confirm what is visible by eye, and despite 
low cytotoxicity in-vitro, SiO2 and carbon black were the most fibrotic compounds 
assayed as implied by collagen deposition, matching or surpassing bleomycin as the 
positive control. However, CuO was also confirmed as highly fibrotic, while the 
pattern between the Fe3O4 standard and iron-ore samples closely resembled in-vitro 
results. 
 
 
Figure 73: Analysis of Masson’s Trichrome stained mouse lung histological sections. Positive to negative pixel count 
ratios for blue/green staining indicative of collagen deposition shown. 
 
The level of effect was on the order of several percent in this analysis, and continued 
development will be required to allow the algorithm to differentiate the effects more 
clearly. Nevertheless, the histological samples provide comparative relationships 
between samples, and do indeed highlight the particulate standards suspected or 
known to be causes of pulmonary fibrosis. Additional unique parameters, including 
interleukin expression profiles, redox activity, proliferative effects and solubility. 
Integration with biochemistry techniques will further enhance these findings in the 
future. 
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6.4 Discussion 
 
Crystalline silica PM10 is frequently used in conjunction with mouse models in 
determining the nature and histological profile of lung fibrosis, often with a trichrome 
stain, in exposure durations as short as three weeks 307. Interest in such experiments 
is typically driven by investigations of silicosis pathology which is a hazardous 
component of many of mine dusts 95. It is therefore expected that in iron oxide 
inhalation experiments in-vivo of a similar concentration and size fraction will involve 
some or all of the mechanisms involved in silicosis, and possibly novel ones. As 
there are established occupational limits for silicon dioxide inhalation by regulatory 
agencies around the world 100, it is therefore useful to compare iron-ore mine site 
samples predominantly to crystalline silica dioxide by suitable endpoints such as 
lung fibrosis pathology. 
 
In a review of in-vivo and in-vitro research on crystalline silica and coal dust, which 
under occupational exposure settings cause the clinically distinct presentations of 
silicosis and anthracosis, Castranova et. al. propose four basic toxicity mechanisms; 
direct cytotoxicity, activation of immunological ROS production, activation of 
immunological recruitment mediators, and activation of fibrotic mediators 95. All four 
mechanisms directly or indirectly mediate the process of fibrosis, through 
inflammatory and proliferative processes. Fibrosis is therefore a key marker of 
particulate driven lung toxicity that captures a broad range of the proposed toxic 
mechanisms, and the lung pathology that it is associated with. However, it must be 
noted that other systemic complications are possible and restrictive lung disease is 
irreversible, increasing mortality from infections and other diseases. Cardiovascular 
disease resulting from chronic hypoxia is also a common cause of death in patients 
with lung fibrosis 95. With exception to some particulate types, fibrosis of the lung is 
generally only mildly associated with cancer outcomes when considering poorly 
soluble particles and silica, when concomitant inhalation of known carcinogens is 
accounted for 118. In coal workers, gastric cancer is increased, the risk of lung cancer 
is not, potentially reflecting bioactivation or bioavailability in the stomach that does 
not occur in the lungs 95.  
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An epidemiological study of urban ambient particle composition highlights the 
transition metals Ni and V as most strongly associated with mortality (risk coefficient 
> 0.5), followed by elemental carbon, Zn, SO4, Cu, PB, organic carbon and total 
PM2.5 259. As these transition metals are largely associated with fuel oil combustion 
they may not necessarily represent the risk pure metal oxides pose, although it is 
clear attributes beyond particle shape and size account for toxic effects. Solubility, 
crystallinity, ROS catalysis and associations with VOC and PAH are key modulators 
308. This is not to say insoluble metal oxides are otherwise invariant in toxicity; it has 
been shown that the cytotoxicity of CuO particles is an order of magnitude higher 
than corresponding doses of TiO2 and Fe3O4 in-vitro 215.  
 
Insoluble metal oxides also exhibit greater biopersistence, although this is not 
strongly indicative of adverse effects. In a study of TiO2 and crystalline SiO2 nano 
and submicron-size particles on rats after a 12 week ambient exposure period, it was 
found that SiO2 submicron-size particles caused post-exposure radiolabelled test 
particle clearance rates to slow by 28 fold. In comparison, the TiO2 exposures 
accumulated a 15 fold higher mass in the lungs over the exposure period and TiO2 
nanoparticles caused a slowing of 8 fold, while TiO2 submicron particles caused a 
relatively mild 2 fold slowing 33. It is likely that given the highly extended nature of 
SiO2 mediated impairment, the reduced clearance rates are related to fibrotic 
changes to the lungs which are not limited to temporary immunological depletion. It 
is also important to note that high particle loads reaching the lung parenchyma 
appear to have relatively little effect on lung function unless such particles are highly 
inflammatory or toxic, either by nature of size or biochemical reactivity. These loads 
must also be consistently applied to reach a critical mass if clearance is to fail, after 
which the combination of impaired macrophage mediated transport and continued 
cytokine signalling can cause acceleration of fibrosis, clinically seen as progressive 
massive fibrosis which can complicate silicosis, anthracosis and other 
pneumoconiosis diseases 205.  
 
The subdued differences in collagen deposition between the particulate types 
observed in Figure 73 may partially be a reflection of the single-dose short duration 
experiment. Over a longer term 90 day experiment in the literature, rats lung weight 
resisted change compared to controls when challenged with welding fume 
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concentrations of 67 mg/m3 for 2 hours per day, whereas 118 mg/m3 caused 
progressive accumulation and fibrosis. Furthermore, fibrotic changes were limited to 
perivascular and peribronchiolar regions by day 30, and interstitial fibrosis had only 
begun to develop by day 60 242. A shorter term 28 day experiment failed to show 
TiO2 as fibrogenic at concentrations less than 50 mg/kg 28, suggesting the 10 mg/kg 
maximum dose of Fe2O3 and iron ore samples may not be enough to elicit a strong 
response. However, comparable studies of bleomycin show increases of over two 
fold in collagen deposition which was not reflected in the positive pixel count 245. The 
exclusion of bronchiolar structures in the count, as well as the effects of outliers 
where instillation has failed may also reduce the observed differences due to the 
small number of animals used. Nevertheless, the visible changes in staining between 
exposures (see Figure 70-Figure 72) do serve to draw attention to the increased 
collagen deposition of belomycin, carbon black, SiO2 and CuO – all compounds with 
known proliferative, fibrotic and cytotoxic potency in the literature. In contrast, Fe2O3 
remains similar in appearance to the control, as do the iron-ore samples, strongly 
supporting to the in-vitro findings mirroring this toxicity profile.  
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7. General Discussion 
 
It is increasingly becoming clear that metal oxide particles pose an imminent health 
threat to not only settlements associated with mining activity, but major centres 
especially in developing nations where airborne industrial pollutants are rich in metal 
oxides whose inhalation toxicity is poorly understood 49. Regulators are left with 
inadequate toxicity information specifically relating to such pollutants, and potentially 
inadequate guidelines and metrics to deal with these issues. Disharmony in the 
measurement of toxicity doubly affects air quality regulation by eroding the 
confidence in its enforcement 97. 
 
Great strides have been made in the development of in-vitro particulate matter 
toxicology assays in an effort to produce reliable toxicity data, however mechanistic 
uncertainties and conflicting in-vivo data have led to a poor translation of 
experimental data to regulatory air quality guidelines. Fundamentally, in-vitro 
experiments can highlight differential cytotoxicity between insoluble metal-oxides 283, 
and with further development complete the mechanistic picture and monitoring 
applications which epidemiological studies and in-vivo studies alone cannot. 
 
A multifaceted approach to both the application and interpretation of in-vitro 
toxicological data is therefore required to reach accurate conclusions for the toxicity 
of PM10 and PM2.5 in the lungs. It is not sufficient to equate cytotoxicity in-vitro to 
fibrotic potency in-vivo, or vice versa. The complex interactions between particles, 
immune system and the lung parenchyma present a system that requires not only a 
unique approach to modelling disease outcomes but also a strategy form 
management of complexity itself, observant of the weight of evidence from all 
sources. 
 
Specifically, emphasis must be given to comparing responses of lung epithelial and 
fibroblast cells with phagocytic cells and in coculture, as immunological activity 
occurs against particulate matter regardless of its toxicity and it is this activity which 
is key in the initiation of fibrosis and the systemic effects that increase the likelihood 
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of cardiovascular events which shape morbidity and mortality in the population 
comparably to pulmonary disease 265.  
 
While unconventional, the interpretation of reverse-toxicity signalling a proliferative 
immune responses correctly associates SiO2 and CB with increased inflammatory 
and cytotoxic potential, in relation to the in-vivo study. It is notable that SiO2 and CB 
inhalation is also billed as potent fibrotic agents in the literature, and that titanium 
dioxide also exhibits unique inflammatory characteristics 212. Similar effects in 
cocultures help examine and define the proliferative potential of particulates and 
simultaneously establish important relationships between macrophage and lung cell 
mediated pro-fibrotic changes which would otherwise require in-vivo experiments to 
detect.  
 
Hyperplasia in fibrotic lung disease is associated with cytokine signalling changes 
243, necessitating the analysis of inflammatory cytokines, which provides data 
essential to interpretation of particle toxicity. However, such analyses carry several 
caveats. Interleukin expression may be time-dependent, and has self-regulating 
properties in coculture. The intricacy of suppressive and stimulatory interactions 
between different cytokines, as well as differences in acute and prolonged 
expression characteristics requires further study to develop the most informative and 
reliable assay protocols. Mitigating these effects requires careful correction for 
cytotoxicity, an advantage of the multiplexed assays used, and gathering a large 
volume of data. The flow cytometric bead array process used lends itself to high data 
throughput and minimizes intra-sample error, as thousands of counts are compiled to 
report concentration.  
 
In the absence of all other considerations of particulate characteristics, a weight of 
evidence based approach to determining a Derived No-Effect Levels (DNEL) of 
exposure for insoluble particulates hinges on particle displacement volume retained 
in the lungs 34.  Overload of the alveolar macrophage pool by a sufficient volume 
(approximately 1 μL/g of lung tissue) of particle reduces clearance time, which is on 
the order of 500 days for particles reaching the acinar surfaces 25,274. Reduced 
clearance and increased inflammation aggravates fibrotic processes, with the 
implication is that increased toxicity reduces the concentration for overload-like 
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symptoms to occur 18,22. For residents of mining towns, this raises concerns on the 
cumulative effect of any chronic exposure to PM10 and PM2.5, and places importance 
on toxicities that may amplify over time 309.  
 
To achieve a better understanding of the toxicity of metal-oxide PM10 and PM2.5, 
large amounts of data must be gathered. The analyses within this thesis are pointed 
towards integration and reduction of bottlenecks in analysis, suitable to this 
objective. Figure 74 summarises the most productive endpoints found in the project 
and how they are linked to one another, as a platform for future studies to assess 
environmental samples in the future. 
 
 
Figure 74: Linking of key steps and endpoints in the high-throughput assay of poorly-soluble PM10 and PM2.5  
  
The current data resulting from this process suggests very similar effects from the 
MAC, Yandi and Newman PM10 samples to general haematite and magnetite PM10 
inhalation. The cytotoxic, oxidative, immunological and physical endpoints employed 
validate this comparison. While this is unsurprising given the nature of the ore, it is 
important in that it is possible to compare iron ore dusts from multiple regions across 
the world, and perform epidemiological studies with greater understanding of any 
site-specific exposure differences. A less conservative approach would be to model 
toxicity directly as a fraction against the standards tested, creating a composite 
picture of toxicity using existing epidemiological data of standards such as CuO, 
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crystalline SiO2, CB and micron-size glass fibre to frame cytotoxic, pro-fibrotic, pro-
inflammatory and carcinogenic endpoints. In relation to these standards, patterns 
such as high solubility combined with high cytotoxicity, or moderate cytotoxicity 
combined with proliferative potential in co-culture and strong induction of 
inflammatory, or high aspect ratio and insolubility, are warning signs to look for in this 
regard. 
 
High throughput in-vitro analysis is extremely useful to minimise risk through 
detection of dangerous particulate emission sources early. What such a strategy 
depends on is good epidemiological data on the translation of very specific material 
exposures at a subacute, chronic dose, over very long periods of time. Thus, a 
careful marriage of epidemiological data sets informed by toxicological data will over 
time produce more direct translations of ambient exposure concentrations and 
durations to fibrotic and systemic health outcomes. 
  
8. Future Work 
Further work with in-vivo samples is necessary to build a thorough picture of how 
comparative data in-vivo links to in-vitro data. Specifically, lung biochemistry can be 
performed as another measure of inflammatory response and collagen deposition, 
while electron microscopy may confirm parenchymal and macrophage particle-
interactions in-vivo.  
 
In the future, more detailed identification of inflammatory responses between 
cocultures of different cell types needs to be conducted, in addition to optimisation. 
Experiments with asynchronous coculture, where media supernatant is transferred 
from one cell line to another after an exposure time interval, may help to clarify the 
responses and timings of interleukin expression between cell types. 
 
Whether the fibrotic potential of high aspect ratio particles such as asbestos and 
glass fibres can be detected in-vitro is important. Warning of the toxicity of such 
compounds is currently implied through TEM observation, although a biochemical 
endpoint would be preferable. 
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